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Cell number plasticity drives organismal growth, and is coupled in the central nervous 
system (CNS) to the emergence of neural circuits, ensuring appropriate function. In 
mammals, neurotrophins (NT) promote cell survival via Trk and p75
NTR
 receptors or 
induce cell death via p75
NTR
 and Sortilin. In Drosophila the DNTs bind Toll receptors 
to promote cell survival, but whether they can regulate cell death within the CNS 
remains unknown.  
 In this thesis, I show that Toll receptors have distinct and overlapping spatial 
and temporal expression and functions. Driving RNAi knockdown and over-
expression of each Toll, I show that Toll-5 and -7 are required in glia for adult 
locomotion; Toll-3 is required in neurons for the regulation of ventral nerve cord size; 
and different Tolls can induce either cell survival or death in distinct contexts. By 
counting Dcp1+ dying cells and Eve+ neurons with DeadEasy imaging software, I 
show Toll-1 and -3 are pro-apoptotic in the VNC. However, Toll-2 and -9 are pro-
apoptotic in the retina. I focused on the signalling mechanisms downstream of Toll-6. 
My data contribute to showing that DNT-Toll-6 signalling switches between 
promoting cell survival or death via NFkB, ERK, or JNK signalling. These outcomes 
depend on the cleavage state of the DNT, time and available downstream adaptors. 
Toll-6 induces cell survival via MyD88 and cell death via dSarm, and these 
alternative outcomes depend on Weckle. 
 Altogether, my data contribute to showing that the Toll receptors, DNTs and 
downstream signalling adaptors constitute a novel mechanism of cell number 
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In order to determine and characterize biological processes occurring within the brain we 
need to understand the link between structure and function. Levi-Montalcini, 1987 first 
described the Neurotrophic theory whereby during development neurons are produced in 
excess and only those that secure synaptic connections survive. Those neurons that fail to 
establish synaptic connections are eliminated through apoptosis. Only in the region of 20% of 
the original population survive, a number, which is not predetermined. During development 
neurons connect with target cells that secrete neurotrophins (NTs), which are the main class 
of molecules that underpin nervous system development and function. They regulate neuronal 
number, circuit formation, synaptic transmission and learning and memory. These events also 
take place in the brains of distant animals including the mollusc and within flies.  
Neurotrophins promote neuronal survival and neuronal death, which they achieve via two 
distinct mechanisms. First, cleaved neurotrophins bind p75NTR receptors in order to activate
NF-κB signalling to promote cell survival and synaptic plasticity. Cleaved neurotrophins can 
also bind Trk receptors to promote cell survival and synaptic plasticity via AKT, ERK, 
CREB, PLC or CaMKII signalling pathways. Secondly, pro-neurotophins bind p75NTR and
Sortilin to activate JNK signalling to promote cell death and axonal degredation. Therefore a 
key aspect of structural plasticity is the ability to regulate both cell survival and death. If a cell 
lives or dies is dependent upon the state of the ligand, the receptor it binds and the 
downstream signalling mechanism. These receptors are the Toll-like receptors (TLRs), named 
due to their similarity to Drosophila Toll identified by Christine Nusslein-Volhard where she 
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is said to have exclaimed “Das ist ja toll!” the english translation of which is ‘this is 
amazing/great’ in response to the severe developmental defects in the Drosophila embryo 
patterning (Hanson and Edfeldt., 2005). TLRs are expressed within neurons where the 
function in the regulation of neurogenesis, apoptosis, neurite growth and collapse. These 
neuronal functions have only been minimally explored, and most strikingly the endogenous 
ligands coupled to these cell outcomes remain unknown.  
For a long time it was thought that the CNS of flies was not plastic. The Hidalgo lab has 
found that Drosophila neurotrophins (DNTs) bind Toll receptors instead of p75NTR and Trk 
receptors in order to regulate neuronal survival, connectivity and behaviour. The aim of this 
thesis is to to investigate the function of the Toll receptors in the CNS. Firstly; to determine if 
they are expressed within the CNS. Secondly; if they function in a similar manner or if there 
are distinct groups between the Tolls in their ability to regulate function. Thirdly to 
investigate the signalling mechanisms downstream of Toll-6 in the regulation of cell death 
and/or survival in the CNS.  
1.1 Vertebrate neurotrophins 
In mammals, four NTs have been identified to date, including nerve growth factor (NGF), 
brain derived neurotrophic factor (BDNF), which shares structural and functional homology 
to NGF, neurotrophin 3 (NT3) and neurotrophin 4 (NT4), all of which are present in most 
vertebrates (levi-Montalacini and Hamburger, 1951; Barde et al., 1982; Leibrock et al., 1989; 
Ernfors et al., 1990; Hohn et al., 1990; Maisonpierre et al., 1990; Rosenthal et al., 1990; 
Hallbook et al., 1991; Berkemeier et al., 1991; Ip et al., 1992). NT4 is not present in avian 
species and bony fish also have the additional NT-6/7, indicating gene loss and duplication 




NTs are synthesized as pre-pro-neurotrophin precursors and processed to give rise to 
proneurotrophins, which are formed of an N-terminal pro-domain and a C-terminal Cys-Knot 
(Bibel and Barde., 2000). NTs can be secreted in their full-length form or as a cleaved NTs. 
Pro-neurotrophins are proteolytically cleaved by members of the pro-convertase family of 
serine proteases, (PC1 and PC2) as well as Furin to produce mature processed proteins (Roux 
and Barker., 2002). NGF can also be cleaved by a kallikrein-family protease (Seidah et al., 
1996, Edwards et al., 1988). Following processing NTs form homodimers, whereby six 
conserved cysteine residues give rise to the cysteine knot form (McDonald and Hendrickson, 
1993; Wiesmann and de Vos, 2001). These homodimers are then secreted through the 
constituitive secretory pathway or the regulated pathway (LessmaNn et al., 2003). 
NTs bind different types of plasma membrane receptors including Receptor Tyrosine Kinases 
including TrkA, TrkB, TrkC, the atypical TNFR superfamily member p75 pan-neurotrophin 
receptor (p75
NTR
), Sortilin and Integrin 91 (Kaplan and Miller., 2000; Dechant and Barde., 
2002; Roux and Barker., 2002; Chao., 2003; Huang and Reichardt., 2003; Staniszewska et al., 
2008) (Figure 1.1). Originally it was believed that the pro-neurotrophins were limited to 
promoting folding of the mature domain (Suter et al., 1991; Rattenholl et al., 2001; Kolbeck 
et al., 1994) or the sorting of mature NTs into either constiuitive or regulated secretory 
pathways (Farhadi et al., 2000). However it is now known that both the pro-neurotrophin and 
mature neurotrophins can have different outcomes dependent upon their binding partners. 
ProNGF and proBDNF can be cleaved in vitro by the extracellular proteases, MMP7 and 
plasmin, which is a protease known to contribute to synaptic plasticity, to form mature NGF 




Mowla et al., 2001; Mowla et al., 1999; Teng et al., 2005). Pro-neurotrophins bind with high 
affinity to p75
NTR
 to promote cell death. Binding of proNGF to p75
NTR
 leads to an increase 
rate of apoptosis, in vascular smooth muscle cell lines that do not express any Trk receptors 
(Lee et al., 2001). This apoptotic phenotype relies on the binding of proNGF to not only 
p75
NTR
 but also to a co-receptor, the type 1 transmembrane receptor sortilin Vps10p (Nykjaer 
et al., 2004). The ability of proNGF to promote cell death has been verified in numerous 
different cell types including, oligodendrocytes (Beattie et al., 2002), corticospinal neurons 
(Harrington et al., 2004) and photoreceptors (Srinivasan et al., 2004). 
In cultured sympathetic neurons binding of proBDNF to p75
NTR
 also results in an increased 
rate of apoptosis. Furthermore by blocking the interaction of proBDNF and sortilin with 
neurotensin results in reduced apoptosis indicating that sortilin is a critical co-receptor for 
proBDNF, like proNGF  (Teng et al., 2005). A single nucleotide polymorphism, which 
replaces valine
66
 with a methionine in the pro region of BDNF, leads to memory associated 
problems as well as abnormal hippocampal function. This Val/Met alteration leads to 
deleterious trafficking of BDNF to synapses, which results in a decline of overall BDNF 
release. (Chen et al., 2004; Egan et al., 2003). 
Mature NTs can bind both p75
NTR
 and Trk receptors.  The NTs having specific affinity for 
different Trk receptors. NGF binds preferentially to TrkA, BDNF and NT4 to TrkB and NT3 
to TrkC (although NT3 can also bind TrkA and TrkB at lower affinities) (Barbacid., 1994). 
The binding of mature NTs to Trk receptors results in the dimerisation and 
autophosphorylation of tyrosine residues and subsequently leads to the activation of numerous 
signalling cascades. These pathways then go onto modulate differential gene expression in 
cell specific manners. 
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Promotion of cell survival can be mediated via the phosphatidylinositol 3-Kinase (PI3K) – 
Akt pathway whereby Akt phosphorylates a multitude of substrates including Forkhead 
(Brunet et al., 1999), B-cell leukaemia/lymphoma 2-associated (BLC-2) death protein (BAD) 
(del Peso et al., 1997; Datta et al., 1997), Caspase 9 (Cardone et al., 1998; Rohn et al., 1998) 
and the I�B kinase (Kane et al., 1999) in a Ras-independent manner. Furthermore, Ras can 
interact directly with PI3-K, where Ras inhibition suppresses NGF activity (Kleese and 
Parada. 1998).  
 Cell surivival can also be mediated via the mitogen-activated protein kinase (MAPK)-MEK 
(MAPK/ERK (extracellular signal-regulated kinase) kinase signalling pathway. This cascade 
induces activity and/or expression of both BLC-2 (Aloyz et al., 1998) and cyclic AMP 
responsive element binding protein (CREB) (Riccio et al., 1999) both of which are anti-
apoptotic proteins. The Trk receptors are also capable of phosphorylating PLC to create an 
active enzyme which has the ability of converting phosphatidyl inositides to inositol 
triphospate (IP3) which in turn increases cytoplasmic Ca
2+
 and diacylglycerol (DAG) which 
activates protein kinase C, a kinase which is involved in the ERK pathway (Vetter et al., 
1991; Corbit et al., 1999). 
Mature NTs also bind p75
NTR
 in the absence of Trk receptors to mediate cell survival via NF-
KB. In cultured cortical neurons expressing p75
NTR
 but not TrkA, mature NGF is able to 
inhibit cell death caused by glutamate-induced cytotoxicity (Shimohama et al., 1993; Klume 
et al., 2000). Binding of NGF to p75
NT 
also promotes cell survival in different cell lines and 
tissues including neocortical neurons (De Freitas et al., 2001), sensory neurons (Hamanoue et 
al., 1999) and human breast cancer cell lines (Descamps et al., 2001). In contrast mature NTs 
can also bind to p75
NTR
 in order to induce cell death via c-Jun amino-terminal kinase (JNK) 
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cascades, whereby dominant-negative JNK and inhibitors of JNK signalling are able to inhibit 
p75
NTR
 induced death in hippocampal neurons and oligodendrocytes (Friedman, 2000; 
Harrington et al., 2002). 
Overall cell survival or cell death outcomes are dependent upon both the cellular context of 
the NT receptors as well as secretion of either a proNT or a mature NT. Generally mature NTs 
preferentially bind Trk receptors to mediate cell survival  and pro-NTs bind p75
NTR
 to mediate 
cell death, however this is not exclusive as mature NTs are also able to bind p75
NTR
 regulating 
both survival and death. 
1.2 Vertebrate TLRs 
Vertebrate TLRs provide pathogen-detecting systems for both innate and adaptive immunity 
(Takeda et al. 2003). The functions of TLRs have primarily been investigated for their roles 
in immunity. However the CNS is not completely removed from pathogenic insult, TLRs are 
required during the regulation of neural innate immunity responses (Rivest, 2009), and found 
to be widespread in microglia (Jack et al., 2005).  
TLRs therefore can function in both immunity and developmental capacities within the CNS. 
TLRs are activated during CNS injury and disease (Hanisch et al. 2008; Salminen et al. 2009; 
Okun et al. 2009; Downes & Crack 2010), cell number regulation (Teng et al., 2005; 
Bandtlow and Dechant., 2004), neurite growth (Gentry et al., 2004; Bandtlow and Dechant., 
2004; Barker., 2004) and learning and memory (Peterson et al., 1999; Wright et al., 2004).  
Microglia are widespread immune cells throughout the mammalian CNS, and through a 
variety of PRRs, including TLRs, can identify numerous pathogens (Lehnardt. 2009). All 
known TLRs are expressed within microglia (Kielian et al., 2002; laflamme et al., 2003; 
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Zekki et al., 2002; Olson and Miller.2004; Rasley et al., 2002; Kielian et al., 2005; Bsibsi et 
al., 2002; Laflamme et al., 2001). 
TLRs are type-1 integral membrane receptors that each contain a N-terminal recognition 
ectodomain, an extracellular LRR motif as well as a C-terminal signalling domain (Bell et al. 
2003). Sequence homologies of the TLRs group them into 6 subfamilies (Matsushima et al. 
2007). Not all vertebrates contain members of each subfamily. For example, human TLRs 
(hTLR) consist of 10 members, which fall into sub-families 1 to 5. Each subfamily contains a 
varying number of LRR motifs as well as variable extent of glycosylation of the N-terminus 
(Botos et al. 2011).  
Group 1 constists of hTLR-1, hTLR-2, hTLR-6 and hTLR-10. They are found on plasma 
membranes and respond to PAMPs that contain lipids such as lipoteichoic acid. Signalling 
occurs via the formation of complexes with hTLR-1 and hTLR-6 (Takeda et al. 2003). The 
extracellular domains contain 19 LRR motifs and there are between 3 and 8 N-linked 
glycosylation sites (hToll-1: 4(7), hToll-2: 3(4), hToll-6: 8(9) and hToll-10: (8))(Botos et al. 
2011). Using semi-quantative RT-PCR and flow cytometry techniques Kielian et al., 2002 
demonstrated that the expression of TLR-1, -2 and -6 increased in N9 microglia following 
S.aureus and PGN exposure.  
Group 2 consists of hToll-3, which is found localized to endosomes and is activated via the 
detection of dsRNA produced by most viruses (Leonard et al. 2008). It contains 23 
extracellular LRRs and at least 11 (predicted to be 15) N-linked glycosylation sites. Okun et 
al. 2010, demonstrated that TLR-3 could negatively regulate the proliferation of neural 
progenitor cells, affecting memory formation and behavior. Town et al, demonstrated that 
mice deficient of TLR-3 show reduced microglial activation following a challenge with west 
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nile virus. This retrovirus produces dsRNA, the authors then determined that primary murine 
microglia identify dsRNA via TLR3 (Town et al., 2006).   
Group 3 consists of hTLR-4, which has been extensively investigated due to its response to 
lipopolysaccharide (LPS), a component of the outer membranes of Gram
-
 bacteria. It requires 
the co-receptors MD-1 and CD-14 to signal most effectively (Beutler & Rietschel 2003). 
hTLR-4 contains 21 extracellular LRRs as well as 5-10 N-linked glycosylation sites (Botos et 
al. 2011). TLR-4 has been shown to regulate cell death. Tang et al, documented that TLR-4 
promotes cell death via a JNK dependent signalling cascade (Tang et al., 2007). Schecter et 
al, provided evidence that TLR-4 in retinal progenitor cells prevents proliferation (Schecter et 
al., 2008).  
Group 4 contains hTLR-5, which responds to bacterial flagellin (Hayashi et al. 2001). This 
receptor is primarily found within the gut in lamina propria dendritic cells (Uematsu & Akira 
2009). hTLR-5 contains 20 LRRs and a predicted 7 N-linked glycosylation sites (Botos et al. 
2011). 
Group 5 contains hTLR-7, hTLR-8 and h-TLR-9, which are localized to endosomes and 
recognize nucleic acids PAMPs (Bell et al. 2003). They have 25 extracellular LRRs and are 
heavily glycosylated with predicted N-linked glycosylation sites of 14 (hTLR-7) and 18 
(hTLR-8 and hTLR-9). He et al, has demonstrated that TLR-9 is induced in microglia by 
morphine, and TLR9 deficiency results in the inhibition of apoptosis. They infer these results 
could point to the capability of TLR-9 inhibition leading to the prevention of brain damage 
following opioid use (He et al., 2011).  
Signalling occurs whereby (except hTLR-4) two extracellular domains are bound by a single 
ligand. In the case of hTLR-4, two MD-2 molecules bind a single receptor. In response, the 
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cytoplasmic TIR domain dimerises and activates downstream targets including MyD88, 
MAL, TRIF and TRAM leading to further downstream signalling events (Palson-McDermott 
& O’Neill 2007). Once activated the intracellular processes are homologous to those already 
described for Drosophila Tolls and culminate in the expression of inflammatory cytokines 
(Gay & Gangloff 2007, Medzhitov et al. 1997). In some circumstances such as necrotic 
processes endogenous ligands such as hyaluronan also have the capability of activating TLRs 
without the requirement of PAMPs (Sloane et al. 2010).  
Some of the 10 hTLRs have been detected within neurons, and evidence shows that they play 
a role in neuronal development utilizing non-canonical signalling pathways for spatially and 
temporally distinct neuronal cell types (Zhou et al. 2009 and Okun et al. 2011). For instance 
in dendrites TLR4 activation signals via MyD88 dependent pathway to activate NFB and 
produce cytokines or TRIF, which produces STAT-1/2. In comparison, astrocytic TLR4 
activate the MyD88 dependent pathway but not a TRIF-dependent pathway (Jung et al., 
2005). The downstream signalling mechanisms have yet to be completely identified (Rolls et 
al., 2007). 
Neuronal functions of the TLRs are increasingly being investigated. TLR-8 is expressed along 
axonal tracts initially, becoming more widespread throughout neuronal soma indicating 
changing functions during development. TLR-8 activation (via R-848) results in a reduction 
of length of primary neurites and independently, neuronal death. TLR-8 inhibition can rescue 
these phenotypes (Ma et al., 2006; Ma et al., 2007). During the development of neuronal 
circuits, neuronal TLR-3 activation via poly 1:C of DAMP mRNA leads to growth cone 
collapse and inhibition of neurite growth, independently of NF-B. This occurs without an 
increase in cell death, in both chick DRG neurons and E14 mouse embryonic brains 
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(Cameron et al., 2007). This demonstrates that the signalling outcomes of the different TLRs 
in different tissues/cells can be markedly different, highlighting the possibility that other 
signalling pathways are involved during development.  
Some TLRs have been shown to be involved in cognition. In mice, loss of TLR-3 resulted in 
both defective working memory formation and retention (Okun et al., 2010) and increased 
anxiety responses (Sloan et al., 2010). Furthermore, TLR-9 loss of function (by CpG DNA) 
results in decreased learning and memory retention (Tauber et al., 2009).  
Following injury, such as ischemic injury (stroke), activation of microglial TLR-2 and TLR-4 
contribute to neuronal damage and promote cell death mediated by the JNK signalling 
pathway and transcription factor AP-1. Levels of both are significantly increased in cerebral 
cortical neurons, and mice deficient for either TLR-2 or TLR-4 show a substantial increase in 
their ability to recover neurologically (Tang et al., 2007). In contrast these phenotypes were 
not seen with either TLR-3 or TLR-9 (Hyakkoku et al., 2010). 
1.3 Evolution of Drosophila Toll and Mammalian Toll Like Receptors 
Genes of the Toll superfamily are present in most eumetazoans (except platyhelminths) with 
their origin preceding the separation of bilaterians and cnidarians over 600 million years ago 
(mya). However, as Toll superfamily molecules have been discovered in sponges and more 
divergent cnidarian species it is likely that these genes first emerged in the common ancestor 
of animals greater than 700mya (Leulier & Lemaitre 2008). The Drosophila Toll protein 
family consists of nine members (Toll-1 - Toll-9). All of the Drosophila Tolls with the 
exception of Toll-9 (a sccTLR) are phylogenetically distinct from known vertebrate TLR 
counterparts (also sccTLRs) forming two separate clades (Leulier & Lemaitre, 2008 and Imler 
& Zheng, 2003). 
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There are two major structural variations of the ectodomains of TLRs (Imler & Zheng 2003). 
Most deuterostomes, as well as Drosophila Toll-9 have a domain structure with a single 
cysteine cluster (sccTLRs) at the C-terminal end of the LRR (CF motif). Whereas, most 
proteostomes have a domain structure with multiple cysteine clusters (mccTLRs) at the N-
terminal end of the LRR (NF motif). 
Drosophila Tolls are transmembrane proteins containing a single membrane-spanning 
domain, with an extracellular N terminal domain and an intracellular C terminal domain 
(Figure 1.2). The ectodomain is comprised of 2 sections. The first contains a repertoire of 
Leucine rich repeats (LRRs), which is flanked at its C terminal by a cysteine rich cluster 
(CRC). The second contains LRRs flanked at both its N and C terminals by a CRC 
(Hashimoto et al., 1988, Imler and Hoffman. 2001).  
The cytoplasmic intracellular region of Drosophila Tolls share signalling similarities to the 
mammalian Interleukin-1 receptor and was thus named the Toll-Interleukin receptor (TIR) 
(O’Neill et al., 2003) This conserved intracellular TIR domain functions to induce 
intracellular signalling via the interaction and recruitment of adaptor proteins (Schneider et 
al., 1991; Gay & keith 1991; Imler and Hoffman. 2001). Drosophila Toll-1, -2, -6, -7 and -8 
contain an intracytoplasmic C-terminal extension following the TIR domain, with Toll-2, -7 
and -8 containing polyglutamine stretches. Furthermore, similar to mammalian TLRs, 
Drosophila Toll-3, -4 and Toll-5 have no C-terminal extension with a stop codon a few 
residues after the TIR domain (Tauszig et al., 2000). 
There are facets of Toll signalling that are similar between Drosophila and mammals, 
particularly in the context of immunity. All mammalian TLRs function within the immune 




Drosomycin and Metchnikowin expression by Toll-5 (Tauszig et al., 2000; Imler and 
Hoffman. 2000; Luo et al., 2001), induction of Dorsal (Dorsal also has immunity independent 
functions) dependent transcription via the interaction between Toll-1, Pelle and Toll-5 (Luo et 
al., 2001). Furthermore; similar to Toll-5, Toll-9 is able to activate Drosomycin expression 
(Ooi et al., 2001) a process which may be dependent upon other Toll signalling components 
(Bettencourt et al., 2004). 
Drosophila Toll-1 and mammalian TLRs interact with MyD88 via TIR domains in order to 
activate their respective protein kinases Pelle (Drosophila) and IRAK (mammals) (Imler and 
Hoffman 2001). Towb et al., 2009 aligned the human IRAK-1 and IRAK-4 death domains 
against the TTLK proteins of eight arthropods. Using a blast search, the authors identified 49 
identical positions. This demonstrated that Drosophila Tube and Pelle are an orthologous pair 
to IRAK4 (with 47% conserved residues) and IRAK1 (with 22% conserved residues) 
respectively. 
Some downstream signalling components are conserved between Drosophila Tolls and 
mammalian TLRs. Drosophila Toll-1 via MyD88 and downstream effectors lead to cactus 
degradation and nuclear translocation of NF-KB transcription factors Dif and Dorsal (Wu et 
al., 1998). Similar mechanisms are seen in mammals, where most mammalian TLRs are able 
to activate numerous signalling cascades including NF-KB signalling, possibly representing 
an evolutionary conserved suite of signalling mechanism between flies and mammals 
(Medzhitov et al., 1997; Muzio et al., 1998; Aliprantis et al., 1999).  
1.4 Drosophila Toll-1 
Through the use of in situ hybridization it was established that during early stages of dorso-
ventral pattern establishment, maternal toll transcripts are distributed throughout the embryo. 
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Trans-locating towards the embryonic plasma membrane during the syncytial blastoderm 
stage, following which expression vastly decreases during cellularisation (Gerttula et al., 
1988; Hashimoto et al., 1991). During gastrulation Toll is expressed at anterior and posterior 
ends forming the midgut as well as within mesodermal invaginated cells of the ventral furrow 
(Gerttula et al., 1988). 
Using antibodies against the cytoplasmic domain of Toll-1, and in situ hybridisation it was 
shown that transcription of zygotic toll-1 occurs around the time of germ band extension. 
During embryonic development Toll-1 is expressed in the posterior and anterior midgut, 
salivary glands and epidermis (Gerttula et al., 1988). Toll-1 is expressed in regions where 
there are high levels of invagination, and following germ band shortening in many embryonic 
tissues including epidermis and muscle attachment sites, at the dorsal midline and segment 
borders (Gerttula et al., 1988; Hashimoto et al., 1991; Halfon et al., 1995). Following 
differentiation during late embryogenesis Toll-1 decreases significantly (Gerttula et al., 
1988). 
Toll-1 is also observed in embryonic neurons. Furthermore Toll-Gal4>UAS-GAP-GFP labels 
the larval and adult neurons of the CNS (Zhu et al., 2008; Sutcliffe B PhD), and is located 
within muscle fibers, their pre-cursors, midline glia and dorsal median cells of the larval CNS 
(Nose et al., 1992; Wharton and Crews et al., 1993). Northern blot and RT-PCR analysis 
show that Toll-1 is expressed during the pupal stage at high levels (Tauszig et al., 2000).  
1.4.1 Drosophila Toll-1 in early development 
Toll is a member of a group of maternal effect genes, now known as the ‘dorsal’ group and 
the toll signalling cascade in development has since been elucidated via the molecular 




of embryogenesis dorso-ventral patterning is determined via the localization of Toll at the 
ventral side of the embryo (Anderson et al., 1985). 
Within the maternal egg chamber nudel is uniformly expressed. Positional cues originating 
during oogenesis in the follicle cell layer lead to the sequential activation of the zymogens 
Gastrulation defective (gd), Snake and Easter within the periviteline space. The 
sulfotransferase Pipe is located ventrally on the follicular epithelium restricting snake activity 
to the ventral region of embryos. Snake activates Easter, which then processes the cysteine 
knot molecule Pro-Spatzle (Spz) in a graded manner along the ventral axis of the embryo 
(Schneider et al., 1994, DeLotto & DeLotto 1998). 
The inactive prepro-protein Spz ligand binds to the first 10 LRRs of Toll with high affinity (K 
d < 0.4 nM) via its C-terminal fragment (Gangloff et al., 2008, Gay et al., 2014). Following 
which Spz is cleaved into its mature form and becomes functional ligand for Toll. 
Dimerization of the Toll receptor operates as a scaffold for downstream adaptor proteins that 
associate via TIR-TIR interactions (Gay et al., 2014). Toll interacts with the TIR domain of 
the signalling adaptor Myeloid Differentiation primary response protein 88 (dMyD88) 
(Tauszig et al., 2002) As well as containing a TIR domain dMyD88 also contains a death 
domain (DD) and is localized at the plasma membrane via a 100 amino acid C-terminal 
extension (CTE) (Kambris et al., 2003). 
Signalling occurs via the association of the DD of dMyD88 and the adaptor protein Tube, 
which contains a DD but does not contain a TIR domain. The serine/threonine protein kinase 
Pelle is then recruited, creating a submembranous signalling complex (Towb et al., 1998, Sun 
et al., 2002, Kambris et al.,2003, Sun et al., 2004). Pelle autophosphorylates and dissociates 
from the complex (Shen et al., 2001) interacting with dTRAF2. Downstream, Cactus (Ik-B-
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like protein) is subsequently degradaded and Dorsal (NF-kB transcription factor) is 
translocated to the nucleus (Hoffman & Reichhart, 2002). This nuclear translocation and 
increasing ventral Dorsal expression leads to activation of the zygotic genes twist and snail as 
well as the reduction of zerknullt and decapentaplegic due to reduced Dorsal protein in dorsal 
regions (Ray et al., 1991). 
1.4.2 Drosophila Toll-1 in immunity 
Subsequent studies revealed Toll-1 to be an essential receptor acting within innate immunity. 
Specifically in the recognition of some gram-positive bacteria and fungi. It was this 
unearthing that paved the way for the identification of vertebrate TLRs and established the 
Toll pathway as an evolutionary conserved signalling pathway (Valane et al, 2011). In 
Drosophila the extracellular machinery required for the activation of the Toll pathway differs 
between developmental and immune requirements (Figure 1.3). 
In mammals TLRs are also primarily known for their functions in immunity. They function as 
pattern recognition receptors (PRRs) in order to directly combat invading microorganisms. It 
has been demonstrated that the resident macrophages of the mammalian nervous system; 
microglia, express TLRs (Rock et al 2004). Unlike TLRs however, Drosophila Toll-1 is 
activated by Spz and does not directly bind to the pathogens. 
In order to control and clear pathogens PRRs recognize specific conserved pathogen 
associated molecular patterns (PAMPs). PAMPS only associate with the pathogen or specific 
virulence factors, allowing the recognition of non-self from self (Janeway 1989). Acting 
upstream of the Toll pathway as PRRs are members of the peptidoglycan recognition protein 
(PGRP) as well as gram-negative binding proteins (GNBP) (Kurata 2010). GNBPs form part 
of the B-glucan-binding proteins (Ochiai & Ashida 1999, Werner et al., 2000). PGRP genes 
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are separated into two classes dependent upon the length of their transcripts, PGRP-LB and 
PGRP-LC form one class (long transcripts) whilst PGRP-SA and PGRP-SD form the other 
(short transcripts) (Bischoff et al., 2004). 
There are multiple ways in which the PRRs work independently or cooperate in order to 
detect PAMPs. PGRP-SA participates with GNBP1 and GNBP2 in order to recognize some 
Gram-positive bacterial cell wall components, for example lysine containing PGN (Lys-type-
PGN) (Bischoff et al., 2004, Gobert et al., 2003). On the other hand the PRR GNBP3 
recognises fungal determinants (mostly the b-glucans), all of which activate the Toll pathway 
(Gottar et al., 2006). 
Binding of PAMPs by the soluble PRRs induces the differential activation of a protease 
cascade whereby ModSP integrates signals from upstream PRRs and activates Gram-positive 
specific serine protease (Grass). The protease Spatzle processing enzyme is then activated 
(SPE) via several serine proteases including the Clip-serine protease Persephone (involved in 
a separate proteolytic cascade detecting virulence factors along with the serine protease 
inhibitor Necrotic), Sphinx1/2, Spirit and Spheroide (Levashina et al., 1999, Ligoxygakis et 
al., 2002, Kambris et al., 2006, Cahmy et al., 2008). 
SPE is the functional equivalent of Easter sharing 44% amino acid similarity as well as 
sharing the same active site upon Spatzle. Once activated SPE cleaves Spz, culminating in the 
generation of a fully functional Toll ligand (Jang et al., 2006). Once bound, the Toll pathway 
leads to the degradation of cactus and nuclear localization of the NF-kB transcription factors 
Dorsal and Dorsal-related Immune Factor (DIF). Subsequent transcription of antimicrobial 
peptides (AMPs) such as Drosomycin occurs which can then combat invading pathogens 




1.4.3 Drosophila Toll-1 during development 
Toll-1 has been documented as being involved in many complex processes such as 
development of the nervous system, epidermis and muscles. Much of the insight into the role 
it plays is accounted for by loss of function (LOF) experiments, in particular within muscles. 
Halfon & Keshishian 1998, demonstrated that similar to mutations in spz, Tube and Pelle, 
epidermal loss of Toll-1 leads to disordering muscle development. 
This disruption in development can lead to the malformation of synapses for example, as 
demonstrated by Suzuki et al. 2000 where they showed that a reduction of muscular Toll-1 
prevents interactions required between muscles and growth cones for correct synapse 
formation. Halfon et al. 1995, presented evidence that Toll-1 is expressed within motor-
neurons and mutations of the Toll-1 gene lead to irregularities of muscles associated primarily 
with motor axon misrouting as well as the loss of motor-neurons. 
Targeting defects are also established in Toll-1 mutant embryos. Loss of Toll-1 in muscles 15 
and 17 lead to inappropriate axon targeting (Rose et al. 1997). Zhu et al. 2008 also showed 
that Toll-1 is required for cell survival in the embryonic CNS and that Toll-1 mutants showed 
an increase in apoptosis as well as the over-expression of Toll-1 in neurons can rescue 
naturally occurring cell death in embryos.  
1.5 Other Drosophila Toll receptors 
1.5.1 Drosophila Toll-2  
Some of the Tolls are highly expressed during embryogenesis and metamorphosis (Tauzsig et 
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al. 2000). Toll-2 is expressed in the early embryo, at the cellular blastoderm stage as 9 
circular stripes that reach the ventral side of the embryo. With the exception of a single 
anterior most dorsal band (Eldon et al., 1994). These bands are immediately posterior and 
adjacent to eve patterning. At germ band extension secondary stripes appear and form a group 
of 18 that overlap wingless expression (Eldon et al., 1994; Kambris et al., 2002). During early 
gastrulation these stripes widen and a further two become visible within the head region. 
Lateral expression in each then declines and a cluster of cells becomes apparent along the 
ventral midline during germ band elongation. During this time there is also accumulation of 
transcipts around the tracheal pits, salivary glands and presumptive head regions. During 
germ band retraction expression becomes more restricted to these regions as well as along the 
dorsal midline, cells that are involved in development of the dorsal vessel.  
 
In situ hybridization, northern blot and RT-PCR analysis revealed that Toll-2 is expressed in 
the fat body (localized to the plasma membrane and within the cytoplasm), within blood cells 
and in the lymph gland of larvae (Williams et al., 1997;Kambris et al., 2002) and during the 
pupal stage of development (Tauszig et al., 2000). Similar to Toll-1, Toll-2 has been shown to 
have some influence over the innate immune response. As well as being located in immune 
response tissues, Toll-2 is induced following bacterial challenge with Escherichia coli 
(Williams et al., 1997). Furthermore, Toll-2 mutants have decreased viability when 
challenged with Escherichia coli or Enterobacter cloacae. They also have reduced ability of 
synthesizing the anti-microbial peptide (AMP) genes attacin and cecropin in response to an 
insult of gram-negative infection (Williams et al., 1997). Chimeric constructs with the 
ectodomain of constitutively active Toll-1 fused to trans- and intracytoplasmic domains of 




The immune functions of Toll-2 may be restricted to the fat body, the primary site of AMP 
production and secretion. A lacZ reporter was constructed with an ecdysone responsive 
fragment attached to a fat body specific gene (Fbp1). When ecdysone is generated in fat body 
cells it results in -gal transcription, which can be monitored. Lixoxygakis et al., 2002, 
determined that wild type flies express -gal normally around 108 hours post egg laying. 
However Toll-2 mutant do not express -gal and therefore these mutants do not have normal 
fat body development. 
 
Furthermore, mutations in Toll-2 result in larval lethality and delayed adult development 
followed by early death (Eldon et al 1994) and therefore it is likely that Toll-2 functions 
during development. Toll-2 may act as a heterophilic cell adhesion molecule and facilitate the 
movement of cells. During morphogenesis as the over-expression of Toll-2 in S2 cells form 
aggregates within 2-4 hours post induction (Eldon et al., 1994). Furthermore, mutations of 
Toll-2 lead to delayed migration of ovarian follicular cells (Kleve et al. 2006). Toll-2 mutant 
escapers showed significant incidences of morphological defects of the legs, wings and 
antennae. This is further indicative of eversion of imaginal discs, a process that requires 
extensive cell migration (Eldon et al 1994). Toll-2 mutants also display embryonic salivary 
gland invagination defects, similar to the defects of embryos lacking Rho-GTPase activity 
(Kolesnikov & Beckendorf 2007). It appears as though Toll-2 has a diverse set of functions, 
however the role of Toll-2 within the CNS still remains to be investigated. 
 




Toll-3 and Toll-4 share 79% structural similarity to each other in respect to their TIR 
domains. Both proteins are shorter than other Toll members as they lack C-terminal 
extensions, instead containing a stop codon only a few residues after the TIR domain (Tauszig 
et al., 2000). Both have very limited expression. Toll-3 transcripts are expressed at very low 
levels, detected by RT-PCR. Toll-4 is located in lymph gland precursor cells in late stage 
embryos (in situ hybridization) and within the fat body and lymph gland cells (RT-PCR) 
(Tauszig et al., 2000; Kambris et al., 2002). Furthermore, chimeric constructs with the 
ectodomain of constitutively active Toll-1 fused to trans- and intracytoplasmic domains of 
Toll-3 and Toll-4 could not induce AMP genes (Tauszig et al., 2000). Transgenic expression 
assays using a suite of different ubiquitous and specific Gal4 (particularly in wing discs) 
drivers resulted in no lethality or phenotypic manifestations (Yagi et al., 2010).  
 
1.5.3 Drosophila Toll-5  
As the closest homologue of Toll-1, Toll-5 and Toll-1 share a 61% identity within their 
intracellular domains. However, structural differences include Toll-5 lacking a C-terminal 
extension, instead containing a stop codon close to its TIR domain (Tauszig et al., 2000). 
During embryonic development stage 10, zygotic Toll-5 is distributed along the ventral 
midline and in clusters of muscle progenitors. By stage 13 Toll-5 protein is located within 
some ventral muscles and the dorsal vessel. Toll-5 is also located throughout regions that 
express Toll-1 in abundance including the salivary glands, fat body and midgut, however 
Toll-5 is not present in the epidermis (Kambris et al., 2002). Furthermore, Toll-5 protein was 
detected in ovaries and throughout all developmental stages via western blotting with Toll-5 
peptide antibodies (Luo et al., 2001).   
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A chimera construct consisting of the ectodomain of constitutively active Toll-1 fused to 
trans- and intracytoplasmic domains of Toll-5 led to efficient induction of the drosomycin 
promoter in S2 cells, indicating Toll-5 may play some role in host defense (Tauszig et al., 
2000). Further to this there was an increase in the level of Toll-5 protein in vivo when adult 
flies were challenged with both gram negative and gram positive bacteria, as well as when S2 
cells where challenged with LPS (Luo et al., 2001). A micro-array of AMP genes and the 
over-expression of Toll-5 led to an up regulation of both drosomycin and metchenikowin (Luo 
et al., 2001) indicating further Toll-5 involvement in immune regulation. 
Not only can Toll-5 initiate immune responses in a similar manner to Toll-1 it may also use 
the same signalling mechanisms. When S2 cells were transfected with differing 
concentrations of Toll-5, there was a significant increase in Dorsal and this was even 
furthered with the co-expression of Toll-5 and Pelle in SL2 cells. Therefore Toll-5 can 
independently activate Dorsal. Toll-5 can also physically interact with Pelle, to induce Dorsal 
activation in a manner similar to Toll-1 (Luo et al., 2001). Furthermore, Toll-1 and Toll-5 
intracellular domains can physically interact in vitro, and co-transfections of Toll-1 and Toll-5 
vectors in S2 cells strongly activate Dorsal (Luo et al., 2001). However, they may be 
structurally similar, and be able to interact, but the over-expression of Toll-5 with several 
Gal4 drivers resulted in no lethality or observable phenotype in contrast to Toll-1 (Yagi et al., 
2010) (Table 1.1). 
1.5.4 Drosophila Toll-6 
Toll-6 shares less structural similarities to the other Drosophila Toll TIR domains (Tauszig et 
al., 2000). Transcription of Toll-6 starts during the cellular blastoderm stage. Several bands, 
from the anterior most regions, appear in altering intensity throughout germ band extension. 
24
Gene/Protein Category Result Reference
Toll-1 Expression
Maternal toll transcripts are distributed throughout the embryo.
Trans-locating towards the embryonic plasma membrane during the syncytial blastoderm
stage, following which expression vastly decreases during cellularisation
Gerttula et al.,
1988; Hashimoto et al., 1991
Toll-1 Expression
During gastrulation Toll is expressed at anterior and posterior ends forming the midgut as well as within mesodermal 
invaginated cells of the ventral furrow Gerttula et al., 1988
Toll-1 Expression
Transcription of zygotic toll-1 occurs around the time of germ band extension.
During embryonic development Toll-1 is expressed in the posterior and anterior midgut,
salivary glands and epidermis Gerttula et al., 1988
Toll-1 Expression
Toll-1 is expressed in regions where there are high levels of invagination, and following germ band shortening in many 
embryonic tissues including epidermis and muscle attachment sites, at the dorsal midline and segment borders Gerttula et al., 1988; Hashimoto et al., 1991; Halfon et al., 1995
Toll-1 Expression Following differentiation during late embryogenesis Toll-1 decreases significantly Gerttula et al., 1988
Toll-1 Expression
Toll-1 is also observed in embryonic neurons. Toll-Gal4>UAS-GAP-GFP labels
the larval and adult neurons of the CNS Zhu et al., 2008; Sutcliffe B PhD
Toll-1 Expression located within muscle fibers, their pre-cursors, midline glia and dorsal median cells of the larval CNS Nose et al., 1992; Wharton and Crews et al., 1993
Toll-1 Expression Toll-1 is expressed during the pupal stage at high levels Tauszig et al., 2000
Toll-1 Signalling 
Essential receptor acting within innate immunity in the recognition of some gram-positive bacteria and fungi as well as 
having developmental functions.
Toll-1 Development Epidermal loss of Toll-1 leads to disordering muscle development Halfon & Keshishian 1998
Toll-1 Development
Disruption in development can lead to the malformation of synapses, reduction of muscular Toll-1 prevents interactions 
required between muscles and growth cones for correct synapse formation Suzuki et al. 2000
Toll-1 Development
Toll-1 is expressed within motorneurons and mutations of the Toll-1 gene lead to irregularities of muscles associated 
primarily with motor axon misrouting as well as the loss of motor-neurons Halfon et al. 1995,
Toll-1 Development
Targeting defects in Toll-1 mutant embryos. Loss of Toll-1 in muscles 15
and 17 lead to inappropriate axon targeting Rose et al. 1997
Toll-1 Development Toll-1 is required for cell survival in the embryonic CNS Zhu et al. 2008
Toll-2 Expression
Toll-2 is expressed in the early embryo, at the cellular blastoderm stage as 9 circular stripes that reach the ventral side of 
the embryo. With the exception of a single anterior most dorsal band. These bands are immediately posterior and 
adjacent to eve patterning. Eldon et al., 1994
Toll-2 Expression At germ band extension secondary stripes appear and form a group of 18 that overlap wingless expression Eldon et al., 1994; Kambris et al., 2002
Toll-2 Expression
During early gastrulation stripes widen and a further two become visible within the head region. Lateral expression in 
each then declines and a cluster of cells becomes apparent along the ventral midline during germ band elongation. 
During this time there is also accumulation of transcipts around the tracheal pits, salivary glands and presumptive head 
regions. During germ band retraction expression becomes more restricted to these regions as well as along the dorsal 
midline, cells that are involved in development of the dorsal vessel Williams et al., 1997;Kambris et al., 2002
Toll-2 Expression
Toll-2 is expressed in the fat body (localized to the plasma membrane and within the cytoplasm), within blood cells and 
in the lymph gland of larvae and during the pupal stage of development Williams et al., 1997;Kambris et al., 2002; Tauszig et al., 2000
Toll-2 Immune response
Toll-2 mutants have decreased viability when challenged with Escherichia coli or Enterobacter cloacae. They also have 
reduced ability of synthesizing the anti-microbial peptide (AMP) genes attacin and cecropin in response to an insult of 
gram-negative infection Williams et al., 1997
Toll-2 Immune response
Chimeric constructs with the ectodomain of constitutively active Toll-1 fused to trans- and intracytoplasmic domains of 
Toll-2 however failed to induce drosomycin or AMP genes Tauszig et al., 2000
Toll-2 Immune response
The immune functions of Toll-2 may be restricted to the fat body, the primary site of AMP production and secretion. A 
lacZ reporter was constructed with an ecdysone responsive fragment attached to a fat body specific gene (Fbp1). When 
ecdysone is generated in fat body cells it results in β-gal transcription, which can be monitored. determined that wild 
type flies express β-gal normally around 108 hours post egg laying. However Toll-2 mutant do not express β-gal and 
therefore these mutants do not have normal fat body development. Lixoxygakis et al., 2002
Toll-2 Development
Mutations in Toll-2 result in larval lethality and delayed adult development followed by early death and therefore it is 
likely that Toll-2 functions during development Eldon et al 1994
Toll-2 Development
Toll-2 may act as a heterophilic cell adhesion molecule and facilitate the movement of cells. During morphogenesis as 
the over-expression of Toll-2 in S2 cells form aggregates within 2-4 hours post induction Eldon et al 1994
Toll-2 Development Mutations of Toll-2 lead to delayed migration of ovarian follicular cells Kleve et al. 2006
Toll-2 Development
Toll-2 mutant escapers showed significant incidences of morphological defects of the legs, wings and
antennae. This is further indicative of eversion of imaginal discs, a process that requires
extensive cell migration Eldon et al 1994
Table 1.1 Structure and Function of the Toll proteins up until 2011
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Toll-2 Development
Toll-2 mutants also display embryonic salivary gland invagination defects, similar to the defects of embryos lacking Rho-
GTPase activity Kolesnikov & Beckendorf 2007
Toll-3 & Toll-4 Structure
Toll-3 and Toll-4 share 79% structural similarity to each other in respect to their TIR
domains. Both proteins are shorter than other Toll members as they lack C-terminal
extensions, instead containing a stop codon only a few residues after the TIR domain
Tauszig
et al., 2000
Toll-3 & Toll-4 Expression
Toll-3 transcripts are expressed at very low levels, detected by RT-PCR. Toll-4 is located in lymph gland precursor cells 
in late stage embryos (in situ hybridization) and within the fat body and lymph gland cells (RT-PCR) Tauszig et al., 2000; Kambris et al., 2002
Toll-3 & Toll-4 Immune response
chimeric constructs with the ectodomain of constitutively active Toll-1 fused to trans- and intracytoplasmic domains of 
Toll-3 and Toll-4 could not induce AMP genes Tauszig et al., 2000
Toll-3 & Toll-4 Development
Transgenic expression assays using a suite of different ubiquitous and specific Gal4 (particularly in wing discs) drivers 
resulted in no lethality or phenotypic manifestations Yagi et al., 2010
Toll-5 Structure
As the closest homologue of Toll-1, Toll-5 and Toll-1 share a 61% identity within their intracellular domains. However, 
structural differences include Toll-5 lacking a C-terminal extension, instead containing a stop codon close to its TIR 
domain Tauszig et al., 2000
Toll-5 Expression
During embryonic development stage 10, zygotic Toll-5 is distributed along the ventral midline and in clusters of muscle 
progenitors. By stage 13 Toll-5 protein is located within some ventral muscles and the dorsal vessel. Toll-5 is also 
located throughout regions that express Toll-1 in abundance including the salivary glands, fat body and midgut, however 
Toll-5 is not present in the epidermis Kambris et al., 2002
Toll-5 Expression
Toll-5 protein was detected in ovaries and throughout all developmental stages via western blotting with Toll-5 peptide 
antibodies Luo et al., 2001
Toll-5 Immune response
A chimerae construct consisting of the ectodomain of constitutively active Toll-1 fused to trans- and intracytoplasmic 
domains of Toll-5 led to efficient induction of the drosomycin promoter in S2 cells, indicating Toll-5 may plays some 
role in host defense Tauszig et al., 2000
Toll-5 Immune response
Further to this there was an increase in the level of Tolll-5 protein in vivo when adult
flies were challenged with both gram negative and gram positive bacteria, as well as when S2
cells where challenged with LPS Luo et al., 2001
Toll-5 Immune response
A micro-array of AMP genes and the over-expression of Toll-5 led to an up regulation of both drosomycin and 
metchenikowin Luo et al., 2001
Toll-5 Immune response
Not only can Toll-5 initiate immune responses in a similar manner to Toll-1 it may also use
the same signaling mechanisms. When S2 cells were transfected with differing concentrations
of Toll-5, there was a significant increase in Dorsal and this was even furthered with the coexpression
of Toll-5 and Pelle in SL2 cells. Therefore Toll-5 can independently activate Dorsal. Toll-5 can also physically interact 
with Pelle, to induce Dorsal activation in a manner similar to Toll-1 Luo et al., 2001
Toll-5 Immune response
 Toll-1 and Toll-5 intracellular domains can physically interact in vitro, and co-transfections of Toll-1 and Toll-5 vectors 
in S2 cells strongly activate Dorsal Luo et al., 2001
Toll-5 Development
The over-expression of Toll-5 with several Gal4 drivers resulted in no lethality or observable phenotype in contrast to 
Toll-1 Yagi et al., 2010)
Toll-6 Expression Toll-6 shares less structural similarities to the other Drosophila Toll TIR domains Tauszig et al., 2000
Toll-6 Expression
Transcription of Toll-6 starts during the cellular blastoderm stage. Several bands, from the anterior most regions, appear 
in altering intensity throughout germ band extension. At the end of this developmental stage transcription reaches its 
maximal levels and is followed by a reduction of expression except for within the CNS Kambris et al., 2002
Toll-6 Expression
Toll-6 is present within longitudinal interneuron axons, ventral HB9+ neurons and Eve+ motorneurons (except for RP2 
neurons) McIlroy et al., 2013
Toll-6 Expression
During larval development Toll-6 protein is located within the CNS along the VNC neuropile
and within aCC motorneurons McIlroy et al., 2013
Toll-6 Expression Toll-6 transcripts are expressed during pupal stages, detected by RT-PCR Tauszig et al., 2000
Toll-6 Expression
Within adults Toll-6 is present within dopaminergic neurons as well as within complimentary layers and rings of the fan 
shaped body (FSB) and ellipsoid body (EB) respectively, both sites of locomotor control McIlroy et al., 2013
Toll-6 Development
Toll-6 (along with Toll-2, Toll-7 and Toll-8) is required for wing and leg imaginal disc development where it has a 
specific function in the formation of the anterior – posterior (A-P) boundaries. When over-expressed with 
decapentaplegic Gal4 (dppGal4) mild splitting of the A-P boundary occurs at the distal wing end due to abnormal folding Yagi et al., 2010
Toll-6 Immune response
Toll-6 mutants induce AMP genes (AttacinA, Diptericin, Drosomycin or Metchnikowin ) in a similar manner to the 
control following septic injury. Indicating Toll-6 may not play a significant role in antimicrobial immune responses Yagi et al., 2010
Toll-6 Signalling
While DNT2;Toll-6 mutant embryos are viable, DNT1;Toll-6 mutants are semi-lethal. A
phenotype that can be rescued by the over-expression of Toll-6 (and Toll-7). This indicates
that Toll-6 acts downstream of DNT-2 and is likely its receptor, furthermore coimmunoprecipitations
showed that Toll-6 can physically interact with DNT-2 McIlroy et al., 2013
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Toll-6 Function
Toll-6 together with Toll-7 is required for normal locomotion as Toll-6; Toll-7 double mutant
larvae crawl slower than controls. McIlroy et al., 2013
Toll-6 Development
Toll-6 together with Toll-7 are required for correct motor axon targeting which was visualised via projections of FasII 
ISNb/d whereby both Toll-6 and Toll- 7 single and Toll-6; Toll-7 double mutants cause deficient targeting due to loss of 
projections and motoraxon misrouting in stage 17 embryos. Over-expression of both Toll-6 and Toll-7 in neurons also 
causes targeting defects McIlroy et al., 2013
Toll-6 Function
Toll-6 and Toll-7 regulate neuronal survival as single and double mutants resulting in increased number of apoptotic 
HB9+ and Eve+ EL interneurons in the embryonic CNS McIlroy et al., 2013
Toll-7 Structure The TIR domain of Toll-7 shares 60% identity with Toll-2 Tauszig et al., 2000
Toll-7 Expression
Toll-7 expression is diverse throughout embryogenesis. Zygotic expression begins during germ band
extension as a strong spot within the head region, with diffuse expression in the trunk. By the end of germ band 
extension, when CNS and PNS differentiation occurs, there are 14 well defined stripes that are in line with engrailed and 
posterior to wingless expression. At germ band retraction Toll-7 is located in leg imaginal disc precursors and epithelium 
of the large intestine Kambris et al, 2002
Toll-7 Expression
Toll-7 is distributed throughout central HB9+ and Lim3+ RP motorneurons projecting along intersegmental nerve b/d 
which targets muscles 6, 7, 12, and 13, motor axons exiting CNS and interneuon axons that cross the midline McIlroy et al., 2013
Toll-7 Expression By stage 16, expression becomes weaker and restricted only to CNS tissues Kambris et al, 2002
Toll-7 Expression Toll-7 projections are visible along the three FasII and longitudinal fascicles McIlroy et al., 2013
Toll-7 Expression
During larval stages Toll-7 is distributed along the VNC neuropile, and in the central complex
of brains, similar to Toll-6, within complimentary layers and rings of the FSB and EB respectively McIlroy et al., 2013
Toll-7 Expression While structurally more similar to Toll-2, Toll-7 protein localisation is more similar to that of Toll-6. McIlroy et al., 2013
Toll-7 Function
As highlighted previously Toll-7 has neurotrophic functions in the Drosophila CNS and is
required in conjunction with Toll-6 for normal locomotion and motor axon targeting and to
maintain neuronal survival McIlroy et al., 2013
Toll-7 Signalling
Toll-7; DNT-2 mutants are semi lethal, and coimmunoprecipitations revealed physical interactions with both DNT-1 and 
DNT-2, therefore Toll-7 and Toll-6 may be promiscuous in its ligand binding McIlroy et al., 2013
Toll-7 Development
Toll-7 mutants whilst viable display leg defects and Toll-7 is located around the wing pouch and hinge region of the wing 
disc, as well as along the A-P border from tarsal to tibia segments of leg discs. A transgenic expression assay identified 
Toll-7, Toll-2, Toll-6 and Toll-8 as required for the formation of the anterior – posterior (A-P) boundaries for wing and 
leg imaginal disc development, and identifies this group of Tolls as possibly being a subgroup Yagi et al., 2010
Toll-7 Immune response
Mutants for Toll-6, -7 and -8 were subjected to septic injury, and displayed a similar increase in the levels of AMPs to 
the wild type control. Therefore Toll-6, -7 and -8 may not play a significant role in antimicrobial immune responses Yagi et al., 2010
Toll-7 Immune response
Toll-7 is involved in anti-viral immune responses Drosophila cells were pre-treated with Toll-7 dsRNAs samples were 
challenged with vesicular stomatitis virus (VSV-GFP) and analysed for infection. Toll-7 viral load was increased by 26% 
in comparison to controls. Furthermore, in vivo Toll-7 RNAi adult flies displayed an increase in viral load 6 and 9 days 
post infection. Loss of function of Toll-7 also lead to increased mortality following VSV infection however it was unable 
to induce expression of Drosomycin, MyD88, Dif, Diptericin and vir-1 indicating that this anti-viral mechanism is not 
dependent upon canonical Toll signalling pathways. Antibodies raised for endogenous Toll-7 show that VSV and Toll-7 
interact at the plasma membrane. Toll-7 precipitates with VSV, whereas Toll-1 and tubulin did not. Thus, it appears that 
Toll-7 is a PRR for VSV. In S2 cells Toll-7 is required for antiviral autophagy. Cells were transfected with GFP-LC3 
reporter and treated with dsRNA against Toll-7 and infected with VSV, resulting in a reduction of VSV puncta. 
Furthermore, in vivo, Toll-7 loss of function flies were infected with VSV-GFP and fat bodies dissected three days later 
and stained with Lysotracker. There was a significant reduction of Lysotracker staining despite extensive viral
infection, and through immunoblot assays determined that VSV autophagy is decreased in Toll-7 RNAi flies Nakamoto et al., 2012
Toll-8 Expression
Toll-8 expression at the cellular blastoderm stage consists of 8 circular bands in the embryo overlaping Eve expression. 
These bands develop into 14 strong stripes during germ band extension and sit posterior to wingless expression. 
Furthermore, during this period Toll-8 is expressed in the head as well as in the presumptive neurogenic region. 
Following germ band retraction Toll-8 is located in both dorsal and ventral epidermis, in the pharynx, proventriculus and 
midgut regions Kambris et al. 2002
Toll-8 Expression
Toll-8 mRNA is localised along the VNC and PNS at sites where neural differentiation occurs, due to localisation of 
neural precursor cells and ectoderm contact sites Seppo et al., 2003
Toll-8 Expression
Overall Toll-8 expression is very similar, but doesn’t overlap that of Toll-2 in the embryo. RT-PCR experiments show 
that Toll-8 transcripts are located in blood cells, lymph gland and the fat body Kambris et al. 2002
Toll-8 Expression
Toll-8 transcripts have been detected by RT-PCR in all developmental stages, and northen blot analysis revealed that 
both the macrophage-like cell lines S2 and l(2)mbn cells express Toll-8 Tauszig et al., 2000
Toll-8 Expression Toll-8 mRNA is highly enriched in the larval tracheal epithelium with an apical subcellular localisation Akhouayri et al., 2011
Toll-8 Function Toll-8 can function as a cell adhesion molecule via the induction of cell aggregations Keith & Gay 1990; Eldon et al. 1994; Kim et al. 2006
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Toll-8 Function Toll-8 linked to glycosylation and neural patterning during embryogenesis
Ayyar et al. 2007 and Seppo et al.
2003
Toll-8 Function Toll-8  is able to antagonize Dpp signaling in wing imaginal discs Kim et al., 2006
Toll-8 Signalling
Furthermore, in imaginal disc epithelium Toll-8 interacts with Rel protein during sensory organ development, and plays a 
role in specification of neurons Ayyar et al., 2007
Toll-8 Development
Toll-8 is required for the formation of the anterior – posterior (A-P) boundaries for wing and leg imaginal disc 
development and forms a functional subgroup with these other Tolls. In the wing disc both Toll-8 and Toll-2 were 
observed in the proximal regions and in leg discs they were observed
in the anterior compartment Yagi et al., 2010
Toll-8 Development
Whilst the Toll-8 single mutant was mostly viable, both Toll-2; Toll-8 as well as Toll-7; Toll-8 double mutants displayed 
increased mortality during late embryogenesis or early larval development suggesting some kind of functional 
redundancy between Toll-2 and Toll-8 and Toll-7 and Toll-8 during development Yagi et al., 2010
Toll-8 Immune response
Toll-8 mutants (similar to Toll-6 and Toll-7) failed to induce AMP genes following septic injury and mortality were the 
same as in wild type flies, indicating that Toll-8 may not function in antibacterial immune responses Yagi et al., 2010
Toll-8 Immune response
Toll-8 inhibition has also been shown to be a negative regulator of the IMD signaling
pathway. Akhouayri et al. 2011
Toll-9 Structure
Structurally the TIR domain of Toll-9 has closer homology to mammalian TLRs containing two introns. The 
extracellular domain is more significantly diverged from the other Drosophila Tolls where it does not contain a N-
flanking CRC at the C-terminus
Bilak et al.,
2003; Imler and Zheng, 2003
Toll-9 Expression
Toll-9 is located in vitellophages, cells which are involved in breaking down yolk during stage 5 of embryonic 
development, and this localisation increases during gastrulation. As germ band extension proceeds there is clear Toll-9 
localisation in the head region where the specification of hemocyte progenitors occurs, thus Toll-9 may have some 
function in hematopoiesis. After this period Toll-9 is no longer detected within the embryo. In tissues implicated in 
immunity, Toll-9 is located in the larval fat body and lymph gland Kambris et al. 2002
Toll-9 Expression Toll-9 is present in S2 cells Ooi et al., 2001
Toll-9 Immune response
In S2 cells, a naturally constituitively active Toll-9, is able to activate the Drosomycin gene reporter, increasing 
luciferase activity >150 fold. This result was similar to the activated form of Toll-1, which contains a cysteine residue 
outside the trans-membrane domain. Therefore the activity of Toll-9 is due to a loss of cysteine or gain of tyrosine 
residues in the same region. This was confirmed due to the introduction of a cysteine residue, forming an inactive form 
of Toll-9. In order to activate drosomycin, Toll-9 works via Pelle and/or Cactus, as mutations of both lead to the 
inhibition of Toll-9 mediated drosomycin activity
Ooi et al.,
2001; Bilak et al., 2003
Toll-9 Immune response
Toll-9 may utilize components of the Toll signaling pathway. Both the dominant-negative form of MyD88 and Pelle can 
block Drosomycin activation by Toll-9. S2 cells transfected with Toll-9 vectors lacking LRRs, were able to activate 
drosomycin. However this activation is inhibited by both dominant-negative Pelle and dMyD88, similar to what is 
known of Toll-1, therefore they may function by the same means Bilak et al., 2003
Toll-9 Immune response
With regards to in vivo functions Toll-9 mutant flies appear to lack any form of phenotype. They generated a null allele 
for Toll-9 and measured transcript levels in whole larvae and adult flies and more localised gut tissues. Transcript levels 
for Toll-9 between normal conditions, flies reared in
axenic conditions or infected with Ecc showed no differences between wild type and Toll-9 mutants. Furthermore levels 
of Drosomycin, Defensin, Diptericin and Drosomycin3 remained the same as wild type during these conditions and 
following infection. Therefore Toll-9 in vivo may not regulate levels of AMP genes within either normal or immune 
induced conditions Narbonne-Reveau et al., 2011
Toll-9 Immune response
However, RNAi isolation and microarray assays have shown that some genes activated by Toll10b, are not activated by 
Toll-9 and vice versa Bettencourt et al., 2004
Toll-9 Development
Transgenic expression analysis also demonstrates that activated Toll-1 and Toll-9 may share
functional similarities. They induce similar phenotypes including, lethality when overexpressed
with numerous imaginal disc Gal-4 driver lines (32B-, 71B-, en- and ptc-Gal4) as well as causing a glazed eye 
phenotypes when over-expressed in eye imaginal discs (GMRand lz-Gal4) However; some differences did occur for 
instance, both Toll-9 and Pelle overexpression with dpp-Gal4 results in leg defects or thickening of anterior cross veins 
respectively whereas activate Toll-1 results in cross vein loss Yagi et al., 2010
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At the end of this developmental stage transcription reaches its maximal levels and is 
followed by a reduction of expression except for within the CNS (Kambris et al., 2002). Toll-
6 is present within longitudinal interneuron axons, ventral HB9+ neurons and Eve+ 
motorneurons (except for RP2 neurons) (McIlroy et al., 2013). 
During larval development Toll-6 protein is located within the CNS along the VNC neuropile 
and within aCC motorneurons (McIlroy et al., 2013) and Toll-6 transcripts are expressed 
during pupal stages, detected by RT-PCR (Tauszig et al., 2000). Within adults Toll-6 is 
present within dopaminergic neurons as well as within complimentary layers and rings of the 
fan shaped body (FSB) and ellipsoid body (EB) respectively, both sites of locomotor control 
(McIlroy et al., 2013). 
Toll-6 (along with Toll-2, Toll-7 and Toll-8) is required for wing and leg imaginal disc 
development where it has a specific function in the formation of the anterior – posterior (A-P) 
boundaries. When over-expressed with decapentaplegic Gal4 (dppGal4) mild splitting of the 
A-P boundary occurs at the distal wing end due to abnormal folding (Yagi et al., 2010). 
Unlike some of the other Tolls, Toll-6 mutants induce AMP genes (AttacinA, Diptericin, 
Drosomycin or Metchnikowin ) in a similar manner to the control following septic injury. 
Indicating Toll-6 may not play a significant role in antimicrobial immune responses (Yagi et 
al., 2010). 
While DNT2;Toll-6 mutant embryos are viable, DNT1;Toll-6 mutants are semi-lethal. A 
phenotype that can be rescued by the over-expression of Toll-6 (and Toll-7). This indicates 
that Toll-6 acts downstream of DNT-2 and is likely its receptor, furthermore co-




Toll-6 together with Toll-7 is required for normal locomotion as Toll-6; Toll-7 double mutant 
larvae crawl slower than controls. Furthermore both are required for correct motor axon 
targeting which was visualised via projections of FasII ISNb/d whereby both Toll-6 and Toll-
7 single and Toll-6; Toll-7 double mutants cause deficient targeting due to loss of projections 
and motoraxon misrouting in stage 17 embryos. Over-expression of both Toll-6 and Toll-7 in 
neurons also causes targeting defects (McIlroy et al., 2013). Toll-6 and Toll-7 also regulate 
neuronal survival as single and double mutants resulting in increased number of apoptotic 
HB9+ and Eve+ EL interneurons in the embryonic CNS (McIlroy et al., 2013).  
1.5.5 Drosophila Toll-7 
The TIR domain of Toll-7 shares 60% identity with Toll-2 (Tauzsig et al., 2000). Toll-7 
expression is diverse throughout embryogenesis. Zygotic expression begins during germ band 
extension as a strong spot within the head region, with diffuse expression in the trunk.  
By the end of germ band extension, when CNS and PNS differentiation occurs, there are 14 
well defined stripes that are in line with engrailed and posterior to wingless expression. At 
germ band retraction Toll-7 is located in leg imaginal disc precursors and epithelium of the 
large intestine (Kambris et al, 2002). Furthermore, Toll-7 is distributed throughout central 
HB9+ and Lim3+ RP motorneurons projecting along intersegmental nerve b/d which targets 
muscles 6, 7, 12, and 13, motor axons exiting CNS and interneuon axons that cross the 
midline (McIlroy et al., 2013). By stage 16, expression becomes weaker and restricted only to 
CNS tissues (Kambris et al, 2002), and projections are visible along the three FasII and 
longitudinal fascicles (McIlroy et al., 2013). 
During larval stages Toll-7 is distributed along the VNC neuropile, and in the central complex 
of brains, similar to Toll-6, within complimentary layers and rings of the FSB and EB 
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respectively (McIlroy et al., 2013). While structurally more similar to Toll-2, Toll-7 protein 
localisation is more similar to that of Toll-6.  
As highlighted previously Toll-7 has neurotrophic functions in the Drosophila CNS and is 
required in conjunction with Toll-6 for normal locomotion and motor axon targeting and to 
maintain neuronal survival. Toll-7; DNT-2 mutants are semi lethal, and co-
immunoprecipitations revealed physical interactions with both DNT-1 and DNT-2, therefore 
Toll-7 and Toll-6 may be promiscuous in its ligand binding (McIlroy et al., 2013).  
Toll-7 mutants whilst viable display leg defects and Toll-7 is located around the wing pouch 
and hinge region of the wing disc, as well as along the A-P border from tarsal to tibia 
segments of leg discs. A transgenic expression assay identified Toll-7, Toll-2, Toll-6 and 
Toll-8 as required for the formation of the anterior – posterior (A-P) boundaries for wing and 
leg imaginal disc development, and identifies this group of Tolls as possibly being a subgroup 
(Yagi et al., 2010).  
Mutants for Toll-6, -7 and -8 were subjected to septic injury, and displayed a similar increase 
in the levels of AMPs to the wild type control. Therefore Toll-6, -7 and -8 may not play a 
significant role in antimicrobial immune responses (Yagi et al., 2010). However, Toll-7 is 
involved in anti-viral immune responses (Nakamoto et al., 2012).  
Drosophila cells were pre-treated with Toll-7 dsRNAs samples were challenged with 
vesicular stomatitis virus (VSV-GFP) and analysed for infection. Toll-7 viral load was 
increased by 26% in comparison to controls. Furthermore, in vivo Toll-7 RNAi adult flies 
displayed an increase in viral load 6 and 9 days post infection. Loss of function of Toll-7 also 
lead to increased mortality following VSV infection however it was unable to induce 
expression of Drosomycin, MyD88, Dif, Diptericin and vir-1 indicating that this anti-viral 
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mechanism is not dependent upon canonical Toll signalling pathways. Antibodies raised for 
endogenous Toll-7 show that VSV and Toll-7 interact at the plasma membrane. Toll-7 
precipitates with VSV, whereas Toll-1 and tubulin did not. Thus, it appears that Toll-7 is a 
PRR for VSV. In S2 cells Toll-7 is required for antiviral autophagy. Cells were transfected 
with GFP-LC3 reporter and treated with dsRNA against Toll-7 and infected with VSV, 
resulting in a reduction of VSV puncta. Furthermore, in vivo, Toll-7 loss of function flies 
were infected with VSV-GFP and fat bodies dissected three days later and stained with 
Lysotracker. There was a significant reduction of Lysotracker staining despite extensive viral 
infection, and through immunoblot assays determined that VSV autophagy is decreased in 
Toll-7  RNAi flies  (Nakamoto et al., 2012). 
1.5.6 Drosophila Toll-8 
Toll-8 expression at the cellular blastoderm stage consists of 8 circular bands in the embryo 
overlaping Eve expression. These bands develop into 14 strong stripes during germ band 
extension and sit posterior to wingless expression. Furthermore, during this period Toll-8 is 
expressed in the head as well as in the presumptive neurogenic region. Following germ band 
retraction Toll-8 is located in both dorsal and ventral epidermis, in the pharynx, 
proventriculus and midgut regions (Kambris et al. 2002). Toll-8 mRNA is localised along the 
VNC and PNS at sites where neural differentiation occurs, due to localisation of neural 
precursor cells and ectoderm contact sites (Seppo et al., 2003).  
Overall Toll-8 expression is very similar, but doesn’t overlap that of Toll-2 in the embryo. 
RT-PCR experiments show that Toll-8 transcripts are located in blood cells, lymph gland and 
the fat body (Kambris et al. 2002). Toll-8 transcripts have been detected by RT-PCR in all 
developmental stages, and northen blot analysis revealed that both the macrophage-like cell 
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lines S2 and l(2)mbn cells express Toll-8 (Tauszig et al., 2000). Furthermore Toll-8 mRNA is 
highly enriched in the larval tracheal epithelium with an apical subcellular localisation 
(Akhouayri et al., 2011). 
From the location and distribution of Toll-8 it could be perceived that it may function in both 
development and immunity. As previously described for Toll-1 and Toll-2, Toll-8 over-
expression can function as a cell adhesion molecule via the induction of cell aggregations 
(Keith & Gay 1990; Eldon et al. 1994; Kim et al. 2006). Toll-8 has also been linked to 
glycosylation and neural patterning during embryogenesis (Ayyar et al. 2007 and Seppo et al. 
2003), and is able to antagonize Dpp signalling in wing imaginal discs (Kim et al., 2006). 
Furthermore, in imaginal disc epithelium Toll-8 interacts with Rel protein during sensory 
organ development, and plays a role in specification of neurons (Ayyar et al., 2007). 
As has been previously described for Toll-2, Toll-6 and Toll-7, Toll-8 is required for the 
formation of the anterior – posterior (A-P) boundaries for wing and leg imaginal disc 
development and forms a functional subgroup with these other Tolls. In the wing disc both 
Toll-8 and Toll-2 were observed in the proximal regions and in leg discs they were observed 
in the anterior compartment (Yagi et al., 2010). Whilst the Toll-8 single mutant was mostly 
viable, both Toll-2; Toll-8 as well as Toll-7; Toll-8 double mutants displayed increased 
mortality during late embryogenesis or early larval development suggesting some kind of 
functional redundancy between Toll-2 and Toll-8 and Toll-7 and Toll-8 during development 
(Yagi et al., 2010). 
A previous report identified Toll-8 has a critical function within the CNS. The loss of Horse 
Radish Peroxidase (HRP) in the TM3 chromosome and 71C deficiency was rescued by Toll-8 
expression (Seppo et al., 2003). However Toll-8 null mutant embryos express normal HRP 
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patterns in the CNS (Yagi et al., 2010). Furthermore Toll-8 mutants (similar to Toll-6 and 
Toll-7) failed to induce AMP genes following septic injury and mortality were the same as in 
wild type flies, indicating that Toll-8 may not function in antibacterial immune responses 
(Yagi et al., 2010).  
Toll-8 inhibition has also been shown to be a negative regulator of the IMD signalling 
pathway. Immune responses following bacterial infection, triggered AMP expression in the 
trachea of Toll-8 mutants and q-RT-PCR shows Drosomycin, Drosocin and Attacin mRNA 
levels are significantly increased in comparison to wild type controls. Using Dipt-cherry 
reporter constructs and q-RT-PCR, Toll-8 was shown not to be required in both the fat-body 
and gut following septic injury or oral ingestion of Erwinia carotovora carotovora (Ecc). 
Furthermore, Toll-8 mutants were still able to activate toll signalling following gram
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bacterial immune responses. Therefore it is likely that Toll-8 is required to reduce IMD 
pathway responses in trachea following infection (Akhouayri et al. 2011).  
This mechanism Akhouayri et al. suggested work via the adaptor protein dSarm. dSarm 
mutants showed an increase of Drosomycin activation in the trachea following infection, a 
phenotype that was not observed in MyD88 mutants. Mutants of DNT-1 also phenocopy 
responses of Toll-8 and therefore it may be the ligand required for this immune response. 
Overall DNT-1, Toll-8 and dSarm may work together to down-regulate the IMD pathway in 
trachea following infection and immune responses (Akhouayri et al. 2011). 
1.5.7 Drosophila Toll-9 
Structurally the TIR domain of Toll-9 has closer homology to mammalian TLRs containing 
two introns. The extracellular domain is more significantly diverged from the other 
Drosophila Tolls where it does not contain a N-flanking CRC at the C-terminus (Bilak et al., 
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2003; Imler and Zheng, 2003). Toll-9 is located in vitellophages, cells which are involved in 
breaking down yolk during stage 5 of embryonic development, and this localisation increases 
during gastrulation. As germ band extension proceeds there is clear Toll-9 localisation in the 
head region where the specification of hemocyte progenitors occurs, thus Toll-9 may have 
some function in hematopoiesis. After this period Toll-9 is no longer detected within the 
embryo. In tissues implicated in immunity, Toll-9 is located in the larval fat body and lymph 
gland (Kambris et al. 2002) and is present in S2 cells (Ooi et al., 2001).  
 
In S2 cells, a naturally constituitively active Toll-9, is able to activate the Drosomycin gene 
reporter, increasing luciferase activity >150 fold. This result was similar to the activated form 
of Toll-1, which contains a cysteine residue outside the trans-membrane domain. Therefore 
the activity of Toll-9 is due to a loss of cysteine or gain of tyrosine residues in the same 
region. This was confirmed due to the introduction of a cysteine residue, forming an inactive 
form of Toll-9. In order to activate drosomycin, Toll-9 works via Pelle and/or Cactus, as 
mutations of both lead to the inhibition of Toll-9 mediated drosomycin activity (Ooi et al., 
2001; Bilak et al., 2003).  
In order to function in this manner, Toll-9 may utilize components of the Toll signalling 
pathway. Both the dominant-negative form of MyD88 and Pelle can block Drosomycin 
activation by Toll-9. S2 cells transfected with Toll-9 vectors lacking LRRs, were able to 
activate drosomycin. However this activation is inhibited by both dominant-negative Pelle and 
dMyD88, similar to what is known of Toll-1, therefore they may function by the same means 
(Bilak et al., 2003).  
However Narbonne-Reveau et al. call this finding into question. With regards to in vivo 
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functions Toll-9 mutant flies appear to lack any form of phenotype. They generated a null 
allele for Toll-9 and measured transcript levels in whole larvae and adult flies and more 
localised gut tissues. Transcript levels for Toll-9 between normal conditions, flies reared in 
axenic conditions or infected with Ecc showed no differences between wild type and Toll-9 
mutants. Furthermore levels of Drosomycin, Defensin, Diptericin and Drosomycin3 remained 
the same as wild type during these conditions and following infection. Therefore Toll-9 in 
vivo may not regulate levels of AMP genes within either normal or immune induced 
conditions (Narbonne-Reveau et al., 2011). However, RNAi isolation and microarray assays 
have shown that some genes activated by Toll
10b
, are not activated by Toll-9 and vice versa 
(Bettencourt et al., 2004).  
Transgenic expression analysis also demonstrates that activated Toll-1 and Toll-9 may share 
functional similarities. They induce similar phenotypes including, lethality when over-
expressed with numerous imaginal disc Gal-4 driver lines (32B-, 71B-, en- and ptc-Gal4) as 
well as causing a glazed eye phenotypes when over-expressed in eye imaginal discs (GMR- 
and lz-Gal4). However; some differences did occur for instance, both Toll-9 and Pelle over-
expression with dpp-Gal4 results in leg defects or thickening of anterior cross veins 
respectively whereas activate Toll-1 results in cross vein loss (Yagi et al., 2010).  
 
1.6 Drosophila ligands for Toll receptors belong to the Neurotrophin superfamily 
 
Spz is the well-known ligand of Toll-1, initially discovered for inducing dorsal-ventral (DV) 
polarity in early Drosophila embryos (Anderson and Nusslein-Volhard., 1984; Morisato and 
Anderson., 1994; Schneider et al., 1994; Stein and Nusslein-Volhard., 1992). Later Spz was 
identified via predicted structural and biochemical analysis as a secreted protein containing an 
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NGF domain (De lotto and De Lotto., 1998; Gay and Gangloff., 2007; Mizuguchi et al., 
1998). At this time though, Spz was thought to be more similar to horseshoe crab coagulogen. 
Coagulogen is involved in blood-clotting cascades, and this presumption led to Spz being 
overlooked as an NGF related protein (Mizuguchi et al., 1998).  
 
The idea that Drosophila expressed any neurotrophic type molecules was widely dismissed. 
This was in part due to a lack of neurotrophin homologues being identified in the Drosophila 
genome once it was published (Adams et al., 2000). Furthermore, in the drosophila CNS cell 
death was thought to be strictly programmed, a fixed mechanism with no regulation of cell 
number (Truman.1984; Barde., 1994; White et al., 1994; Jaaro et al., 2001).  
DNT1 was identified as related to BDNF during a search of the Drosophila genome using 
vertebrate neurotrophin sequences. DNT1 was identified as spz2, a paralog of spz (Parker et 
al., 2001; Zhu et al., 2008). Structural prediction then identified that both DNT1 and DNT2 
are more similar in structure to the mammalian NTs than either are to Spz, and FUGUE 
analysis revealed that both are more closely related to the NTs than coagulogen, which had 
previously been thought to resemble Spz (Zhu et al., 2008). 
 
Subsequently Spz was crystallised. The confirmed structure of NGF was superimposed upon 
the crystal structure of the cysteine knot domain of Spz confirming it as a member of the NT 
superfamily (Hoffman et al., 2008; Hoffman et al., 2008b; Arnot et al., 2010; Weber et al., 
2010). Spz is secreted as a pro-protein and is extracellularly cleaved by either the serine 
protease Easter in DV patterning or SPE in immunity to release the active cysteine knot (Gay 




All three Drosophila NTs have the same protein structure as the other NT superfamily 
members which incorporates a pro-domain, signal peptide and a cystine-knot domain (Figure 
1.4). This cystine-knot domain is highly conserved between members of the NT superfamily 
and is also different from other cystine-knots [De Lotto and De Lotto 1998; Mizugucgu et al., 
1998; Parker et al., 2001; Zhu et al., 2008; Weber et al., 2007; Arnot et al., 2010; Weber et 
al., 2010]. 
 
Processing of Spz is similar to the cleavage of proBDNF at the synaptic cleft by plasmin (also 
a serine protease). Following proteolytic cleavage by the tissue plasminogen activator (tPA) 
under high frequency neuronal activity (Gualandris et al., 1996). Dimerization of the DNTs 
occurs following cleavage, in a manner similar to mammalian NTs (Zhu et al., 2008). 
 
Now we know, three members of the Drosophila NT family are spatzle (Spz), Drosophila 
neurotrophin-1 (DNT1) and Drosophila neurotrophin-1 (DNT2) (Parker et al., 2001; Zhu et 
al., 2008). Drosophila also has other neurotrophic factors including DmMANF, homologous 
to mammalian MANF and CDNF, as well as Netrins. DmMANF is produced by glial cells 
and maintains dopamine (DA) levels and protects dopaminergic neurons. Reductions in 
DmMANF levels result in decreased DA neurites and larval lethality (Palgi et al., 2009; 
Lindholm and Saarma 2010). Homologues of mammalian NTs as well as Drosophila Spz 
have now also been characterised in other invertebrates including Daphnia pulex (Wilson., 
2009). 
During embryonic development DNT1, DNT2 and Spz are expressed in neuronal CNS target 
cells including en-passant midline (interneurons), muscles (motor-neurons) and optic lobes 




mutants of DNT-1, DNT-2 and Spz, resulted in increased cell death and Eve+ and HB9+ 
neuron loss in the CNS, and whereas over-expression of the mature CK forms (DNT-1CK, 
DNT2-CK and spzCK) reduced apoptosis. DNTs also promote motor-axon targeting and 
connectivity. Loss of function of all three resulted in misrouting, mistargeting and sprouting 
defects in motor axon terminals. Functionally they may be similar, however there are some 
interesting differences. In embryonic muscles DNT-1, DNT-2 and spz are required by 
different neuronal types. DNT1;DNT2 double mutants affect the targeting of  ISNb/d 
motoraxons, whereas spz mutants affect targeting of SNa motoraxons (Zhu et al., 2008).  
1.7 Downstream signalling events 
Drosophila MyD88 is comprised of an N-terminal death domain, a TIR domain and a 150 
amino acid C-terminal extension (Horng et al. 2001, Tauzsig-Dalamasure et al 2001; Charatsi 
2003). Prior to Toll activation MyD88 requires to form a pre-signalling complex via death 
domain interactions with Tube (Sun et al. 2004, Towb et al. 1998).  
Weckle (Wek) encodes a linking adaptor protein for Toll and MyD88 and is located dorsally 
at the plasma membrane of embryos. Wek is also localized to the nucleus and cytoplasm of 
fat body in larvae and adults. Localization is independent of the activation status of Toll. 
Chen et al,  showed via genetic and S2 cell experiments that Wek is epistatic of Toll and acts 
upstream of both Dorsal and Cactus. They also established through yeast-2-Hybrid assays that 
Wek-FL self-associates, thus it is likely that it homodimerises and deletion mapping and co-
immunoprecipitation studies provide evidence that WekN (N terminus of protein comprising 
amino acids 1-103) is the dimerization domain. Furthermor; co-immunoprecipitation studies 
using HA-tagged Wek transfected S2 cells interact with Flag-tagged Toll-1, Toll-9, Toll-5 and 
V5-tagged MyD88. All three domains of Wek (WekN, WekM amino acids 104-272 and 
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WekC C-terminus amino acids 273-470) are able to form stable complexes with Toll whereas 
only WekM and WekC can interact with MyD88 indicating that Wek is targeted to plasma 
membrane via the interaction with multiple sites of both Toll-1 and MyD88 in order to form a 
Toll-1/Wek/MyD88 complex (Chen et al., 2006). 
Chen et al, also showed that Wek is not required to activate a drosomycin reporter, as 
knocking down Wek mRNA levels with RNAi, had a negligible effect on the induction of 







) where exposed to Gram
+
 bacteria and a fungus however the 
expression of drosomycin mRNA was not altered between them in northern blots. Conversely 
knocking down MyD88, depleted the levels of activity of the drosomycin reporter. Therefore 
it is unlikely that Wek is required for the induction of drosomycin, and thus is not involved in 
the humoral innate immune response.       
Another Toll receptor signalling adaptor is Drosophila sterile alpha and Armadillo Motif 
(dSarm) was identified by Osterloch et al. 2012 via a forward genetic screen for loss of 
function mutants that are able to inhibit Wallerian degeneration. The dSarm gene encodes for 
a protein that contains an Armadillo/HEAT (ARM) domain, two sterile alpha motifs (SAM) 
as well as a Toll/Interleukin1 receptor homology (TIR) domain. Due to its combination of 
three protein-protein interacting domains it has the unique ability to interact with a large and 
varied range of molecules (Rodet et al. 2015).  
In vertebrates SARM1 has shown to be influential in numerous processes including 
associating with mitochondria as well as microtubules in neurons and T cells (Zhou et al. 
2013; Yuan et al. 2010). Furthermore it has also been shown that SARM1 has the ability to 
influence TLR signalling through interacting with Myd88, TRIF and TRAF6 (Zhou et al. 
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2013, Carty et al. 2006, Yang et al. 2010, Yuan et al. 2010).  
Gerdts et al, cultured DRG neurons from SARM1 mutant mice and showed that when severed 
there is a delay in degeneration of the axons, a phenotype that is rescued by the over-
expression of SARM1 by lentivirus. Furthermore, they demonstrated in vivo that severing 
SARM1 mutant sciatic nerves leads to only limited nerve loss in comparison to the control 
which by 7 days post injury resulted in complete nerve loss (Gerdts et al., 2013). Osterloh et 
al, also determined that whilst wild type mice display a breakdown of axon and myelin 
sheaths as quick as three days post lesion, SARM1 mutants are protected for up to 14 days 
and furthermore axons and myelin sheaths are preserved (Osterloh et al., 2012). These data 
indicate that SARM1 in mice is required for axonal degeneration in both sensory and motor 
fibres.  
Gerdts et al, showed that SARM1 is required for non-apoptotic neuronal death as the 
expression of SARM1 mutant lacking amino acids 1-408 (SAM-TIR fragment) is capable of 
inducing axonal degeneration in the absence of injury, and apoptotic inhibitors do not inhibit 
this (Gerdts et al., 2013).  In Drosophila dSarm is widely expressed throughout the CNS and 
has been shown to be important in driving axon degeneration and the promotion of Wallerian 
degeneration. Osterloh et al, expressed full-length dSarm cDNA and OR22Gal4 in mutant 
clones and showed it suppressed the promotion of axonal degeneration seen in the dSarm 
mutant. They also show that over-expressing full-length dSarm by OR22a-Gal4 in a dSarm 
mutant background was able to rescue lethality and inhibition of wallerian degeneration seen 
in transheterozygotes. They conclude that dSarm is required in neurons to induce axonal 
degeneration (Osterloh et al., 2012). 
1.8 The use of Drosophila CNS as a Model System: 
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The Drosophila nervous system is a powerful model organism to investigate central nervous 
system development and function. In order to carry out complex functions, the Drosophila 
central nervous system requires being just as complex. As different functions are required 
during different developmental stages, the complexity of connections needs to reflect the 
requirements at that specific stage.  
1.8.1 Cell number regulation 
Organ growth is only finalised when the required amount of cells is reached, resulting in the 
cesation of cell division (Garcia-Bellido and Garcia-Bellido, 1998). The size an organ is 
determined by the proliferative state of the cell and regulated via local cell-to-cell 
interactions. The number of cell divisions is determined by its cell fate. Cells originate from 
neuroblast populations that are able to divide to generate precursor cells. The number of 
precursor cells is dependent upon two main factors. The first is the starting number of 
neuroblasts and the second is the neuroblast fate. Cell fate is whether or not a daughter cell 
retains stem cell properties and influences the outcome of becoming a precursor cell. Cell 
cycle exit and apoptosis of the neuroblasts and precursor cells determine the number of cell 
divisions that can occur. 
Apoptosis can occur in a cell autonomous pre-determined cell fate to restrict cell number. 
Apoptosis can also occur non-autonomously following the incorrect promotion of cell 
survival from neighbouring cells. Neighbouring cells maintain survival via the production of 
pro-survival trophic factors (Raff, 1992; Raff et al., 1993). In Drosophila and mammalian 
nervous systems approximately 50% of cells undergo programmed apoptosis, and to a greater 
extent, if non-autonomous disruption occurs (White et al., 1994; Raff et al., 1993).  
Non-autonomous control of cell survival enables the adjustment of cell number for the correct 
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formation of tissues. For instance, more neurons are created than required. Only neurons that 
innervate the correct tissue, the source of trophic factors, will survive (Hamburger and Levi-
Montalcini. 1949). CNS growth is thus dependent on a fine balance of cell cycle progression 
and survival/death. Cell cycle progression and cell survival are dependent upon correct 
nutrient uptake, temperature and growth factors. Growth factors work via the activation of 
insulin receptors that induce two signalling cascades. The RAS/MAPK kinase (Bergmann et 
al., 2002) and PI3K kinase pathways (Fernandez et al., 1995; Chen et al., 1996; Brogiolo et 
al., 2001).  
In flies apoptosis is first seen during embryonic stage 11, after which it occurs throughout all 
development stages (Abrams et al., 1993). There is a peak of apoptosis during metamorphosis 
where larval tissues that are no longer required for adult development are removed (Jiang et 
al., 1997). Conservation of the main components involved in apoptosis occurs from mammals 
to flies, and involve numerous pro-apoptotic genes, initiator (in Drosophila these are Dronc, 
Dredd and Strica) and effector (in Drosophila these are drICE, dcp-1, decay and damm) 
caspases as well as inhibitor of apoptosis proteins (IAPs eg; Diap1 in Drosophila), which 
inhibit caspase activity (Xu et al., 2009). 
1.8.2 Structure of Drosophila CNS 
Precursors of the embryonic CNS (neuroblasts) derive from neurogenic regions of the 
ectoderm. Formation of neuroblasts is regulated by both proneural and neurogenic genes to 
promote or inhibit neuroblast formation respectively (Skeath and Carooll. 1994; Campos-
Ortega 1995). Neuroblasts delaminate from the ectoderm in three waves starting during 
embryonic stage 9, continuing until stage 11 (Campos-Ortega and Hartenstein, 1985). 
Neuroblasts then progress through eight rounds of mitosis, forming ganglion mother cells 
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(GMC) which themselves then divide during stage 12 to create two neurons or glial cells (or a 
neuron and a glial cell) (Goodman and Doe, 1993). Commisural pioneer axons cross the 
midline of embryos in order to create two commissures (anterior and posterior). Longitudinal 
fibers form connectives for each segment (Hidalgo and Brand, 1997).  It is the formation and 
anatomical positioning of these two commissures and their connection to longitudinal 
connectives that produce the laddered appearance of the embryonic neuropile (Goodman and 
Doe, 1993). Condensation of the VNC begins during stage 17 of embryo development.   
During larval development the rate of CNS growth increases and the overall anatomy changes 
markedly in preparation for development into a fully formed adult. Neuroblasts derived from 
embryonic stages divide for a second time generating numerous immature, post-mitotic 
neurons (Prokop and Technau, 1991).  
During metamorphosis interneurons extend both axons and dendrites and immature neurons 
differentiate sending out axons to target cells. Those cells that are no longer required or in 
abundance undergo programmed cell death in order to efficiently eliminate them (Truman, 
1990). Optic lobes proliferate giving rise to both the outer and inner optic anlagen, which will 
go onto develop into the laminae, medulla, lobula and lobula plate (Hofbauer and Campos-
Ortega 1990). Pupae undergo extensive remodeling with extensive programmed cell death 
and presumptive adult neurons differentiate. The optic lobes and some central brain 
compartments develop into the supraesophageal zone. A region of the adult brain that 
includes three fused neuromeres, the protocerebrum, deutocerebrum and tritocerebrum. 
Furthermore the VNC develop into the subesophageal ganglion. This region consists of fused 
ganglia of three gnathal segments the mandibular ganglion, maxillary ganglion and labial 




1.8.3 Circadian Rhythms 
Circadian clocks regulate numerous rhythmic outputs including eclosion and locomotion. 
They do this through the involvement of numerous “clock” genes. The genes function to 
activate or repress transcription or modify stability, location, or the degradation of proteins 
(Hall, 2003). Transcriptional activators include Clock (Clk) and Cycle (Cyc) and Par domain 
protein 1ε (PDP1ε) (Rutila et al., 1998; Allada et al., 1998; Darlington et al., 1998; Cyran et 
al., 2003). Transcriptional repressors include Period (Per) and Timeless (Tim) that inhibit the 
functions of Clk-Cyc (; Darlington et al., 1998; Cyran et al., 2003). Proteins involved in 
stability and location include Doubletime (Dbt) (Price et al., 1998; Kloss et al., 1998), Casein 
kinase 2 (CK2) (Lin et al., 2002; Akten et al., 2003), Shaggy (Sgg) (Martinek  et al., 2001) 
and protein phosphatase 2a (PP2a) (Sathyanarayanan et al., 2004). Proteins associated with 
Per degradation include Slimb (Slmb) (Ko et al., 2002; Grima et al., 2002).  
 
Regulation of circadian rythyms is via two intracellular feedback mechanisms. The first is a 
Per/Tim loop and the second is a Clk loop (Hardin et al., 1990; Glossop et al., 1999). 
Transcription of associated clock genes is regulated via the protein products associated to 
each loop.  
 
In the Per/Tim feedback mechanism, Clk-Cyc heterodimers activate transcription of Per and 
Tim as they bind to E-boxes from mid-day to early evening (Darlington et al., 1998; Hao et 
al., 1997; Wang et al., 2001). Per is phosphorylated by Dbt and CK2 (Price et al., 1998; Kloss 
et al., 1998; Akten et al., 2003; Nawathean and Rosbash, 2004). Tim binds to and stabalises 
the phosphorylated Per-Dbt complex. PP2a also works to stablises this Tim-Per-Dbt complex 
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(Lin et al., 2002; Akten et al., 2003;  Martinek  et al., 2001). Sgg and CK2 phosphorylates 
this complex translocating it from cytoplasm to nucleus (Kloss et al., 2001; Ashmore et al., 
2003; Shafer et al., 2002). The complex then binds Clk-Cyc, subsequently inhibiting the 
transcription of Per and Tim (Lee et al., 1999). Dbt phosphorylation destabilizes and degrades 
Per and Clk. Tim is degraded via tyrosine phosphorylation. Non-phosphorylated Clk and Cyc 
accumulate and trigger further cycles of Per and Tim transcription.  
 
In the Clk feedback mechanism, during early evening Clk-Cyc heterodimers activate 
transcription of PDP1ε and Vri. Vri binds to V/P boxes to inhibit Clk transcription (Cyran et 
al., 2003; Glossop et al., 1999). PDP1ε accumulates during this time to remove Vri and 
activate Clk transcription (Cyran et al., 2003). A clock independent activator (Act) activates 
Clk and potentiates accumulation of non-phosphorylated Clk, which again forms 
heterodimers with Cyc, and the cycle begins again (Cyran et al., 2003; Glossop et al., 1999). 
This loop also controls Cryptochrome (Cry) transcription, which encodes a photoreceptor that 
function in numerous tissues (Stanewsky et al., 1998; Emery et al., 1998; Krishnan et al., 
2001; Ivanchenko et al., 2001). 
 
Small ventral lateral neurons (sLNvs) are required for regular locomotor activity rhythms 
under dark/dark (DD) conditions. These sLNVs project into the dorsal brain, and contain the 
neuropeptide pigment-dispersing factor (PDF), which is pivotal in maintaining free running 
locomotor activity rhythms (Renn et al., 1999; Park et al., 2000).  In light/dark (LD) 
conditions there are two main activity peaks, the first in the morning, and the next in the 
evening. Different oscillators differentially regulate the different peaks with morning activity 
driven by venterolateral neurons (LNVs) and the evening by dorsolateral neurons (LNDs) 
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(Stoleru et al., 2004; Grima et al., 2004). In all there are in the region of 150 neurons that 
express “clock” genes dispersed throughout the adult brain (Nitabach and Taghert, 2008) that 
are activated/suppressed by Zeitgebers. 
1.8.4 Drosophila Tools 
Since the sequencing of the Drosophila genome in 2000 and the continuing development of 
different genetic tools there has been an increase in the ability to monitor or express an 
exogenous gene in a tightly regulated manner. Detection of gene enhancers were originally 
identified for their use in bacteria by Casadaban and Cohen 1979, who designed a vector, 
which was able to randomly integrate into the Escherichia coli chromosome, and carried a 
promoterless lac operon. The first gene enhancers for use in Drosophila were generated from 
transposable P-elements introducing the lacZ gene into the genome (O’Kane and Gehring, 
1987). A P-element promoter then drives the gene and gene expression monitored via β-
galactosidase activity (O’Kane and Gehring, 1987). Over time this gene enhancer has been 
developed further to incorporate mechanisms for their effective use such as carrying a 
dominant mini-white marker for increase genetic manipulation (Bier et al., 1989). 
One of the most widely used gene enhancer tools for targeted gene expression is the 
GAL4/UAS system (Figure 1.6). Originally identified in the yeast Saccharomyces cerevisiae 
as a potent gene regulator GAL4 encodes an 881 amino acid protein induced by galactose 
(Oshima et al., 1982; Laughon et al., 1984). In 1988, Fisher et al. demonstrated that the 
GAL4 transcriptional activator also functions in the Drosophila system where it is able to 
induce transcription of a specific reporter gene under Upstream Activating Sequences (UAS; 
series of GAL4 binding sites) control. The UAS/Gal4 system has become one of the most 




Furthermore there appears to be no deleterious phenotypic effects of this system, as the gene 
of interest (responder) is controlled by presence of UAS element, and its transcription is 
reliant upon the presence of GAL4 (driver), both of which are maintained in separate parental 
flies and thus requires mating for expression. This combination results in offspring, which 
express the responder wherever the GAL4 is driven (Duffy. 2002). The transgenes that were 
expressed in flies using the UAS/Gal4 system during this thesis are detailed in Table 2.1. A 
known limitation of GAL4 lines is that they may not always reflect endogenous expression of 
the gene of interest. This may be due to the lack a enhancer and/or repressor element required 
or the insert may affect the region into which it was inserted (Duffy. 2002). Furthermore the 
size, orientation and position (namely distance to promoter) have to be accurate for specific 
reflection of endogenous signal (Mayer et al., 2013). 
Minos Mediated Integrated Cassette (MiMIC) transposons were derived via TE mobilization 
using Mi{MIC} construct. This construct carries a gene trap cassette as well as a yellow+ 
marker and a Avic\GFP fluorescent marker, all flanked by two inverted attP sites. These sites 
allow the conversion of a transposon sequence with any other via ϕC31 recombinase-
mediated cassette exchange (RMCE) (Venken et al., 2011). The transposon is exceptionally 
versatile as it can be modified due to the inversion of the attP sites allowing rapid change over 
of cassettes. For example, protein traps are achieved via the conversion of MiMIC insertions 
within coding introns into an artificial exon which encodes a protein tag e.g. GFP and thus 
creates protein fusion allowing the visualization of endogenous protein (Gnerer et al., 2015).  
Antibodies allow the detection of highly specific molecules within cells and tissues. They 
allow investigation into location and function of desired proteins, and when used correctly 
provide consistent results. Two antibodies that are used widely throughout this thesis include 
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anti-cleaved Drosophila death caspase-1 (Dcp-1) and anti-even skipped (Eve). Dcp-1 is one 
of seven known caspase genes (three initiator and four effector caspases). Dcp-1 is an effector 
caspase involved in the induction of apoptosis, and is therefore a very good readout of cell 
death (Steller et al., 1994; Hay and Guo., 2006; Song et al., 1997; Florentin and Arama., 
2012). Eve is expressed in a small subset of neurons, which include qCC, pCC, RP2, CQ and 
















1.9 Aims of thesis 
The aims of this thesis are to investigate if all of the Toll receptors are functionally equivalent 
in the Drosophila central nervous system and whether they can regulate cell number plasticity 
via the promotion of cell death and/or survival. 
The specific research objectives are: 
1. To visualize and test if all of the Toll receptors are expressed within the CNS of 
Drosophila 
a. This will be achieved through the use of immunohistochemical techniques and 
Drosophila genetic tools.  
2. To test if all of the Toll receptors effect behaviour equally 
a. This will be achieved through the use of Trikinetics behavioural assays using 
over-expression and knockdown of the Toll receptors in neurons and glial 
cells.  
3. To test if all of the Toll receptors affect CNS size, shape and cell number equally 
a. This will be achieved via the over-expression and knockdown of Toll receptors 
in neurons and glia following which VNC length and CNS area are measured. I 
will then test Toll receptors and DNTs ability to regulate cell survival and cell 
death using antibodies stainings and deadeasy software 
4. To determine the signalling mechanisms downstream of Toll-6 that regulate both cell 
survival and death 
a. Test the effects of altering candidate downstream adaptors of Toll-6 using cell 





MATERIALS AND METHODS 
2.1 Genetics 
2.1.1 Fly Stocks 
 
Drosophila melanogaster was maintained on standard agar medium at 18 degrees for all 
stocks and at 25 degrees for all experimental flies along with a 12 hour light/dark cycle 
unless otherwise stated. Full lists of fly stocks used in experiments are shown in Table 
2.1.  
 
2.1.2 Genetic protocols  
 
Drosophila is such a powerful model organism for use in biological research due in a 
large part to the conventional genetic techniques that can be utilised in order decipher 
different mechanisms which underpin fundamental biological processes. Throughout 
this thesis I have used a number of conventional genetic approaches to obtaining the 
desired fly lines for my research, including combinations of alleles on the second and 
third chromosomes (Figure 2.1) as well as recombination’s on both the second (Figure 
2.2) and the third chromosomes (Figure 2.3).  
 
Drosophila has three pairs of autosomal chromosomes, each containing a left (L) and 
right (R) arm, as well as an X and Y chromosome. Each chromosome arm is assigned 
recombination units that allow the calculation of frequency of recombination between 







during every meiotic event, particularly in cases where the two gene positions are very 
close to each other on the chromosome. Thus the frequency with which recombination 
events take place is proportional to the distance between the two loci of interest along 
the chromosome. If these locations are known in relation to the cytogenetic map, their 
recombination frequency can be roughly estimated (Figure 2.4 for an example). If the 
positions of one or both are not known, estimations can not be made to determine 
recombination frequency and thus single mating’s at F3 is usually set to 50 in the first 
instance to increase the likelihood of establishing a recombinant line. 
 
Numerous transgenic lines contain the P{3xP3-EGFP) promoter which drives a 3xP3-
RFP or GFP fluorescent phenotype as seen in Figure 3.13. 3xP3 was inserted using the 
Cre-LoxP system and therefore I was able to genetically remove this promoter with Cre-
recombinase to ensure that any fluorescent phenotype that was visualised could be 
accurately attributed to the gene of interest and not the 3xP3 promoter (Figure 2.5). 
 
2.1.3 CNS Area and VNC Length study  
 
Driver strains included the post mitotic neuronal driver Elav-Gal4 and the pan-glial 
driver Repo-Gal4. Flies homozygous or balanced over SM6aTM6B for the UAS-RNAi 
(Knock-down) or UAS-Toll (over expression) were crossed to those carrying the above 
transgenic driver promoting UAS transgene expression. Control lines carrying the 
GAL4 transgene were crossed to YW for comparison. The CNS of wandering larvae 
were dissected and fixed for 50 minutes in 4% formaldehyde in PEM (0.1M PIPES, 





10 minutes. Brains were then stored in 80% glycerol until mounted onto glass slides. 
Bright field images were acquired using a Zeiss Axioplan 2 microscope and 40x 
objective. Image J was then used to measure both the CNS area and VNC size using a 
free hand area selection tool and a line selection tool respectively (Figure 2.6 for 
example and landmarks).   
 
2.2 Behavioral Assays 
 
2.2.1 Adult locomotion 
 
Driver strains were crossed to flies homozygous or balanced UAS-RNAi (Knock-down) 
or UAS-Toll (over expression). Control lines carrying only the GAL4 transgene without 
the UAS-RNAi or UAS-Toll were used for comparison. Male flies between 1-3 days 
old were collected and separated as virgins and were used to monitor activity. Flies 
were monitored using Trikinetics DAM2 activity monitors. Thirty-two flies per 
genotype were individually analysed in activity assays tubes for 3 days in 12-h light and 
12-h dark cycles, with a constant temperature of 25 °C settings of the incubator. 
Locomotor activity was determined as the average number of infrared beam crossings 
per 5-min bin spanning the full three-day period. Any fly that died during the 
experiment was excluded from the results. A behavioural analysis software package 









2.3 Molecular Biology 
 
2.3.1 RT-PCR 
Collection of embryos, dissection of second instar, third instar wandering larvae or 
pupae, and whole head preparations of Oregon-R (wild type) or ElavGal4>UASgcm 
(embryos only) were the starting materials. Total RNA was extracted from the starting 
samples by Trizol (Ambion) reagent. RNA integrity and concentration was confirmed 
via Nano-drop. RNA samples were DNase treated to remove residual genomic DNA 
contamination. 300ng of RNA was used for cDNA synthesis following GoScript™ 
Reverse Transcriptase methods. Samples were diluted 1:3 with Nuclease free H20, and a 
no RT sample of 300ng of RNA made up to 60µl with Nuclease free H20. Standard 
PCR reaction was performed to amplify each of the Toll receptor cDNA using GoTaq 
PCR protocol. PCR primers were designed using primer-BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) and 2uM of forward and reverse 
primers specific to each sample were used (See table 2.2 and 2.3 for primer list and 
PCR programme). GAPDH is a general housekeeping gene that was used as a positive 
control during every round of PCR. Gel electrophoresis for RT-PCR products were then 
carried out.   
2.3.2 Immunohistochemistry 
 
In order to ensure maximal stages were gathered for embryonic samples, embryos were 
collected from grape juice plates supplemented with yeast after 16.5 hours at 25°C. 
Embryos were then dechorionated (16% sodium hypochlorite), and fixed (4% 





Formaldehyde was removed and replaced with methanol to devitillinise embryos 
through gentle vortexing. Methanol was then used to wash the embryos, followed by 
washing with PBT for six times every 10 minutes. Embryos were then incubated with 
primary antibodies (Full list see table 2.4) at 4°C overnight, followed by washing steps 
to remove primary, and the addition of secondary antibodies which were incubated in 
the dark overnight at 4°C. Following a final round of washing embryos were allowed to 
settle in glycerol prior to mounting on glass slides and image analysis.  
 
Larval, pupal or adult brains were dissected in cold PBS for no longer than 20 minutes. 
They were directly placed into a fixative solution for 50 minutes (5 minutes for anti-Eve 
staining) after which they were washed 5 x 10 minutes, allowed to rest in Normal Goat 
Serum for one hour and then transferred to primary antibodies, which were used no 
greater than five times. After incubation of the brains in the primary antibody at 4°C 
overnight, brains were washed in PBT, and secondary antibodies were added and 
incubated again at 4°C overnight. Following a final round of washing brains were 
allowed to settle in glycerol (generally 1-2 hours) before mounting on glass slides and 
image analysis. 
 
Staining’s were carried out on wandering third stage larvae, one day pupae for general 
antibody staining or when staining to detect apoptosis only pupae within the first 10 
minutes were dissected to reduce any biological variety, and 1-5 day old adults. Staining 
was completed in batches of 5 to 10 brains under the same conditions for direct 
comparison experiments. Most often staining’s were repeated on multiple occasions to 




sections removed from two slices of sticky tape acting like a bridge. The area was then 
saturated in 70% glycerol and a cover slip gently placed on top ensuring that pressure 




All fluorescent confocal scanning was carried out on a Leica SP2-AOBS and a 20x or 
40x oil immersion lens at either 512:512 or 1024:1024 pixel resolution, with between a 
0.5 > 1.0um step increase. Confocal stacks were then analysed and processed using 
Image J software. Adobe Photoshop and Illustrator were subsequently used to process 
the images in order to generate image plates.  
 
Numerous image J plugins were used in order to quantify phenotypes. Retinal pJNK+ 
cells were counted manually from a complete confocal stack using the cell counter 
macro. DeadEasy Larval Caspase software (Forero et al. 2009; Kato et al., 2011) was 
used to count Dcp1+ apoptotic cells in both complete stacks of the retina, as well as 
along the entire VNC of the pupal CNS. The full VNC was counted for apoptotic cells 
with boundaries specified as surrounding the VNC and up to the edges of optic lobes 
(Figure 2.8). DeadEasy larval glia software (Forero et al. 2012) counts nuclear stains 
and was used to quantify the number of Eve+ cells in the larval and pupal VNC. The 







2.4 Statistical Analysis 
 
All data have been analysed using SPSS statistical software. Continuous data including 
counts of Dcp1+, pJNK+ and Eve+ cells were tested for normality by kurtosis and 
skewness, and a Levenes test to determine homogeneity of variance. If Leven’s did not 
pass significance, data were analysed using a One Way ANOVA. If Leven’s test was 
significant a Welch ANOVA was used. Post-Hoc testing compared multiple genotypes 
to a control via the Dunnett test, or when comparisons were made to each other via a 








TOLLS ARE EXPRESSED WITHIN THE CNS OF 
DROSOPHILA AT DIFFERING TIMES 
3.1 INTRODUCTION 
It has been reported previously that not all of the Toll receptors are involved in immunity 
related functions. Therefore they may function within the nervous system. In order to 
characterize the functions of the different Toll receptors, it was pivotal in the first instance to 
investigate where they are expressed. The aim of this chapter was therefore to determine a 
spatial and temporal profile of Toll receptor expression within the CNS. RT-PCR was utilized 
to determine the stages of development that each of the Tolls is expressed, in wild type CNS. 
Using a combination of genetics and RT-PCR allowed the determination of the Tolls within 
glial and/or neuronal cells.  
Immunohistochemistry was then utilised to further characterize the expression profiles of 
three of the Toll receptors (Toll-2, Toll-3 and Toll-8). The expression of Toll-1, Toll-6 and 
Toll-7 in the CNS has already been documented (McIlroy et al., 2013; Sutcliffe B PhD 
Thesis; Lim A PhD Thesis, and M.P.Nallasivan unpublished data). Genetic tools were not 
available for Toll-4 and Toll-5. Toll-9Gal4 flies became available, however unfortunately it 
contains the P{3xP3-EGFP) promoter (Figure 3.14) which is expressed within the central 
nervous system. I have genetically removed this promoter from this line however time 
limitations prevented the expression profile from being characterised. These data show that 
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some of the Toll receptors are expressed to different levels during different developmental 
stages. 
3.2 RESULTS 
3.2.1 Toll receptors are expressed throughout development in neurons and glia 
To determine if any of the Toll receptors are expressed within the CNS, RT-PCR was carried 
out during differing developmental time points. Collection of embryos, dissection of second 
instar, third instar wandering larvae or pupae brains, and whole head preparations of Oregon-
R (wild type) or ElavGal4>UASgcm (embryos only) were the starting materials. Total RNA 
was extracted from the starting samples by Trizol (Ambion) reagent. RNA integrity and 
concentration was confirmed via Nano-drop. RNA samples were DNase treated to remove 
residual genomic DNA contamination. 300ng of RNA was used for cDNA synthesis 
following GoScript™ Reverse Transcriptase methods. Samples were diluted 1:3 with 
Nuclease free H20, and a no RT sample of 300ng of RNA made up to 60ul with Nuclease free 
H20. Standard PCR reaction was performed to amplify each of the Toll receptor cDNA using 
GoTaq PCR protocol. 2uM of forward and reverse primers were designed specific to each 
Toll gene of interest (See table 2.2 and 2.3 for primer sequences and PCR programme). 
GAPDH is a general housekeeping gene that was used as a positive control during every 
round of PCR. Gel electrophoresis for RT-PCR products were then carried out.   
Toll-1, Toll-2, Toll-5, Toll-6, Toll-7 and Toll-8 are expressed in abundance during all 
developmental stages. Toll-4 and Toll-9 are also expressed during all developmental stages. 
Toll-3 is slightly different again to the other Tolls as there is no detectable expression during 
second instar larvae, and only low expression during all other time points (Figure 3.1). 





cell missing (gcm) transcription factors. Gcm functions via downstream transcription factors 
in order to maintain glial gene expression. To determine if the Toll receptors are expressed 
within neurons or glial cells I changed cell fate to a glial cell fate and tested if there were 
changes in expression of the Toll receptors. ElavGAL4, a neuronal and post-miotic driver 
line, was crossed to UASgcm. This cross leads to the expression of gcm in all neurons, and 
thus all cells ultimately have a glial fate.  
In Elavgal4>UASgcm embryos, all of the Tolls are detected during the embryonic stage 
(Figure 3.2). This includes those Tolls (Toll-3, Toll-4 and Toll-9), which were expressed 
much lower levels (Figure 3.1). This suggests that some or all of the Tolls are expressed in 
glia or that the expression of gcm somehow regulates the Toll receptors.  
3.2.2 Toll-2 is expressed in the CNS during all developmental stages 
 
Toll-2 (also known as 18w) expression was visualized using a lacZ enhancer trap line 
y1w67623(PlacW)18wK02701 (here after named Toll-2K02701) and anti-βgal antibodies (Figures 3.3 
to 3.5). The lacZ insertion is located 4bp upstream of the Toll-2 transcriptional start point, and 
is in the correct orientation. Toll-2K02701 is distributed throughout the stage16/17 embryo 
(Figure 3.3). Toll-2K02701 is located in the head region (Figure 3.3A arrow 1), origin of 
heamocytes, the procephalic mesoderm (Figure 3.3A arrow 2), along the ventral midline 
(Figure 3.3A arrow 4) and within the ventral muscles (Figure 3.3A arrow 3). 
 
In third star wandering larvae, Toll-2K02701 is predominantly distributed throughout the optic 
lobes. There is expression of Toll-2K02701 within cells of the laminae that innervate the 







located within the corpus allatum of the ring gland (Figure 3.4). In the Adult brain Toll-
2K02701 is distributed throughout the medulla. There are a couple of individual cells within the 
central brain region in close proximity to the wedge region (Figure 3.5).  
 
3.2.3 Toll-3 is expressed at low levels in the larvae increasing in the adult stage 
 
Toll-3 (also known as Mstprox) expression was visualized using Toll-3MIMICMIO2994 flies 
bearing a MIMIC- GFP insertion 1.6kb into the Toll-3 locus in the correct orientation. There 
was no expression of Toll-3MIMICMIO2994 in either early stage or late stage embryos (Figure 
3.6). In the larval CNS Toll-3MIMICMIO2994 was distributed throughout the VNC at very low 
levels along the neuropile. Within the optic lobes there is expression of Toll-3MIMICMIO2994 in 
the lateral most regions, possibly close to the developing laminae. Furthermore there is some 
expression located within the central brain (Figure 3.7). In the adult brain Toll-3MIMICMIO2994 
is distributed throughout the outer medulla and a small group of highly expressed cells located 
in the region of the gnathal ganglion (Figure 3.8Ai & B). Toll-3MIMICMIO2994 is also 
distributed within the fan shaped body and the mushroom bodies (Figure 3.8Ai, Aii & B).  
 
3.2.4 Toll-8 is widely distributed throughout the wandering L3 and adult CNS.  
 
Toll-8 (also known as Tollo) expression was visualized using Toll-8Gal4MD806 flies bearing a 
GAL4 enhancer located 180bp upstream of Toll-8 transcriptional start site. These flies were 
used to drive the expression of membrane-tethered 10xUAS-myr-td-Tomato, in conjunction 
with anti-DsRed antibodies. Toll-8Gal4MD806>myr-td-Tomato is distributed widely within the 






projections that innervate the CNS (Figure 3.9 Ci & Cii). Toll-8Gal4MD806>myr-td-Tomato is 
widely distributed throughout the optic lobes in particular within the medullae and the central 
brain (Figure 3.9 Bi & Bii). In the adult brain, Toll-8Gal4MD806>myr-td-Tomato is distributed 
throughout the outer medulla (Figure 3.10B: blue; Figure 3.12), fan shape body and 
mushroom bodies (Figure 3.10B: yellow and green; Figure 3.11), ventro lateral 
protocerebrum (Figure 3.10B: orange). Overall expression of Toll-8Gal4MD806>myr-td-Tomato 
is widely distributed throughout both the optic lobes and central brain of the larvae and adult 
























In this chapter I have shown (Figure 3.13 and Table 3.1): 
1) Most of the Tolls are expressed during all developmental stages 
2) All of the Tolls are either expressed in glia or are regulated by gcm 
3) Toll-2K02701 is widely distributed throughout the embryo, and is predominantly 
confined to the optic lobes in both larval and adult stages. 
4) Toll-3MIMICMIO2994 is not expressed during embryonic development. There are very 
low levels of expression within the VNC and optic lobes during larval stages and 
within the optic lobes of the adult.  
5) Toll-8Gal4MD806 is very widely distributed throughout the entire CNS in both larval and 
adult stages. 
 
I have used a combination of genetic tools, including lacZ, MiMIC and Gal4 fly lines, and 
molecular techniques to determine if the Tolls are located within the CNS and in which cell 
types. I have established that whilst the Toll receptors belong to the same protein family, they 
are required in different areas of the CNS and in different cell types during development. The 
use of whole embryo and adult head instead of dissection of CNS could add robustness to this 
assay in the future. However as the data show no concerning results this work provides 
evidence that the Tolls are likely to be expressed within the CNS at these stages.  
 
Through the use of RT-PCR and antibody staining’s I have shown that Toll-2K02701 is 
expressed during all developmental stages. In later developmental periods including the larval 




Similarly Toll-3MIMICMIO2994 was shown to be restricted in both the larval and to greater 
extent to the adult optic regions only. There was no detectable expression of Toll-
3MIMICMIO2994 during embryonic stages via immune-histochemical means. This may be due 
to the fact that Toll-3 is simply not expressed or that the endogenous expression levels are so 
low or restricted to only a few cells, possibly outwith the CNS. RT-PCR results also confirm 
the finding that Toll-3 is likely to be expressed at low levels or not at all as in early larval 
stages. Contrastingly, Toll-8
MD806
 was detected in abundance throughout the CNS in both the 
larval and adult stages. These findings were confirmed by RT-PCR data. 
 
The use of molecular tools in order to determine the patterns of gene expression is a sound 
starting point for any analysis. The use of Gal4 lines can identify cell morphology normally 
expressing the gene of interest (in this case Toll-8). Furthermore the amplification effect can 
greatly enhance detection levels. However these tools also have certain limitations, as they are 
crucial during the interpretation of any result. For instance, perdurance of the gene product 
(e.g. B-galactosidase) following endogenous gene switch off resulting in longer temporal 
expression than the endogenous protein. The location of the reporter related to the gene of 
interest is also an important consideration. For instance if only a part of an upstream 
intergenic region is cloned into the vector, regulatory elements may not be incorporated into 
the fragment to be amplified. Furthermore dependent upon where the construct lands within 
the genome following transformation, influences positional effects of either enhancers or 
repressors.   
 
Furthermore the location of endogenous genes both spatially and temporally does not always 
relate to function. To be more confident in regards to detecting the cellular distribution of my 
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Toll genes, In situ hybridisation to detect specific mRNA would be beneficial. However, a 
draw back of in-situ is the difficulty of obtaining reliable data. Poor resolution during this 
process means that you are unable to determine what cell type the gene of interest is located 
in, and you can thus only determine a rough spatial profile. For instance the resulting signal is 
restricted to mRNA location, in neurons this is typically the soma. Therefore in order to 
establish specific cell types double in situ staining’s would be required.   
 
All of the Toll receptors (with the exception of Toll-3 in second instar larvae) are expressed 
during all developmental stages. Toll-3, Toll-4 and Toll-9 are different to the others in that 
they are expressed at much lower levels. Indicating they are either more transient in nature or 
are expressed in fewer cells. For example Toll-9 in embryos is expressed only during stage 9 
of embryonic development (Kambris et al., 2002).  
 
It is interesting to note that the entire Toll receptor group are expressed when gcm is over-
expressed in all neurons. This indicates that all are expressed in glial cells or may be regulated 
by gcm. Interestingly even the Tolls that were expressed at lower levels (Toll3, Toll-4 and 
Toll-9) in wild type samples were detected when gcm is over-expressed in neurons. RT-PCR 
testing however is qualitative, and for quantitative results qRT-PCR would be required. 
Furthermore, the embryo’s were full mount and adult was full head samples. Both of which 
would be more representative if they were only CNS samples, however; this would have been 
much more time consuming considering the number of samples required for each reaction.   
 
Furthermore gcm mutants may have been a better control than wild-type as mutant’s lead to 
the failure of presumptive glial cell differentiation into glia. When over-expressing gcm in 
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neurons, this results in lethality following the embryonic stage and therefore I was unable to 
test any of the later developmental time points. It may be possible to use the Gal80 system in 
order to only switch on UASgcm function when desired (e.g. L2, L3, Pupae and adult) to 
perform the same test and determine if any of the Tolls expressed in glia or regulated by gcm 
at later developmental time points.   
 
Some early differences between the Toll receptors have been established. Using the RT-PCR 
data Toll-3, Toll-4 and Toll-9 may be expressed at lower levels within the CNS. Expression 
data via anti body staining shows that Toll-2 and Toll-3 are much lower expressed than Toll-
8. Furthermore when over-expressing gcm in neurons, there is an increase in Toll-9 indicating 
it may be more glial than neuronal. Whereas Toll-3 and Toll-4 levels still remain relatively 
low. Therefore I initially propose that there are two groupings of the Toll receptors that are 
dependent upon the cell type involved (Figure 3.13 & Table 3.1). 
 
In the next chapter I will investigate if the Toll receptors function in the same manner within 
the CNS. Using both knockdown and over-expression conditions I will test if all nine 
receptors affect behaviour equally. To do this I will use TriKinetics assays to monitor activity 






TOLL RECEPTORS HAVE DISTINCT 




In the previous chapter I showed that all Toll receptors are expressed in the embryo, CNS of 
stage 2 larvae (except for Toll-3), stage 3 larvae and pupae, and in adult heads. Toll-2K02701, 
Toll-3MIMICMIO2994 and Toll-8Gal4MD806 are expressed within the CNS during larval and adult 
stages, particularly in the optic lobe regions. Toll-3, Toll-4 and Toll-9 are more transient in 
nature than the other Toll receptors and group together. Toll-9 in particular appears to be 
more glial than the other Tolls.  
 
Overall data from chapter 3 show that the Tolls are not equal. The aim of this chapter 
therefore was to determine if there were any functional differences between the Toll receptors 
in the CNS. I used phenotypic assays to ask these questions. I asked whether all nine Toll 
receptors affected locomotion equally. Using over-expression and knockdown conditions, I 
tested their behaviour via their activity levels over a three-day period.  
 
Drosophila behaviour is a very common tool to investigate nervous system function 
(Heisenberg, 1997). Circadian clocks regulate numerous rhythmic outputs including eclosion 
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and locomotion. They do this through the involvement of numerous “clock” genes. These 
genes function to activate or repress transcription or modify stability, location, or the 
degradation of proteins (Hall, 2003). Regulation of circadian rhythms are via transcriptional 
feedback mechanisms that result in the oscillation of numerous gene products. These 
feedback loops are the Per/Tim loop and the Clk loop (Hardin et al., 1990; Glossop et al., 
1999). Importantly different neuronal types are required for the regulation of locomotion due 
to different environmental conditions (Renn et al., 1999; Park et al., 2000; Stoleru et al., 
2004; Grima et al., 2004), and there are in the region of 150 neurons that express “clock” 
genes dispersed throughout the adult brain (Nitabach and Taghert, 2008).  
 
These clock genes are activated/suppressed by Zeitgebers. Originally coined by Jurgen 
Aschoff, Zeitgebers are exogenous cues that influence timing of biological clocks. Zeitgebers 
include light, temperature, exercise, social cues, feeding behaviours and pharmacological 
manipulations (Rusak, 1981; Moore-Ede et al., 1982; Roenneberg and Foster, 1997; 
Saunders, 2002; Dunlap et al., 2003; Sharma. 2003). Circadian rhythms rely upon Zeitgebers 
in order to maintain desired routines. Zeitgeber time is now widely used in the study of 
circadian rythyms to depict the daily cycles that occur within a 24-hour period.  
 
With the advent of TriKinetics systems, the ability to monitor and quantify the movement of 
multiple animals at any given time has benefited this area of exploration. Multiple behaviours 
can be simultaneously observed and measured including but not excluded to circadian 
rhythms, sleep and activity levels and thus these assays provide a invaluable tool in order to 
probe gene function (Pfeiffenberger et al., 2010). Throughout this thesis ‘day’ is defined by 
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the 12 hour period where the incubator lights are switched on, and ‘night or evening’ when 
they are switched off. Temperature remains constant throughout experiments at 25°C. 
 
I have shown that some of the Toll receptors are located throughout the optic regions and 
central brain of both larvae and adult flies. Furthermore it has been shown that all Toll 
receptors are not required in immunity, thus they may have other functions in the CNS. And I 
have now shown that they are not all equal in their expression. To determine if the Tolls are 



















4.2.1 Different Tolls have different consequences in locomotion 
 
Under laboratory light-dark (LD) conditions wild-type flies display a bimodal activity pattern 
(Dubruille and Emery, 2008) the first activity peak occurs just prior to dawn (morning peak) 
where there is anticipation of increasing light conditions. The second activity peak occurs just 
prior to dusk (evening peak) and anticipates lowering light conditions. This bimodal pattern 
does not solely rely on environmental conditions but is an intrinsic feature of internal clock 
whereby there is reciprocal synergy between many clock factors including several genes 
involved in regulatory feedback loops to initiate circadian cycling (Hall, 2003). McIlroy et al 
2013, showed that both Toll-6 and Toll-7 are distributed throughout regions of locomotor 
control, and are required in larval locomotion (McIlroy et al., 2013). To test if the nine Tolls 
had different or equal functions in locomotion, the activity of adult flies that either over-
expressed each of the Tolls or had them knocked-down by RNAi, in neurons or glia, was 
monitored over a three-day period.   
 
4.2.2 Different Tolls in glia have different consequences in locomotion 
 
Over-expression of Drosophila Tolls in glia, with the exception of midline glia, using 
RepoGal4+ caused minor behavioural phenotypes with UAS Toll-3, UAS Toll-6 and UAS 
Toll-8 displaying hyperactive overshooting in both morning and evening activity peaks 
(Figure 4.1). Once the evening period had begun, they subsequently remained active for 





The most striking results however where seen with the over-expression of Toll-1 and Toll-9. 
Over-expression of UAS Toll-1 (RepoGAL4>Toll-1) (Figure 4.2A) resulted in relatively 
normal daytime activity followed by a phase shift during the evening. They fail to anticipate 
changes in light at the appropriate time; consequently failing to meet the activity levels seen 
in the control groups. Over-expression of UAS Toll-9 (Figure 4.2B) in glial cells leads to a 
greater incidence of day and night time activity with a bout of increase anticipatory response 
just prior to the normal morning peak.   
 
Knockdown of several of the Tolls with RNAi (RepoGAL4>UASToll-RNAi) in glia resulted 
in disruption of normal waking activity levels (Figure 4.3). Toll-4 and Toll-9 displayed lower 
activity levels during the day whilst UAS Toll-1, UAS Toll-2 and UAS Toll-8 had increased 
activity levels during the evening period (Figure 4.3).  
 
Knocking down Toll-5 in glia (RepoGAL4>UASToll-5RNAi) Figure 4.4A) displayed normal 
rhythmic patterns during the day. However they have a slower anticipatory response to the 
changing light conditions prior to dusk, followed by a substantial peak of hyperactivity at the 
onset of the evening period and greater activity levels throughout most of the evening hours. 
Contrastingly; knocking down Toll-7 (Figure 4.4 B) leads to visible arrhythmicity during both 
day and evening periods. Instead of presenting a bimodal activity pattern they display more 
crepuscular patterns. They are hyperactive later during the day and entering the evening 
period. This hyperactivity peak is subsequently followed by a crash during the later phase of 







4.2.3 Different Tolls in neuropile glia have different consequences in locomotion 
Since RepoGAL4 drives expression in all glia except midline glia, which includes glia 
forming the blood-brain barrier and enwrapping the CNS, I wondered whether the Tolls may 
have distinct functions in the neuropile glia, which are the glial class in contact with axons 
and synapses. Over-expression of the Tolls in neuropile glia with AlrmGal4 caused 
behavioural phenotypes in Activity (Figure 4.5): all of the Tolls were more active at night and 
their behaviour was more variable during the day. UAS Toll1, UAS Toll-6, UAS Toll-8 and 
UAS Toll-9 appear more active during the day whereas UAS Toll-3, UAS Toll-4 and UAS 
Toll-7 have lower activity levels (Figure 4.5). 
Over-expression of UAS Toll-1 and UAS Toll-9 in neuropile glia results in arrhythmic 
activity levels (Figure 4.6 A & 4.6 B). During both the day and evening periods over-
expression of both leads to higher levels of activity compared to the controls. UAS Toll-1 
(Figure 4.6 A) are unable to anticipate the onset of dusk and fail to have a peak of activity 
entering the evening period, however; they return to control levels at the onset of dawn and 
have an increase in activity levels similar to the controls. A similar profile was found when 
UAS Toll-1 was over-expressed using RepoGal+ (Figure 4.2 A). AlrmGAL4>UAS Toll-9 
(Figure 4.6 B) flies fail to anticipate lowering light levels during the dusk period altogether 
and only partially recover this anticipatory response at the onset of dawn (Figure 4.6 B). 	
RNAi knockdown for all Tolls in neuropile glia with alrmGAL4 also resulted in variability of 





phenotype that is un-reproducible over the time course. Therefore I am unable to draw any 
conclusions from this data set.  
4.2.4 Toll-8 in neurons has different consequences to the other Toll receptors in 
locomotion 
All Overexpression of Drosophila Toll receptors in ElavGal4+ (all subsets of neurons) did not 
cause behavioural phenotypes in activity (Figure 4.8). All of the distributions are very similar 
to the control, with any differences being too subtle and too variable. Therefore I do not see 
any phenotype with this assay. 
Knockdown of Tolls in neurons (ElavGAL4>Toll-RNAi) caused activity phenotypes (Figure 
4.9), whereby the majority of the Tolls caused a mild effect at different periods of the night 
and/or day periods. The most consistent of the Tolls was knocking down Toll-8 
(ElavGAL4>UASToll-8RNAi), as there was a dramatic increase in daytime activity (Figure 
4.10). 
4.2.5 Different Tolls in ellipsoid body neurons do not cause locomotion phenotypes 
Over-expression and knockdown of Drosophila Toll receptors in c232Gal4+ (ellipsoid body 
neurons) do not cause behavioural phenotypes in Activity (Figures 4.11 and 4.12). The 
majority of the Tolls display control levels of activity. Any mild effect in activity was not 










In this chapter, through the use of an adult locomotion assay I have shown (Table 4.1): 
1) Over-expression of Toll-1 and Toll-9 particularly in neuropile glia can influence 
activity  
2) Knocking-down Toll-5 and Toll-7 in glia (except midline and neuropile glia) indicates 
that both Toll-5 and Toll-7 are required for locomotion phenotypes 
3) Toll-8 is required in neurons for locomotion 
 
When over-expressed in both RepoGal4+ (glia, except midline glia) and AlrmGal4+ 
(neuropile glia) both Toll-1 and Toll-9 can influence locomotion phenotypes. This is 
consistent with data from chapter 3, whereby Toll-1 and Toll-9 group together (along with 
other Tolls) in glial cells. It is interesting to note that the locomotion phenotypes are more 
severe when over-expressed in neuropile glia. RepoGal4>UASToll-1 flies display a lower 
night-time peak, due to failing to anticipate lights off. These flies then return to wild type 
behaviours. However AlrmGal4>UASToll-1 flies also fail to anticipate lights off. Following 
which they remain more active throughout the rest of the evening and the following day. 
RepoGal4>UASToll-9 flies anticipate lights off and have a normal evening peak but remain 
more active during the evening. Whereas, when over-expressed in neuropile glia Toll-9 flies 
no longer have an evening peak, remaining arrhythmic during both the day and particularly 
during the evening periods.  
 
Neuropile glia are found in association with axons and synapses. They extend along outer 
surfaces to ensheath axon bundles in order to isolate and protect neurons. Or they can extend 
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into the neuropile to function in the modulation of neuronal connections (Awasaki et al., 
2008). It is therefore likely that ectopic expression of both Toll-1 and Toll-9 is somehow 
involved in the modulation of locomotion activities. This may be dependent upon the 
proximity of these neuropile glia expressing these two receptors to the neurons that control 
locomotor function.  
 
Contrastingly, knocking down Toll-5 and Toll-7 in RepoGal4+ glial cells resulted in altered 
locomotion. This indicates that these genes are normally required in glia for normal function 
of this behaviour. I previously showed that Toll-5 and Toll-7 group together and are 
expressed in glial cells during embryonic development. However, as this locomotion 
alteration was not seen when knocking down Toll-5 and Toll-7 in neuropile glia, they are 
likely to be required in a different subset of glial cells. McIlroy et al., has previously reported 
that Toll-6 and Toll-7 are required in the locomotion of larvae. Double mutants of both Toll-6 
(Toll-626 /Toll-631) and Toll-7 (Toll-7P8/Toll-7P114) crawl much slower than control animals. 
Furthermore both of these mutants result in deficient targeting and axonal misrouting in 
embryos (McIlroy et al., 2013). Therefore it is interesting that whilst Toll-7 retains 
behavioural abnormalities from embryo through larvae and into adult, that Toll-6 does not.  
 
Toll-8 is the only Toll receptor that is required in neurons for locomotion. It is interesting that 
this result was not replicated when knocking down Toll-8 in the ellipsoid body. The ellipsoid 
body is one of the four synaptic neuropile domains of the adult brain. The other three regions 
include the fan shaped body, paired nodulli and Protocerebral Bridge. In chapter 3 I showed 
that Toll-8MD806 is highly expressed within the fan shaped body. This central complex is 
involved in locomtor control with both the fan shaped body and ellipsoid body are known to 
be involved in visual pattern memory (Liu et al., 2006; Pan et al., 2008; Wang et al., 2009). It 
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would be interesting to use other more neuronal specific Gal4 lines to see if knocking down 
Toll-8 in a certain subset of neurons impacts locomotion. Furthermore it would also be 
interesting to see if Toll-8 is expressed in any neurons in which clock factors such as PDF are 
also expressed.   
 
Overall these results show that there are functional groupings within the Toll receptor family 
(Figure 4.13). Toll-1 and Toll-9 can influence activity in neuropile glia. Toll-5 and Toll-7 are 
required by glia, but not neuropile or midline glia. Comparing these results to the data 
obtained by RT-PCR, Toll-1, Toll-5, Toll-7 and Toll-9 group together as being expressed 
highly in glial cells. Conversely, Toll-8 is the only Toll receptor required by neurons 
locomotion. 
 
These conclusions have been based on the results that are reproducible over the entire time 
course. For instance genotypes, which display a phenotype appearing to be arrhythmic, but 
which were not consistent over the full time course were not included. This way I have 
eliminated any phenotype that may be due to other factors, including ageing or death of the 
flies. Subsequently only those results that are convincing have been analysed further. It would 
therefore be beneficial to re-test genotypes that were not included as they may provide 
important information on the genes in question and their locomotion functions.  
 
Furthermore, TriKinetics assays allow the evaluation of continuous recordings of multiple 
flies across multiple behavioural phenotypes. This high-throughput assay can monitor activity 
levels, sleep patterns and circadian rhythms (Pfeiffenberger et al., 2010). The work completed 




expanded upon to provide more data on both sleep and circadian rhythms. Assays based on 
LD conditions provide qualitative information regarding free running conditions including 
bouts of daily activity. Thus allowing the assessment of phase changes from wild type 
conditions. In the future it would be beneficial to test those flies with a phenotype following a 
LD entrainment period by a constant darkness condition (DD) (LD DD). This would provide 
insight regarding internal clock state and the ability of these clocks to drive rhythmic outputs. 
 
In the next chapter I will continue to use phenotypic assays in order to investigate if there is 
any functional differences within the CNS between the Toll receptors. I will ask if all Toll 
receptors affect the maintenance of cell number within the CNS. I will test these behaviours 
through a variety of measures. By over-expressing and knocking down the Toll receptors I 
will measure CNS area and VNC size. I will then test their ability to promote neuronal 
survival by over-expressing the Tolls in neurons and quantifying the number of neurons using 
anti-Eve staining. Subsequently I will then test the Tolls ability to promote neuronal death by 
over-expressing and knocking down the Tolls in neurons and quantifying the number of dying 





TOLL RECEPTORS HAVE DISTINCT 
FUNCTIONS IN THE MAINTENANCE OF 
LARVAL CNS SIZE AND IN THE REGULATION 




In the previous chapter I showed that the Tolls function in different cell types in order to 
influence activity levels. Toll-1 and Toll-9 function in neuropile glia, Toll-5 and Toll-7 in glia 
(but not including neuropile or midline) and Toll-8 in neurons. Consistent with the findings in 
chapter 3, it is apparent that all of the Toll receptors are not equal in function. 
 
The size and shape of the Drosophila nervous system grows in a dynamic manner throughout 
the life of a fly in order to adjust to the developing nervous system. Remodelling depends on 
both internal and external factors and requires large amounts of cell number regulation in 
order to generate a fully functional nervous system. During development at the end of 
embryogenesis the VNC undergoes co-ordinated reduction in size (Poulson, 1965). During 
VNC condensation two pivotal processes are taking place at the same time. The first is 
extracellular matrix (ECM) deposition and the second is neural activity, both of which are 
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required for condensation (Olofsson and Page 2005). VNC condensation is impaired if there 
is a lack of haemocyte migration, as this prevents ECM components being deposited. 
Furthermore, VNC condensation is impaired if there is disruption of Rac1 function in neurons 
and glia which leads to incorrect cytoskeleton re-arrangement (Olofsson and Page 2005).  
When Rac1 is mutant in peripheral and longitudinal glia cellular extension, glial migration 
and axon ensheathment are disrupted and thus do not generate the required condensation 
force. In neurons, when Rac1 is mutant, there is axonal outgrowth defects (Olofsson and Page 
2005). These defects prevent correct neurite extension and prevent the required 
anteroposterior condensing force (Luo et al., 1994).  
 
In conjunction with correct ECM deposition and neural activity, there is also another process 
that is pivotal in VNC condensation. During embryogenesis the CNS and epidermis originate 
from a common ectodermal layer. Proneural and neurogenic signalling mechanisms determine 
if cells are driven to neural or epidermal fates (Urbach and Technau, 2004). As VNC 
condensation occurs programmed cell death ensures correct separation of these two tissues 
(Page and Olofsson, 2008). It is a combination of all three processes that ensure the VNC is 
condensed by at least 25% prior to larval development (Olofsson and Page 2005; Page and 
Olofsson, 2008). 
 
The aim of this chapter was to determine if there are functional differences between the Toll 
receptors in the CNS in the regulation of maintenance of CNS size, and during the regulation 
of cell number. I used phenotypic assays to ask these questions. Firstly, I asked whether gain 
or loss of function for each of the Tolls affects the size of the larval central nervous system. 
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Secondly, I tested their involvement in the maintenance in cell number regulation and death. I 




5.2.1 Regulation of VNC Length and CNS Area by Toll receptors in neurons 
 
As another means to ask the question of whether the nine Tolls have equivalent functions in 
the CNS or not, I used the larval VNC as a context to test the effects of over-expressing or 
knocking down the Tolls in both neurons and glial cells. The total CNS area and VNC length 
were measured.    
 
Over-expression of Toll-3 in neurons (ElavGAL4>UASToll-3) led to a reduced VNC length 
in comparison to controls (Figure 5.1). Toll-3 knock-down (ElavGAL4>UASToll-3RNAi) 
had the opposite effect causing an increase in VNC length in comparison to the control 
(Figure 5.2). The over-expression of Toll-9 in neurons (Elavgal4>UASToll-9) resulted in an 
increase in VNC length in comparison to controls (Figure 5.1). However when knocked-down 
(ElavGal4>UASToll-9RNAi) there was no phenotype, and VNC length was the same as the 
control (Figure 5.2). This was similar to the knockdown of Toll-7 in neurons 
(ElavGal4>UASToll-7RNAi) that resulted in an increase in VNC length (Figure 5.2). 
However when Toll-7 was over-expressed (ElavGal4>UASToll-7) there was no phenotype 
(Figure 5.1).  Overall the most interesting candidate from these comparisons was Toll-3 







When looking at the CNS area as a whole, the over-expression of Toll-3 in neurons 
(ElavGal4>UASToll-3) resulted in a much-reduced CNS area (Figure 5.4). Furthermore when 
Toll-3 is knocked down in neurons (ElavGal4>UASToll-3RNAi) there is an increase in CNS 
area (Figure 5.5). Similar to VNC length, over-expression of Toll-9 in neurons 
(ElavGal4>UASToll-9) resulted in a larger CNS area (Figure 5.4) but there was no effect 
when Toll-9 was knocked down (ElavGal4>UASToll-9RNAi) (Figure 5.5). Conversely, 
knocking down Toll-4 and Toll-7 (ElavGal4> UASToll4RNAi, -7RNAi) (Figure 5.5) resulted 
in an increase in CNS area. But there was no effect when over-expressed (ElavGal4> 
UASToll4, -7) (Figure 5.4). Again the most interesting candidate was that of Toll-3 (Figure 
5.6) whereby the over-expression and knockdown resulted in opposite effects. This indicates 
that of all the Toll receptors Toll-3 in neurons is different from the rest. It is required for the 
maintenance of both CNS area and size.  
 
5.2.2  Toll receptors in glia do not regulate VNC Length and CNS Area  
 
Over-expression of UASToll-7 and -9 in glia (RepoGal4>UASToll-7, -9) resulted in an 
increased VNC length (Figure 5.7). However when either were knocked-down 
(RepoGal4>UASToll-7RNAi, -9RNAi) there was no effect on VNC length (Figure 5.8) and 
therefore would not be investigated further. This was also the case for knocking down Toll-4 
and -8 in glia (RepoGal4>UASToll-4RNAi, -8RNAi). These genotypes resulted in an 
increase in VNC length (Figure 5.8). But no observable phenotype was seen when either 
genotype was over-expressed (RepoGal4>UASToll-4, -8) (Figure 5.7). Furthermore the over-







(RepoGal4>UASToll-3RNAi; Figure 5.8) resulted in the same phenotype with an increase in 
VNC length. 
  
Similar results were obtained when measuring CNS area. The over-expression of Toll-3, -6, -
7 and -9 (RepoGal4>UASToll-3, -6, -7, -9; Figure 5.9) resulted in increase CNS area. 
However Toll-3 knockdown (RepoGal4>UASToll-3RNAi) resulted in the same phenotype, 
whereas Toll-6 knockdown was not tested and Toll-7 and -9 (RepoGal4>UASToll-7RNAi, -
9RNAi) there was no difference from the controls (Figure 5.10). Furthermore knocking down 
Toll-4 and Toll-8 (Repogal4>UASToll-4RNAi, -8RNAi; Figure 5.10) resulted in increase 
CNS area, but no observable phenotype when either was over-expressed 
(RepoGal4>UASToll-4, -8; Figure 5.9).  
 
5.2.3 Toll receptors in the regulation of neuronal cell number 
 
In order to establish if different Toll receptors had similar effects on neuronal  number or not, 
I over-expressed them in neurons and tested whether or not they influenced Eve+ neuron 
number (Figure 5.11). To do this I used third instar larvae brains, stained with anti-eve 
antibodies and counted Eve+ cells in only the abdominal segments using DeadEasy software.  
 
There was an increase in Eve+ cell number when I over-expressed UAS Toll-2, UAS Toll-4, 
UAS Toll-6, UAS Toll-7, UAS Toll-8 and UAS Toll-9 suggesting that these Toll receptors 
may play some function in promoting cell survival. The only members of the Toll family that 






possible that these Toll family members are not required in the regulation of cell survival in a 
similar manner to the other Toll receptors or they may be required to promote cell death. 
 
5.2.4 Toll receptors in the regulation of cell death 
 
In conjunction with correct ECM deposition and neural activity, there is also another process 
that is pivotal in VNC condensation. During embryogenesis the CNS and epidermis originate 
from a common ectodermal layer. Proneural and neurogenic signalling mechanisms determine 
if cells are driven to neural or epidermal fates (Urbach and Technau, 2004). As VNC 
condensation occurs programmed cell death ensures correct separation of these two tissues 
(Page and Olofsson, 2008). It is a combination of all three processes that ensure the VNC is 
condensed by at least 25% prior to larval development (Olofsson and Page 2005; Page and 
Olofsson, 2008). 
 
Therefore as another assay to ask the question of whether all Tolls are functionally equivalent 
or not, I tested how each of the Tolls regulated apoptosis in the CNS. Toll-6 and -7 have 
already been shown to promote neuronal survival in embryos (McIlroy et al., 2013). I over-
expressed or knocked down all of the Toll receptors in the retina (as it is a much smaller 
tissue) using GMRGal4 and then tested if their expression increased the number of Anti Death 
Caspase 1+ (DCP1+) cells, a read out of apoptosis using the software DeadEasy Larval 




Over-expression of UAS Toll-2, UAS Toll-8 and UAS Toll-9 (GMRGal4>UASToll-2, -8, -9) 
resulted in increased rates of apoptosis in the retinal discs of wandering larvae. Whereas the 
over-expression of UAS Toll-3, UAS Toll-4, UAS Toll-6 and UAS Toll-7 
(GMRGal4>UASToll-3, -4, -6, -7) lead to a decrease in the rates of apoptosis (Figure 5.12).  
Knockdown of UAS Toll-1, UAS Toll-2, UAS Toll-3, UAS Toll-4, UAS Toll-7 and UAS 
Toll-9 (GMRGal4>UASToll-1RNAi, -2RNAi, -3RNAi, -4RNAi, -7RNAi, -9RNAi) led to a 
decrease in the rate of apoptosis, whereas; knocking down UAS Toll-5, UAS Toll-6 and UAS 
Toll-8 (GMRGal4>UASToll-5RNAi, -6RNAi, -8RNAi) resulted in an increase in apoptosis 
in the retina (Figure 5.13).  
 
The most interesting of these phenotypes are the effects seen with Toll-2, Toll-6 and Toll-9. 
Over-expression of both UAS Toll-2 and UAS Toll-9 (GMRGal4>UASToll-2, -9) resulted in 
an increase of apoptosis in the retina, whereas their knockdown (GMRGal4>UASToll2RNAi, 
-9RNAi) had the opposite effect decreasing the rate of apoptosis (Figure 5.14 A&B). 
Indicating that both Toll-2 and Toll-9 are more pro-apoptotic than the other Toll receptors. 
Interestingly I previously showed that the over-expression of UAS Toll-2 and UAS Toll-9 
resulted in an increase in Eve+ cells suggesting their role in regulating cell survival. However 
these data suggests that these receptors may be involved in cell death pathways. It appears 
that for these receptors at least their role in survival or death is dependent upon the stage of 
development and the specific tissues they are expressed in.  
 
UAS Toll-6 on the other hand, when knocked down (GMRGal4>UASToll-6RNAi), results in 






(GMRGal4>UASToll-6) there was an increase in cell survival. This further confirms that 


























Throughout this chapter I have shown (Figure 5.16 & Table 5.1): 
1) Toll-3 is required in neurons to promote the maintenance of CNS area and VNC size 
2) Over-expression of Toll-2, -4, -6, -7, -8 and -9 in neurons results in an increase in 
Eve+ neurons indicating that these Tolls may function in cell survival 
3) Over-expression of Toll-1 and Toll-3 in neurons results in no change to the number of 
Eve+ neurons indicating that these Tolls may have no function in survival or death 
outcomes 
4) Over-expression of Toll-2 and Toll-9 in retina results in an increase in apoptosis, 
indicating that these Tolls are pro-death in this tissue 
5) Over-expression of Toll-6 in retina results in a decrease in apoptosis, indicating that it 
has pro-survival functions. 
 
When Toll-3 is expressed within neurons it is able to regulate the maintenance of both VNC 
length and CNS area. This is interesting, as I have shown that this appears to be the only 
phenotype where Toll-3 has a role to play. In both neurons and glial cells, expression is low 
indicating that it may be restricted to only a few specific cells. Furthermore, anti-body 
staining has demonstrated that expression is mainly restricted to later developmental time 
points and within the visual system. There was no observable phenotype in locomotion 
assays, or in the regulation of cell survival or death. There was also no lethality or 
morphological defects when Toll-3 was over-expressed in a transgenic expression assay (Yagi 





Even though I have shown that by knocking down Toll-3 in neurons (ElavGal4>UASToll-
3RNAi) results in a larger CNS area and VNC length the physical processes that are occurring 
remain elusive. There could be multiple processes that generate this phenotype. For instance 
there may be an increase in cell number, cell size or apoptosis levels. An increase in cell 
number does not seem likely as the over-expression of Toll-3 (ElavGal4>UASToll-3) resulted 
in a decrease in CNS size, but Eve+ neuron number in the VNC was the same as wild-type. 
Furthermore the over-expression of Toll-3 resulted in a reduction in apoptosis in the retina. 
This however is a different tissue and would need to be confirmed in the CNS. Cell size is an 
exciting avenue to explore as is the cell adhesion properties of Toll-3. 
 
Some of the genotypes were missing from this assay due not having the appropriate flies at 
the time of the experiment. There is of course the possibility that the missing genotypes 
would provide essential data on their function in the maintenance of the CNS. For instance 
over-expression of Toll-2 in neurons (ElavGal4>UASToll-2) resulted in an increase in the 
CNS area, however the knock down of Toll-2 (ElavGal4>UASToll-2RNAi) was not tested. 
This was also the case for both the over-expression and knockdown of Toll-2 in glial cells. As 
Toll-2 is believed to function as a heterotypic cell adhesion molecule during development 
when cell movement is required (Eldon et al., 1994), this would have been an ideal candidate 
to test. Therefore it is important that the missing genotypes, particularly Toll-2 are testing in 
the future. 
 
In the regulation of neuronal cell number, all Tolls, with the exception of Toll-1 and Toll-3 
lead to an increase in Eve+ neurons. Indicating that many of the Toll receptors could play 
important function in the regulation of neuronal survival. For Toll-7 this result is consistent 
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with findings from McIlroy et al. where they over-expressed the constitutivly active form of 
Toll-7 in neurons and found that it is able to rescue naturally occurring cell death (McIlroy et 
al., 2013). However this is inconsistent with findings for two of the Toll family members. 
Over-expression of both Toll-2 and Toll-9 in retina resulted in an increase in the rate of 
apoptosis. This could be due to the fact that these assays were completed in two very different 
tissues. Neuron number was counted in the VNC and apoptosis in retina.  
 
Programmed cell death (PCD) is not only essential for the removal of dying cells but also for 
tissue patterning and homeostatic maintenance. During larval development PCD is most 
evident throughout CNS tissues (Rusconi et al., 2000), where apoptosis is controlled by the 
steroid hormone ecdysone (Baehrecke 2000). In the retina, there are two bands of apoptotic 
cells, the first in the posterior margin and the second anterior to the morphogenetic furrow 
(Wolff and Ready. 1991; Bonini et al., 1999). The structure of this tissue is highly complex 
and exceptionally sensitive to perturbation and mutation (Tanenbaum et al., 2000). Therefore 
the extensive rate of apoptosis may be due to the maintenance of the quality and number of 
ommatidial precursor cells (Werz et al., 2005). Therefore it is possible that in different tissues 
these two Toll receptors perform opposing functions. Promoting neuronal survival in the 
VNC and cell death in the retina. It would therefore be beneficial to look at the rate of 
apoptosis in the VNC for these two receptors.  
 
Toll-6 is different to the other receptors in that it is involved in the regulation of cell survival 
in both the VNC and retinal discs. This is consistent with the finding of McIlroy et al., 2013 
whereby there was an increase in apoptosis in Toll-6 double mutant embryos. Furthermore 
they show that the over-expression of the constitutively active form of Toll-6 in neurons is 
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able to rescue naturally occurring cell death. Both of these findings indicate that Toll-6 in 
both the embryonic and larval CNS is required for the promotion of cell survival (McIlroy et 
al., 2013). It would therefore be interesting to determine the downstream signalling 
mechanisms that are mediating this pro-survival effect.   
 
In the next chapter I will investigate the upstream and downstream signalling mechanisms of 
Toll-6. I hope to establish if the different forms of the neurotrophins (DNT-1 and DNT-2) are 
capable of mediating cell death and/or survival outcomes. I will then try to determine the 




DOWNSTREAM SIGNALLING OF TOLL-6: 





In the previous chapter I showed that different Tolls are able to regulate cell survival and/or 
cell death. And this function may change temporally and/or spatially. Toll-2 and Toll-9 
mediate cell death in the retina, but survival in the VNC. Toll-6 however appears to be 
primarily pro-survival. These results again show that the Toll receptors appear to be able to 
mediate very different cellular events. It is therefore conceivable that ligand and receptor 
complexes work together to facilitate cell outcomes. 
 
The aim of this chapter was to determine if the specific cleavage state of the NTs had 
differing effects in the regulation of downstream signalling outcomes. Furthermore I wanted 
to determine the downstream mechanisms that regulate cell number downstream of the Toll 
receptors (Toll-6).  
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Toll-1 (no other Toll receptor) has been shown to bind MyD88 (Tauszig et al., 2000; Tauszig-
Delamasure et al., 2002) and activate pro-survival Nf-κB signalling (Carter et al., 1996; Foehr 
et al., 2000; Hoffman and Reichhart 2002). Furthermore Toll-6 and Toll-7 have been 
suggested to function via NF-κB (McIlroy et al., 2013). However, other Toll receptors have 
been proposed to function in different roles independently of MyD88 function. For example 
Toll-2 is believed to work as a cell adhesion molecule, which does not require MyD88 
function (Eldon et al., 1994). Therefore the Toll receptors may function via two distinct 
mechanisms, the first a MyD88 dependent mechanism and the second in a MyD88 
independent manner.  
 
There are two main peaks of cell death during the development of the CNS. The first 
occurring during embryogenesis.  The second during the pupal stage, where the CNS is 
restructured to give rise to an adult CNS. However the regulation of death by the Toll 
receptors remain uncharacterised. Sarm1 is known to promote neuronal apoptosis in mammals 
and inhibit MyD88 (Kaiser and Offermann, 2005; Carty et al., 2006; Ma et al., 2006; Kim et 
al., 2007). In flies it is known to induce degeneration of axons following injury (Osterloch et 
al., 2012), however if it is involved in the regulation of apoptosis remains to be determined. 
Another adaptor protein is Wek, which is epistatic of Toll and acts upstream of both Dorsal 
and Cactus. Furthermore Wek has been shown to interact with Toll-1, -5 and -9 as well as , 








6.2.1 DNTs in the regulation of cell death via the pJNK pathway 
 
As the Tolls appear to be able to influence different outcomes, namely death and survival 
depending on where they were being expressed and we know that the ligands for Toll-6 and 
Toll-7 can be promiscuous (McIlroy et al 2013) I wondered if the ligand-receptor binding 
partnership influenced cell fate. And also whether or not the different forms of the ligand 
determined specific outcomes or if they themselves have distinct functions similar to the 
Tolls?  
 
In Zhu et al 2008, the mature cleaved form of DNT1 (DNT1-CK) was able to cell 
autonomously regulate neuronal survival in the embryonic CNS, however; both the full length 
(DNT1-FL) and DNT1 pro domain proteins were unable to reduce neuronal apoptosis in a 
similar fashion to DNT1-CK. In mammals, apoptosis is achieved via the JNK signalling 
pathway thus to determine if differentially processed DNTs are able to activate JNK 
signalling in flies, I used anti-phospho JNK antibodies to stain phospo-JNK+ cells of retina 
discs of wandering larvae. 
 
Using GMRGal4 to over-express the different forms of DNT1 and DNT2, DNT1-CK, DNT2-
CK and DNT2-FL led to a reduction in the number of pJNK+ cells in comparison to the 
control (Figure 6.1). Therefore it appears that these forms of the DNTs can promote the 




increase in the number of pJNK+ cells, and it is therefore likely that DNT1-FL is able to 
activate in wandering larval retina discs the pro-apoptotic JNK signalling pathway.  
 
Consistent with the findings in the embryonic CNS (Zhu et al 2008) DNT1-CK, DNT2-FL 
and DNT2-CK are pro-survival, whereas the full-length form of DNT1 works to activate the 
pro-apoptotic JNK pathway in larval retina discs.  
 
6.2.2 DNTs in the regulation of cell survival via the pERK pathway 
 
In order to investigate which forms of the DNTs, if any, regulate cell survival via the pERK 
pathway I tested if the in vivo over-expression of both DNT1-FL and DNT2-FL (Figure 6.2) 
in neurons of the larval optic lobes and the ring gland with RG-Gal4. The over-expression of 
DNT2-FL led to the activation of ERK in a collection of neurons within the optic lobe as well 
as within the corpora cardiaca of the ring gland. In contrast the over-expression of DNT1-FL 
did not lead to the activation of pERK in either of these tissues.  
 
6.2.3 MyD88 is expressed throughout the CNS in both larval and pupal developmental 
stages 
 
Canonical Toll-1 signalling is via the downstream adaptor MyD88. The death domain of 
MyD88 forms a signalling complex with both Tube and Pelle in order to recruit MyD88 to the 
membrane (Tauszig-Delamasure et al., 2002; Gay and Gangloff, 2007). Therefore to establish 
if MyD88 functions as a downstream adaptor of Toll-6, I first determined its expression 




10xUAS-myr-td-Tomato, and anti-DsRed antibodies. In larvae, MyD88NP6394 is expressed 
throughout the CNS in both the VNC and optic lobes (Figure 6.3). The expression of 
MyD88NP6394 is restricted mainly to the thoracic region of the VNC in thoracic interneurons, 
dorsal projections into and out of the CNS, with some expression in abdominal neurons and 
central brain region. In pupae MyD88NP6394 is expressed at higher levels than were seen in the 
larval stage (Figure 6.3). Particularly in the VNC were there is an increase in the expression 
throughout the neuropile and innervations into/out of the neuropile. A lot of the regions where 
MyD88NP6394 is expressed are regions involved in motor circuitry.  
 
6.2.4 Levels of MyD88 control Eve+ neuron number 
 
As previously mentioned canonical Toll-1 signalling functions via MyD88 (Tauszig-
Delamasure et al., 2002). In mammals, mature NTs bind p75NTR in order to promote cell 
survival via NF-κB activation (Carter et al., 1996; Foehr et al., 2000; Roux and barker 2002; 
Gutierrez and Davies, 2011), and MyD88 is required for NF-κB activation (Muzio et al., 
1997; Wesche et al., 1997).  In order to determine if Toll-6 can function via a pro-survival 
MyD88-NF-κB signalling mechanism I first established if MyD88 is able to regulate neuronal 
number.  
 
I over-expressed MyD88 in neurons, and tested how this affected Eve+ neuron number in 
both larval and pupal stages. Over-expression of MyD88 in neurons resulted in an increase in 
Eve+ neurons in larvae (Figure 6.4; ElavGal4>MyD88) in comparison to the control 
(ElavGal4/+) and there is a further increase in pupae (Figure 6.5; ElavGal4>MyD88), 





of Eve+ neurons in comparison to the control (ElavGal4/+). This implies that MyD88 
promotes neuronal survival at both larval and pupal stages and this effect is particularly 
important during the pupal stage of development, as there is a further increase in neuronal 
survival. In order to substantiate the requirement of MyD88 as a pro-survival effector, and its 
interaction with Toll-6, it was necessary to determine their role in the regulation of a pro-
death situation, namely apoptosis. 
6.2.5 Apoptosis increases in a MyD88 mutant background 
To test whether MyD88 was required downstream of Toll-6 to regulate neuronal survival, it 
was necessary to determine if it had a role in the regulation of apoptosis. McIlroy et al., 2013 
has previously shown that Toll-6 and Toll-7 in the embryonic CNS are able to promote 
neuronal survival. And I have now shown that Toll-6 is required for cell survival in the larvae. 
We now know that there is also a period of cell death at the pupal stage of development and 
needed to determine if MyD88 is required to maintain neuronal survival during this time. 
Furthermore; MyD88kra56 flies are semi-lethal when homozygous and they die at late pupation, 
another indication of the requirement of MyD88 proper function during this period.  To 
further test if MyD88 was required for survival I tested whether the levels of MyD88 
influence the incidence of apoptosis. To test this I used Cleaved Drosophila DCP-1 antibodies 
as a marker of apoptosis and automatic counting of apoptotic cells via Deadeasy software 
(Forero et al., 2009; Kato et al., 2011; Forero et al., 2012). 
Homozygous MyD88kra56 apoptosis levels in 10 minute pupae remained the same as in both of 
the controls (Figure 6.6: YW and ElavGal4/+) but there was a significant increase in 
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apoptosis when in trans over its deficiency (MyD88kra56.DFBSC279) and to the same level as 
the new CRISPR null mutant generated by the post-doc in our lab Dr Neale Harrison 
(MyD88CR2.8.DFBSC279).  These data show that MyD88 is required for cell survival, and 
Toll-6 may require this signalling pathway for neuronal survival in the CNS. Interestingly 
when MyD88 is over-expressed (ElavGal4>UASMyD88) there is also an increase in the 
levels of apoptosis. 
However, over-expression of Toll-6 (ElavGal4>Toll-6) in neurons also resulted in an increase 
in apoptosis, and this increase was furthered in a MyD88 mutant background 
(MyD88kra56;ElavGal4>Toll-6) which is interesting as it implies that Toll-6 has pro-apoptotic 
functions in the pupal CNS. This effect may be independent of MyD88 function and therefore 
require a different signalling effector. 
6.2.6 dSarm is expressed throughout the CNS of embryos, larvae and pupae 
In mammals, SARM (Sterile alpha and armadillo motif-containing protein) binds to TRIF (a 
TLR adaptor) in order to inhibit signalling (Carty et al., 2006) and can suppress MyD88 
mediated signalling (Carlsson et al., 2016). Furthermore, SARM is able to activate neuronal 
apoptosis (Oneill and Bowie., 2007). In Drosophila the homologue of SARM, dSarm, was 
shown to facilitate axonal destruction following axonal severing (Osterloch et al., 2012) and 
mediates a signalling pathway involving DNT1 and Toll-8 during immune responses within 
the trachea (Akhouayri et al., 2011). Therefore I tested if dSarm was involved in the pro-
apoptitic signalling that Toll-6 is involved in. 
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First I wanted to determine how the expression of dSarm relates to that of MyD88 (Figure 
6.3) I used immune-histochemistry in the embryonic, larval and pupal stages. dSarm 
expression was visualized with Ect4MIO8854GFP (Figure 6.7; Ect4 is a synonym of dSarm) 
which contains a MIMIC-GFP insertion into the dSarm locus and anti-GFP antibodies. In 
stage 17 embryos, Ect4MIO8854GFP was expressed throughout the CNS neuropile. In both third 
instar larvae and white pupal stages Ect4MIO8854GFP was dispersed throughout the VNC, 
particularly within segmentally repeating projections into and out of the neuropile as well as 
with some projections into the central brain region. The larval patterning was similar 
MyD88NP6394, however by the pupal stage there are significant differences between the two. 
Whereas MyD88NP6394 is expressed in motor circuits, Ect4MIO8854GFP is localised to regions 
pertaining to sensory circuits. This indicated that there might be some requirement during the 
pupal stage for MyD88 and dSarm to have differing functions.	
6.2.7 dSarm leads to an increase in apoptosis and antagonises MyD88 function 
In order to determine if dSarm facilitates the Toll-6 pro-apoptotic function, I over-expressed 
EP3610 (EP3610 drives multiple isoforms of Ect4) in neurons in the VNC of 10’ pupae. This 
resulted in a significant increase in the number of apoptotic cells. Furthermore, when EP3610 
was over-expressed in a MyD88 mutant background (MyD88kra56;ElavGal4>EP3610) the rate 
of apoptosis increased further indicating that not only can dSarm induce apoptosis, but it also 
antagonises Myd88 function in order to do so (Figure 6.8).  
In order to test if dSarm functions via JNK, I tested if knocking down JNK signalling 





the over-expression of dSarm (ElavGal4>EP3610) (Figure 6.8). JNK knockdown resulted in a 
significant reduction in the level of apoptosis, indicating that dSarm induces apoptosis and via 
the JNK signalling pathway.  
 
6.2.8 dSarm activates JNK signalling in vivo and antagonises MyD88 function 
 
In order to confirm that dSarm is able to activate JNK signalling in vivo and to determine if 
MyD88 had any influence, I stained third instar larvae retinal discs (using GMRGal4) with 
pJNK and counted the number of pJNK+ cells. I used retinal discs as phospho-JNK antibodies 
stain axons within the neuropile, preventing nuclear signal being visualised. MyD88 mutants 
(MyD88kra56.DFBSC279) displayed no increase of pJNK+ cells in comparison to the control 
(GMRGal4/+). Over-expression of dSarm (GMRGal4>EP3610) in retina resulted in an 
increase in the number of pJNK+ cells and this was further increased in a MyD88 mutant 
background (MyD88kra56GMRGal4>EP3610) (Figure 6.9). Therefore dSarm is able to induce 
apoptosis via the JNK signalling pathway and is able to antagonise MyD88 function in doing 
so. 
 
6.2.9 Over-expression of dSarm leads to a decrease in Eve+ neurons 
 
In order to determine if the apoptotic effects of dSarm results in the loss of Toll-6 neurons, I 
used the Eve antibody (Eve neurons express Toll-6) to stain Eve neurons which where 
counted with Deadeasy software. Both the over-expression of dSarm (Elavgal4>EP3610) as 
well as in a MyD88 mutant background (MyD88kra56ElavGal4>EP3610) resulted in a 
reduction in the number of Eve+ neurons in comparison to the control (ElavGal4/+) (Figure 
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6.10). This indicates that not only can dSarm induce apoptosis but it also leads to neuronal 
loss.  
6.2.10 Apoptosis increases in a Wek mutant background 
In order for Toll-6 to be pro-apoptotic in the pupal stage of development, there must be 
another adaptor protein that links both Toll-6 and dSarm in order to regulate their pro-
apoptotic functions. Luschnig et al., 2004 identified Weckle (Wek), which encodes a zinc 
finger transcription factor that controls embryonic dorso-ventral patterning. Furthermore; 
Chen et al., 2006 identified Wek as an adaptor protein that stabilises the Toll-Wek-MyD88-
Tube complex by binding to Toll and then binding to and localising MyD88 to the plasma 
membrane in embryos. Therefore it was imperative to test the relationship of Wek in the pro-
apoptotic functioning of Toll-6 and dSarm. 
In order to test this relationship I carried out epistasis experiments using Wek mutant flies to 
determine the effects of loss and gain of function of Wek on the rates of apoptosis. The over-
expression of Wek (Figure 6.11; ElavGal4>Wek) resulted in an increase in apoptosis in 
comparison to the control (ElavGal4/+), and this was rescued in a Wek mutant background 
(WekEX14;ElavGal4>Wek). Furthermore; the increase of apoptosis caused by the over-
expression of Toll-6 (ElavGal4>Toll-6) is rescued by the loss of Wek function 
(WekEX14;ElavGal4>Toll-6), indicating that Toll-6 requires Wek in order to induce apoptosis.  
The over-expression of Wek in a dSarm loss of function (ElavGal4>dSarmRNAi,Wek) again 




dSarm (ElavGal4>EP3610) results in an increased rate of apoptosis; however; the loss of 
function of Wek (WekEX14;ElavGal4>EP3610) did not rescue this increased apoptotic rate 
from the over-expression of dSarm and thus Wek functions upstream of dSarm in order to 
regulate cell-death (Figure 6.11).  
6.2.11 Over-expression of Wek leads to a decrease in Eve+ neurons 
As Wek is required for the pro-apoptotic signalling down-stream of Toll-6 and upstream of 
dSarm, and both Toll-6 and dSarm can lead to apoptosis, it was important to establish the 
effect of Wek on the regulation of cell number via neuronal loss. In order to confirm if the 
functioning of Wek results in the loss of Toll-6 neurons I used the Eve antibody to stain Eve+ 
neurons in white pupae. I counted Eve+ cells in the abdomen (See Figure 2.8 for landmarks) 
and counted cells using automatic Deadeasy software (Forero et al., 2009; Kato et al., 2011; 
Forero et al., 2012). 
Wek mutants (Figure 6.12: WekEX14.DFBSC690) had the same number of Eve+ neurons as 
the control group (ElavGal4/+). However; the over-expression of Wek (ElavGal4>Wek) in 
neurons as well as in a MyD88 mutant background (MyD88kra56.ElavGal4>Wek) resulted in a 
decrease in the number of Eve+/Toll-6+ cells. This indicates that Wek is not only capable of 




6.2.12 Over-expression of Wek, Toll-6 and dSarm in MyD88 cells leads to a reduction in 
Histone-YFP+ cell number  
 
It appears that Wek is functioning as the link between pro-survival and pro-death outcomes 
mediated by the Toll-6 - MyD88 and Toll-6 – dSarm pathways. In order to determine if Wek 
and dSarm altered the fate of MyD88 neurons, I utilised MyD88Gal4 and drove the 
expression of Histone YFP, a nuclear marker. The over-expression of Wek 
(MyD88Gal4;UAShistoneYFP>Wek), Toll-6 (MyD88Gal4;UAShistoneYFP>Toll-6) and 
dSarm (MyD88Gal4;UAShistoneYFP>Wek), resulted in a reduction of MyD88+ cells (Figure 
6.13). It appears as though in pupal VNCs when there is an increase of Toll-6, pro-death 
outcomes are more likely, most likely facilitated by Wek and dSarm. And similarly the 
increase of both Wek and dSarm in MyD88 expressing cells has the ability to control cell 
death downstream of Toll-6.   
 
6.2.13 Over-expression of Wek, Toll-6 and dSarm in MyD88 cells leads to a reduction in 
Eve+ neurons 
 
To test this ability to control cell death I looked at the effect the over-expression of Toll-6, 
Wek and dSarm in MyD88+ cells had on neuronal cell number using Eve antibodies. A 
similar profile to the over-expression of Wek and dSarm in MyD88Gal4+ expressing cells 
was seen with Eve+ cell number. Whereby, their over-expression 
(MyD88Gal4;UAShistoneYFP>Wek, -dSarm) resulted in a decrease in the number of Eve+ 
neurons in comparison to the controls (Figure 6.14). Thus by increasing the amount of Wek 




this complex with all three adaptor proteins as well as the receptor, play a crucial role in 


























In this chapter I have shown (Figure 6.15 & Table 6.1): 
1) DNT1-FL activates pro-apoptotic JNK signalling  
2) DNT2-CK activates pro-survival ERK signalling 
3) MyD88 is expressed throughout the CNS motor circuits and is required for neuronal 
survival 
4) In the pupae, Toll-6 is pro-apoptotic, independently of MyD88 function 
5) dSarm is expressed in sensory circuits, and expression of dSarm and MyD88 diverge 
during the pupal stage 
6) dSarm promotes apoptosis via JNK signalling pathway and antagonises MyD88 
function 
7) Overexpression of dSarm results in neuronal loss 
8) Wek can promote apoptosis and Toll-6 requires Wek for its pro-apoptotic functions 
9) Wek functions upstream of dSarm 
10) Wek can mediate the loss of Toll-6 neurons 
11)  In pupae an increase in Toll-6 results in elevated cell death via dSarm and Wek, and 
contains positive regulatory feedback mechanisms. 
  
In mammals, the regulation of cell number by NTs is dependent upon the cleavage state of the 
ligand, the receptor it binds and finally downstream signalling pathways. Full length NTs bind 
p75NTR and sortilin in order to activate JNK signalling and induce apoptosis. Mature NTs bind 
p75NTR and Trk receptors in order to activate NF-κB and MAPKinase/ERK signalling 
pathways (Carter et al., 1996; Foehr et al., 2000; Roux and Barker 2002; Lu et al., 2005; 





DNT1-FL activates pro-apoptotic JNK signalling. In contrast the mature forms of DNT-1 and 
DNT-2 (Foldi, Anthoney et al., 2017) as well as DNT2-FL are able to activate ERK. 
Furthermore DNT2-CK can also activate NF-κB signalling downstream of Toll-6 and Toll-7, 
and Toll-6 and Toll-7 can activate ERK (Foldi, Anthoney et al., 2017). 
 
 Interestingly from this assay it appears as though the full-length form of DNT-2 activates 
ERK. However site directed mutagenesis of DNT-1 and DNT-2 proteins show DNT-1 is 
secreted as a pro-protein, whereas DNT-2 is cleaved and secreted as a mature protein (Foldi, 
Anthoney et al., 2017). Therefore, DNT2-FL may not be able to activate ERK as described, 
instead it may be cleaved and the expression is that of the mature form. Therefore these 
results are highly similar to what occurs in the mammalian system whereby full-length 
neurotrophins are able to activate the pro-apoptotic JNK pathway, and cleaved neurotrophins 
are able to activate the pro-survival pathways. 
 
In flies, DNTs bind Toll receptors in order to promote neuronal survival (Weber et al., 2003; 
Zhu et al., 2008; McIlroy et al., 2013), and I had previously shown that Toll-6 is pro-survival 
in larvae. Canonical Toll-1 signalling occurs via MyD88 (Tauszig-Delamasure et al., 2002), 
and MyD88 can form a signalling complex with both Toll-6 and Toll-7 (Foldi, Anthoney et 
al., 2017). Therefore in order to determine if MyD88 is involved in the promotion of cell 
survival, I showed that MyD88 is expressed throughout the CNS of both larva and pupae. 
Furthermore when MyD88 is over-expressed there was an increase in neuronal number, 




We then asked if MyD88 mediate the pro-survival functions of Toll-6? Except for pCC and 
RP2 neurons, all other Eve+ neurons also express Toll-6 (McIlroy et al., 2013) and therefore 
are a good readout to determine the genetic interactions between both MyD88 and Toll-6. In 
embryos MyD88kra56;Toll-6 double mutants had fewer Eve+ neurons in the CNS, indicating 
that MyD88 promotes cell survival via functioning downstream of Toll-6 (Foldi, Anthoney et 
al., 2017). 
 
To further quantify that MyD88 is required for cell survival downstream of Toll-6, I 
investigated the rates of apoptosis when MyD88 is in excess or reduced. Here I found that in 
the pupae Toll-6 is pro-apoptotic and this is likely to be independent of MyD88 function. This 
was interesting, as Toll-6 has previously been shown to be more pro-survival in other 
developmental stages. Another interesting result was that the over-expression of MyD88 also 
resulted in an increase in apoptosis. A finding which directly contradicted the increase in 
apoptosis in a MyD88 mutant background. The causative factor for this effect may be taking 
place downstream of Toll-6 (or any of the Tolls) but upstream of MyD88. This therefore 
requires to be investigated further. 
 
As Toll-6 was able to induce apoptosis independently of MyD88, it indicated the involvement 
of another downstream signalling adaptor. Sarm1 is a known inhibitor of MyD88 (O’Neill 
and Bowie, 2007), and I have shown that Toll-6 functions via dSarm to induce apoptosis. The 
functions of dSarm are via the JNK pathway, and by inhibition of MyD88 function. 
Furthermore not only is dSarm capable of inducing apoptosis but an increase in dSarm levels 
leads to a reduction in overall neuronal number. Interestingly, whilst Co-
immunoprecipitations shows that dSarm can physically interact with MyD88, they show that 
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there is no direct interaction between dSarm and Toll-6 (Foldi, Anthoney et al., 2017). 
Therefore the pro-apoptotic Toll-6 signalling required another downstream adaptor in order to 
facilitate the interaction between dSarm and Toll-6. 
 
Through epistasis experiments I found that Wek is that adaptor. Toll-6 requires Wek in order 
to induce apoptosis, and dSarm functions downstream of Wek. Furthermore Wek can mediate 
the loss of Toll-6+ neurons presumably by dSarm and with the possibility that there is 
negative feedback occurring. However, by increasing the levels of Toll-6, Wek and dSarm the 
result is a reduction in the number of MyD88+ cells, and increasing Wek and dSarm in 
MyD88+ cells leads to neuronal loss. The interaction between Wek and Toll-6 requires to be 
confirmed.  
 
In conclusion the downstream adaptors (Wek, dSarm and MyD88) of Toll-6 that are available 
both spatially and temporally can switch cell fate outcomes between cell survival and cell 
death during different developmental requirements. I have shown that Wek acts like a link 
between MyD88 and dSarm to facilitate Toll-6 signalling outcomes whereby Toll-6 – Wek – 











7.1 Summary of findings 
 
The aims of this thesis were to 1) investigate if all Toll receptors are functionally equal 2) 
establish if all Tolls can promote cell death as well as cell survival 3) determine how Toll-6 
regulates cell number plasticity by characterising its downstream signalling mechanism.  
 
7.2 Members of the Toll family are differentially expressed during development 
 
During my PhD I have established that all Toll receptors are not equal either spatially or 
temporally. During the determination of the levels of the Toll receptors by RT-PCR during 
different developmental stages I showed Toll-3, Toll-4 and Toll-9 are expressed at reduced 
levels in comparison to the other Tolls. Toll-3 and Toll-4 are structurally different, as they do 
not contain a C-terminal extension. Toll-9 is also structurally different from the other 
receptors containing only one cysteine rich motif (Tauszig et al., 2000; Imler and Zheng, 
2003). However these structural differences are unlikely to be the primary cause of being 
expressed at lower levels. The protein structure of Toll-9 as stated is different to Toll-3 and 
Toll-4 and furthermore Toll-5 also has a premature stop codon and was expressed at higher 
levels during RT-PCR analysis. This raises the possibility that these receptors are more 
transient in nature or are expressed in fewer cells. 
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When gcm was over-expressed in embryonic neurons both Toll-3 and Toll-4 were expressed 
at low levels. Interestingly there was an increase of Toll-9 transcripts when gcm is expressed 
in neurons in comparison to wild-type conditions. However as RT-PCR is qualitative, qRT-
PCR and endogenous expression of the Toll-9 protein would be required to quantify this. As 
gcm is embryonic lethal only this developmental time point could be investigated. 
 
7.2.1 Differential expression of Toll-2, Toll-3 and Toll-8 
 
In embryos Toll-2 is expressed in all developmental stages (RT-PCR and immuno-
histochemical visualisation). In embryos Toll-2 was located in the region of haemocyte 
development, the procephalic mesoderm. Haemocytes are not only involved in innate immune 
responses but are also crucial during development. During development haemocytes are 
pivotal in apoptotic processes as they eliminate cells that are no longer required and in doing 
so help shape various tissues during embryogenesis (Franc et al., 1990). Furthermore, 
haemocytes are involved in the production and secretion of extracellular matrix (ECM) 
molecules, which provide structural and biochemical support to neighbouring cells. Some of 
the ECM molecules known to be secreted by haemocytes include papilin, peroxidasin, 
glutactin, tiggrin (Fessler and Fessler., 1989; Fogerty et al., 1994; Nelson et al., 1994; 
Kramerova et al., 2000), basement-membrane-associated dSPARC (Martinek et al., 2002), 
MDP-1 (Hortsch et al., 1998), laminin A (Kusche-Gullberg et al., 1992), Cg25C and Viking 
which are collagen IV molecules (Mirre et al., 1988; Knibihler et al., 1987; Le Parco et al., 
1989;Yasothornsrikul et al., 1997). This is interesting; as it has previously been identified that 
Toll-2 may act as a heterophilic cell adhesion molecule (Eldon et al., 2004; Kleve et al., 
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2006). It would be ideal to explore the expression of Toll-2 within the NMJ, as many cell 
adhesion molecules localise to synaptic junctions in order to release neurotransmitters.  
 
During larval development Kambris et al., 2002 determined via RT-PCR that Toll-2 was 
present within anti-microbial peptide (AMP) producing regions including the fat body, lymph 
gland and haemocytes. I found that within the CNS of both larvae and adults expression is 
restricted to primarily to optic lobes and central brain. However, expression was high in the 
corpus allatum (CA) of ring gland which secretes sesquiterpenoid juvinille hormone (JH) and 
interacts with ecdysone to determine moulting development into larval, pupal or adult forms 
(Harvie.,1998; Truman., 2007). In adults JH, affects learning and memory, diapause and 
innate immunity (Denlinger., 1985;Flatt et al., 2008). These data show that Tol1-2 may have 
a diverse reportoire of functions that need to be explored further. 
 
There was no embryonic expression of Toll-3 within the CNS, Kambris et al., 2002 were also 
unable to obtain expression via in situ hybridisation and northern blot analysis. However RT-
PCR results whilst very low showed that there are at least some cells that express Toll-3 
during embryonic development. However as results were gathered using whole embryos it is 
possible that if Toll-3 is expressed only in a limited number of cells they may be located in 
tissues outside the CNS. In adults expression of Toll-3 is localised to the lamina and medulla 
regions of the optic lobes indicating a possible role of Toll-3 in the visual system. 
Furthermore Toll-3 was also located within the mushrooms bodies that are central to olfactory 
learning and memory (Heisenberg et al., 1985; Zars et al., 2000; Yu et al., 2006; Krashes et 
al., 2007) as well as visual attention-like behaviours (Xi et al., 2008). Yagi et al., 2010 could 
not identify any phenotypic manifestations when Toll-3 was over-expressed in different cells 
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using numerous Gal4 drivers. However this was not an exhaustive list and may have not been 
the correct assay to define the function of Toll-3. Therefore more specific testing of Toll-3 in 
both the visual and learning and memory pathways could elucidate its endogenous function. 
During the larval stage expression was throughout the VNC neuropile and optic lobes, albeit 
at very low levels.  
 
Toll-8 was identified via RT-PCR as expressed during all stages of development. Previous 
reports identified that during embryogenesis Toll-8 is located posterior to wingless expression 
and in a very similar profile, which do not overlap, to Toll-2 (Kambris et al., 2002) and is 
involved in neural patterning (Seppo et al. 2003; Ayyar et al. 2007). I have shown that Toll-8 
is distributed throughout larval, pupal and adult CNS tissues. In larvae and pupal stages Toll-
8 is located throughout VNC interneurons of thoracic and abdominal regions, projections 
innervating CNS and in optic lobe throughout medulla and central brain. This is in agreement 
with Seppo et al., 2003, who identified Toll-8 mRNA expression along the VNC at sites of 
neuronal differentiation. In adults expression is throughout the medulla, mushroom body and 
central brain regions. Similar to Toll-3 these regions within the adult brain are known to be 
involved in the regulation of visual, olfactory learning and memory pathways.  
 
The characterisation of these three Toll receptors highlights some similar and different 
patterns of expression. All three are located in the optic lobes, which are regions of the visual 
system. In adults Toll-3 and Toll-8 are both expressed in the mushroom bodies, which are 
regions required for learning and memory. And only Toll-2 is located in the CA of the ring 
gland, which is pivotal in hormone release during moulting. Both Toll-6 and Toll-7 are 
expressed in the embryonic, larval and adult CNS. They are distributed throughout the 
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locomotor circuits, which include interneurons, motorneurons, and within the FSB and EB of 
the adult brain (McIlroy et al., 2013). Toll-1 is also expressed during all developmental 
stages. In the embryo Toll-2 is expressed in the midline glia and CNS axons. In larvae and 
adults stages Toll-1, similar to Toll-6 and Toll-7 located throughout locomotor circuits and 
FSB and EB (Sutcliffe B PhD thesis). This highlights the possibility that all three may be 
involved in different processes within the CNS. 
 
7.3 Toll receptors regulate adult locomotion  
 
To test if the nine Tolls had different or equal functions in locomotion, I examined the activity 
of adult flies that were over-expressing each of the Tolls or had them knocked-down by 
RNAi, in neurons or glia. The over-expression of Toll-1 and Toll-9 can influence adult 
locomotion, and the knockdown of Toll-5 is required in glial cells for locomotion. In neurons 
there appears to be no strong correlation between adult locomotion and their Toll receptor. 
Toll-6 and Toll-7 are expressed within locomotion centres, and Toll-7;Toll-6 double mutants 
have been shown to be required for normal larval locomotion and motor axon targeting 
(McIlroy et al., 2013). Therefore whilst no phenotype with single knock-down flies were 
observed during this thesis, it would be interesting to test the double mutant to see if this 
effect is retained in adult flies. Similarly, there may be synergistic effects in double mutants 






7.4 Toll-3 in neurons is involved in the regulation of CNS size 
 
As another means to ask whether the nine Tolls have equivalent functions in the CNS or not, I 
tested the effects of over-expressing or knocking down each of the Tolls in larval neurons or 
glial cells and measured overall larval CNS size. Toll-3 is required in neurons to regulate the 
maintenance of CNS size. This is independent of cell number as there was no increase in 
neuronal number in ElavGal4>UASToll-3 flies. The maintenance of CNS size may however 
be reliant on an increase in cell size, which was not explored. It was undetermined if any of 
the Toll receptors were important in the regulation of CNS size when expressed in glial cells. 
It may be possible that the Toll receptors do not influence glial cell number as increasing glial 
proliferation results in a longer VNC (Kato et al., 2011; Losada-Perez et al., 2016). 
 
7.5 Toll receptors regulate cell number  
 
In larval VNC the over-expression of Toll-2, -4, -6, -7, -8 and -9 in neurons resulted in an 
increase in Eve+ neurons. This increase in cell number may be due to increased cell survival 
or proliferation. McIlroy et al, showed that there are increased rates of apoptosis in Toll-6 and 
Toll-7 mutant embryos. This is consistent with both Toll-6 and Toll-7 as being pro-survival 
factors in the embryonic and larval stages of development.  
 
In larval retinal discs however, the over-expression of Toll-2 and Toll-9 resulted in an 
increase of Dcp1+ cells and the knockdown of these genes subsequently decreases apoptotic 
rates. In contrast to the above findings this indicates that these genes are required for cell 
death functions in larval retina. It is possible that different genetic pathways are functioning in 
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the VNC compared to retinal discs in order to regulate cell death or cell survival. It is 
interesting to note that Wu et al, demonstrated that Toll-1 signalling induces caspase 
independent cell death in retinal discs. They state that the activation of cell death is via 
Spz6>Toll-1>NF-κB signalling pathway, and not via JNK signalling. However I have used 
Dcp1 to monitor apotosis in the retinal discs, which is a caspase.  However Toll-6 knockdown 
in retina resulted in an increase apoptosis indicating that it functions as a pro-survival receptor 
in the larvae.  
 
Furthermore the over-expression of Toll-6 results in an increase in the number of Eve+ 
neurons and can activate pro-survival NF-KB signalling (Foldi, Anthoney et al, 2017) again 
indicating its role in pro-survival signalling. Interestingly the number of Eve+ neurons after 
over-expressing of Toll-1 and Toll-3 was the same as the control, and together these results 
indicate that some of the Tolls are likely to be pro-survival whilst others are pro-apoptotic. 
However it should be noted that the over-expression of Toll-2 and Toll-9 also resulted in 
increase Eve+ neuron number. Previously I showed evidence that both of these Toll receptors 
increased cell death in the retina, a result which may imply tissue specificity These data are 
also consistent with findings that different Toll receptors are involved in regulating different 
functions in both immunity and in developmental processes (Tauszig et al., 2000; Yagi et al., 
2010; McIlroy et al., 2013; Meyer et al., 2014; Pare et al., 2014).  
 
The downstream signalling adaptors may change between tissue or cell, and thus influence the 
outcome upon over-expression or knockdown of certain genes. Furthermore, it is also possible 
that there is a compensatory mechanism in place whereby an increase in apoptosis leads to an 
increase in cell number in order to maintain neuronal homeostasis. In order to confirm if it is 
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gene regulation or compensatory mechanisms providing differing results, it would be 
beneficial to make comparable measurements of neuronal number and death in the retina or 
VNC. Thus my data suggest that tolls regulate cell death via a canonical caspase dependent 
pathway.  
 
7.6 DNTs in the regulation of cell number plasticity 
 
As different Toll receptors are involved in differentially regulating cell survival and/or cell 
death, I asked if the same was true of the DNT ligands. I provide evidence that similar to the 
Tolls the DNTs are able to regulate cell number plasticity by promoting both cell survival and 
cell death in the Drosopihla CNS. I have previously mentioned that DNT-1 and DNT-2 bind 
Toll-7 and Toll-6 receptors (McIlroy et al., 2013), and that this binding may be promiscuous 
as Toll-7 can also function as the DNT-2 receptor (Foldi, Anthoney et al, 2017). Here I have 
shown that DNT1-FL is able to activate apoptotic JNK signalling, whereas mature DNT1, 
DNT2 and DNT2-FL activate the pro-survival signalling ERK pathway (This thesis and 
Foldi, Anthoney et al. 2017). DNT2-FL is cleaved intracellularly giving rise to mature DNT2 
protein. In comparison to mammalian NTs, there are remarkable similarities. I have found that 
pro-NTs function via JNK signalling pathways to elicit cell death functions and conversely it 
is the mature cleaved NTs that via pro-survival signalling pathways NF-KB and ERK, initiate 
cell survival (Vetter et al., 1991; Aloyz et al., 1998; Riccio et al., 1999; Corbit et al., 1999; 
Lee et al., 2001, Nykjaer et al., 2004; Beattie et al., 2002; Harrington et al., 2004; Srinivasan 
et al., 2004). This mechanism of cell survival and death is dependent upon ligand cleavage 
processes as well as ligand-receptor complex specificity. This suggests that the structure of 
the DNT, whether it is a pro or mature NT, binds to differing Toll receptors or receptor 
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heterodimers in order to activate cell death or survival. 
7.7 Downstream signalling events of Toll-6 
 
To elucidate downstream signalling adaptors that facilitate Toll and DNT functioning in cell 
death or survival, I worked in collaboration with Dr Istvan Foldi and Dr Neale Harrison 
(Postdocs in the Hidalgo lab at UOB) focusing on Toll-6. I have shown that MyD88 was 
expressed in the CNS of larval and pupal stages. The levels were higher throughout the pupal 
stage, which also corresponds to the second wave of cell death and significant remodelling of 
the CNS. MyD88 is able to influence cell survival as over-expression in neurons results in an 
increase in Eve+ neuronal number. Furthermore both a MyD88 missense allele as well as a 
MyD88 null allele resulted in an increase in apoptosis.  
Whilst in the embryo and larval stage, Toll-6 promotes cell survival (McIlroy et al., 2013 and 
this thesis); during pupal development Toll-6 induced apoptosis. This indicates that Toll-6 is 
able to switch between a pro-survival and pro-death state. Furthermore this effect is 
independent of MyD88. In mammals TLRs can also signal in a MyD88 dependent or 
independent fashion. dSarm is expressed in the embryonic CNS as well as in the CNS of both 
larvae and pupae, and levels increase as development progresses. dSarm is able to induce 
apoptosis and neuronal loss and is able to antagonize MyD88 pro-survival function in doing 
so. Furthermore, this pro-apoptotic effect of dSarm is via the JNK signalling pathway.  
However, dSarm is unable to bind Toll-6 directly (Foldi, Anthoney et al, 2017) and requires 
the interaction of Wek in order to induce apoptosis. Wek acts upstream of dSarm giving rise 
to the DNT - Toll-6 – Wek – dSarm – JNK mode of cell death. dSarm can also activate cell 
death via direct inhibition of MyD88 and Wek can act as the link between Toll-6 function and 
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cell survival outcomes giving rise to Toll-6 – MyD88 – NF-KB/ERK cell survival. Wek 
therefore functions like a hinge, and is able to facilitate the actions of either MyD88 or dSarm 
downstream of Toll-6, depending on the cell requirement. 
Over-expression of MyD88 and dSarm can influence Wek levels indicating that Wek is 
regulated by competitive interactions between dSarm and MyD88.It is therefore likely that the 
different cell survival or cell death outcomes that are Toll-6 mediated are due to the changing 
levels of different downstream adaptors. In embryos, it is likely that Toll-6 binds MyD88 and 
activates cell survival signalling pathways in order to actively maintain neuronal survival for 
neural circuit formation. Beginning in embryogenesis, Toll-6 is therefore promoting neuronal 
survival (McIlroy et al., 2013), via the Toll-6 - MyD88 – NF-KB/ERK signalling pathway. 
This signalling pathway can occur due to the low levels of Wek, which prevents the dSarm 
pro-apoptotic signalling pathway from being activated and also prevents the interaction and 
direct inhibition of MyD88 from dSarm.  
However, as development continues both MyD88 and dSarm activate an increase in Wek, 
which by the pupal stage facilitates association of either MyD88 or dSarm with Toll-6. This 
association with Toll-6 can either activate cell survival via MyD88 and NF-KB as in embryos, 
or activate cell death via dSarm and JNK signalling. During this stage it is also interesting to 
note that dSarm can directly inhibit the function of MyD88, which continues the apoptotic 
signalling mechanism but also prevents the canonical pro-survival signalling. Therefore Toll-
6 can not only promote cell survival in embryonic stages, but also promote survival and death 
during pupal stages.  
Regulatory feedback mechanisms have been shown in other parts of Toll signalling. For 
example both Toll-6 and Toll-7, and DNT-1 can up-regulate the NF-KB homologues Dif and 
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Dorsal (McIlroy et al., 2013). Furthermore, Toll signalling activates Hippo pathway 
components, and via negative feedback leads to Pelle phosphorylation and Cactus degradation 
(Liu et al., 2016). It is becoming ever more apparent that signalling pathways can be in 
control of numerous different signalling outcomes and not simply single linear signalling 
events.  
For another example of positive regulation, Toll signalling can be activated via the generation 
of reactive oxygen species (ROS) and DAMPs from CIN cells (Liu et al., 2015).. This 
activation leads to induction of two possible outcomes. The first, JNK and Mmp1 activation 
followed by JNK dependent apoptosis occurs in neighbouring CIN cells via TNFα secretion. 
Or the second pathway whereby JNK activation results the production of ligands for the Toll 
receptor, positively regulating Toll signalling (Liu et al., 2016). 
7.8 Final conclusions, implications of research and future directions 
 
Throughout this thesis I have shown that the Toll receptors are functionally different in their 
signalling outcomes. Cell survival and death within the Drosopihla nervous system is reliant 
upon the different form (either full length pro-DNT or mature DNT) of DNT that a single (or 
combination) Toll receptor binds. Then which adaptor proteins are available and functional 
for downstream signalling pathways. In conjunction with Foldi, Anthoney et al, I have shown 
throughout development different signalling pathways are required to facilitate cell death or 
survival outcomes. This is reliant upon the changing abundance and availability of the adaptor 
proteins Wek, MyD88 and dSarm. This system reveals a novel mechanism of cell number 
control within the Drosopihla nervous system. Regulation occurs in a highly plastic manner 
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via positive and negative feedback mechanisms that drive alternative outcomes. These 
downstream signalling outcomes are therefore highly context dependent.  
 
Whilst chapter 7 focused solely on Toll-6, I have presented evidence that some of the Toll 
receptors (in particular Toll-8) are widespread throughout the CNS of Drosopihla. Some of 
the Toll receptors may function in a manner similar to Toll-6 to regulate cell survival via 
MyD88 - ERK /NF-KB signalling or cell death via Wek - dSarm - JNK signalling. Or they 
may function via different signalling mechanisms, as throughout this thesis I have shown that 
context matters. For example time is an important consideration. Toll-6 is initially pro-
survival in the embryo and larval stages but is pro-apoptotic from pupal stages. Furthermore, 
it has become apparent that the specific tissue or cell a Toll receptor is expressed in can have 
very different signalling outcomes. Toll-2 and Toll-9 regulate neuronal survival in the VNC 
of larvae, however, they regulate cell death in the retinal discs. Therefore we cannot 
theoretically extrapolate between different developmental stages, the different tissues or even 
between the different Toll receptors. There appears to be no general mechanism that governs 
all of the Toll receptors functionally. There is also the possibility that the Tolls may form 
heterodimers and certain combination of the Tolls depicts the outcome of a function.  
 
During the course of this PhD, published articles also confirm that the Tolls have very 
different signalling outcomes through a variety of downstream signalling pathways (Figure 
7.1). A recent publication has demonstrated that Toll-6 (and not Toll-7) functions in the 
promotion of axon transport and structural plasticity of motor neurons through a different 
complex of signalling mechanisms including dSarm and dFoxO (McLaughlin et al., 2016). 
Furthermore Ward et al., show independently of downstream signalling both Toll-6 and Toll- 
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7 are capable of regulating different aspects of olfactory circuit wiring, with Toll-7 primarily 
involved in ORN axon targeting and Toll-6 in the regulation of PN dendrite targeting. The 
authors also state that Toll receptor cytoplasmic domains are dispensable for action (Ward et 
al., 2015). In motor neurons however, McLaughlin et al., demonstrate that Toll-6 requires the 
cytoplasmic domain to function effectively to promote microtubule stability at the NMJ.  
 
DNT-1, -2 and Spz are required for synaptogenesis, with involvement in synaptic growth and 
morphology at the neuromuscular junction (NMJ) (Sutcliffe et al., 2013). These 
neurotrophins regulate growth in a cell specific manner, with Spz regulating growth of NMJ4 
and DNT-1 and DNT-2 regulating growth of NMJ 6 and 7 (Sutcliffe et al., 2013). Toll-6 and 
Toll-7 bind and genetically interact with DNT-2 and DNT-1, most likely in a promiscuous 
manner (Foldi, Anthoney et al., 2017). These ligand-receptor complexes utilise different 
signalling mechanisms from vertebrate NTs, which use the canonical p75NTR, Trk and sortilin 
signalling. The DNTs have distinct biochemical properties with DNT2 always being cleaved 
intracellularly, whereas DNT-1 is secreted in both the pro-DNT protein and mature protein 
forms. The cleavage proteases involved still remain to be elucidated (Foldi, Anthoney et al., 
2017; McIlroy et al., 2013).  
 
Downstream of the Toll receptors McLaughlin et al., 2016 have shown that Toll-6 acts 
upstream of dFoxO in order to promote growth at NMJ4 and NMJ 6/7. Furthermore they 
show that Toll-6 regulates microtubule organisation at the NMJ through non-canonical 
signalling pathways. This pathway does not engage the function of Dorsal, MyD88, Cactus, 
Pellino, Wek or Relish. Instead works via dSarm and dFoxO and the repression of a mitotic 
kinesin Pavarotti-KLP (Pav-KLP). Furthermore Ballard et al, demonstrate that Toll-8 
200
regulates NMJ growth via a Dorsal - NF-κB and Cactus - IκB independent pathway. Instead, 
pre-synaptic Toll-8 is activated by Spz3 activating a JNK signalling cascade, resulting in the 
activation of Jun and Fos and enhancement of NMJ growth (Ballard et al., 2014). McLaughlin 
et al, demonstrate that Toll-6, like Toll-8, activates JNK signalling, but this is not required for 
NMJ development. And as yet the ligand for Toll-6 and Toll-7 at the NMJ is not known in 
this Toll-6 – dFoxO – Pav-KLP pathway (McLaughlin et al., 2016).  
 
In the regulation of cell death Meyer et al, demonstrates that dSarm promotes apoptosis in 
epithelial cells during cell competition. The authors propose two different signalling 
mechanisms dependent upon the cell context. When mutant cells surround a wild type cell, a 
Spz ligand binds Toll-2, -3, -8 or -9 resulting in the activation of dSarm and downstream 
apoptotic signalling in order to eliminate it. This is in agreement with my findings whereby 
Toll-6 works via Wek and dSarm in order to promote cell death. However, the authors also 
propose that cell death can occur in a dSarm independent manner. In this instance when wild-
type cells surround a mutant cell, Spz binds Toll-3 or Toll-9 activating NF-κB transcription 
factors to promote cell death. Wu et al, also propose that within retinal cells Spz6 binds Toll-1 
activating NF-κB signalling and this activation results in caspase independent cell death. 
Neither of these papers investigates the interaction between the Toll receptor, MyD88 and 
downstream signalling. Interestingly, Adachi et al, identified that MyD88 is required for cell 
proliferation, the induction of NF-KB as well as JNK signalling in mammals (Adachi et al., 
1998). Furthermore Tauszig-Delamasure et al., has shown that MyD88 interacts with the 
apical caspases dFADD and Dredd. These caspases regulate effector caspases such as DCP1 
and Drice to drive apoptosis (Tauszig-Delamasure et al., 2002). MyD88 interacts with Toll-1 
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(Tauszig Delamasure et al., 2002), Toll-6 and Toll-7 (Foldi, Anthoney et al., 2017). However, 
whether these interactions result in cell death in specific tissues remain to be investigated.  
 
In conclusion, DNTs and Toll receptors and their downstream targets regulate structural 
plasticity within the CNS of Drosopihla. However, there are multiple pathways that govern 
the signalling outcome, which is completely dependent upon numerous factors. Different 
neurotrophins bind to a range of Toll receptors to elicit specific cellular outcomes. The 
outcome is determined by the combination of neurotrophin and Toll, Toll receptor and 
adaptor protein/s, and downstream signalling mechanisms. I have shown that multiple Toll 
receptors are involved in a range of functions including locomotion, regulation of CNS size, 
cell survival and cell death. For Toll-6, we have established that there are two main signalling 
pathways governing cell death (DNT - Toll-6 – Wek – dSarm – JNK) or cell survival (DNT- 
Toll-6 - MyD88 – NF-KB/ERK). It will be interesting to determine if other Tolls also regulate 
cell death and/or survival in the CNS and function via this route. Or if they function in a 
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eTOC SUMMARY 
A three-tier mechanism involving distinct neurotrophin family ligand forms, different Toll 
receptors and different adaptors, regulates both cell survival and death. This rich mechanism 
confers cell number plasticity, could underlie structural plasticity in the nervous system, and 
structural integrity, homeostasis and regeneration in wider contexts.  
 
ABSTRACT 
Cell number plasticity is coupled to circuitry in the nervous system, adjusting cell mass to 
functional requirements. In mammals, this is achieved by Neurotrophin (NT) ligands, which 
promote cell survival via their Trk and p75NTR receptors, and cell death via p75NTR and 
Sortilin. Drosophila neurotrophins (DNTs) bind Toll receptors instead to promote neuronal 
survival, but whether they can also regulate cell death is unknown. Here, we show that DNTs 
and Tolls can switch from promoting cell survival to death in the central nervous system 
(CNS), via a three-tier mechanism. First, DNT cleavage patterns result in alternative signaling 
outcomes. Second, different Tolls can preferentially promote cell survival or death. Third, 
distinct adaptors downstream of Tolls can drive either apoptosis or cell survival. Toll-6 
promotes cell survival via MyD88-NFκB, and cell death via Wek-Sarm-JNK. The distribution 
of adaptors changes in space and time, and may segregate to distintict neural circuits. This 










Balancing cell death and cell survival enables structural plasticity and homeostasis, 
regeneration and repair, and fails in cancer and neurodegeneration. In the nervous system, cell 
number plasticity is linked to neural circuit formation, adjusting neuronal number to 
functional requirements (Levi-Montalcini, 1987). In mammals, the neurotrophin (NT) protein 
family – NGF, BDNF, NT3 and NT4 - regulates neuronal number through two mechanisms. 
First, full-length pro-NTs - comprised of a disordered pro-domain and a cystine-knot (CK) 
domain - induce cell death; in contrast, mature NTs formed of CK dimers, promote cell 
survival (Lu et al., 2005). Second, pro-NTs bind p75NTR and Sortilin receptors inducing 
apoptosis via JNK signaling, whereas mature NTs bind p75NTR promoting cell survival via 
NF-κB (Carter et al., 1996), and TrkA,B and C promoting cell survival via PI3K/AKT and 
MAPKinase/ERK (Lu et al., 2005). As the NTs also regulate connectivity and synaptic 
transmission, they couple the regulation of cell number to neural circuitry and function, 
enabling structural brain plasticity(Lu et al., 2005; Minichiello, 2009; Park and Poo, 2013). 
There is abundant evidence that cell number plasticity occurs in Drosophila central nervous 
system (CNS) development – with neurotrophic factors including neurotrophins and MANF 
(Palgi et al., 2009; Zhu et al., 2008) -, but fruit-flies lack p75NTR and Trk receptors, raising the 
question of how this is achieved in the fly. Finding this out is important, as it could lead to 
novel mechanisms of structural plasticity for both flies and humans.  
Drosophila neurotrophins – Spätzle (Spz), Drosophila Neurotrophin 1 (DNT1) and 
DNT2 – share with mammalian NTs the characteristic structure of a pro-domain and a 
conserved CK of 13-15 kDa, which forms a disulfide-linked dimer (Arnot et al., 2010; 
Hepburn et al., 2014; Hoffmann et al., 2008a; Hoffmann et al., 2008b; Zhu et al., 2008). Spz 
resembles NGF biochemically and structurally, and binding its Toll-1 receptor resembles that 
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of NGF to p75NTR (Arnot et al., 2010; DeLotto and DeLotto, 1998; Hepburn et al., 2014; 
Lewis et al., 2013; Mizuguchi et al., 1998). DNT1 (also known as spz2) was discovered by 
homology to BDNF, and DNT2 (also known as spz5) as a paralogue of spz and DNT1 (Parker 
et al., 2001; Zhu et al., 2008). DNT1 and -2 promote neuronal survival, and DNT1, 2, Spz and 
Spz3, are required for connectivity and synaptogenesis (Ballard et al., 2014; Sutcliffe et al., 
2013; Zhu et al., 2008). Spz, DNT1 and DNT2 are ligands for Toll-1, -7 and -6, respectively, 
which function as neurotrophin receptors and promote neuronal survival, circuit connectivity 
and structural synaptic plasticity (McIlroy et al., 2013; McLaughlin et al., 2016; Sutcliffe et 
al., 2013; Ward et al., 2015; Weber et al., 2003; Zhu et al., 2008). Tolls belong to the Toll-
receptor super-family, which underlies innate immunity (Imler and Zheng, 2004; Leulier and 
Lemaitre, 2008). There are nine Toll paralogues in flies, of which only Toll-1, -5, -7 and -9 
are involved in immunity (Leulier and Lemaitre, 2008; Tauszig et al., 2000). Tolls are also 
involved in morphogenesis, cell competition and epidermal repair (Ballard et al., 2014; 
Carvalho et al., 2014; Halfon et al., 1995; McIlroy et al., 2013; Meyer et al., 2014; Pare et al., 
2014; Ward et al., 2015; Yagi et al., 2010). Whether DNTs and Tolls can balance cell number 
plasticity is unknown.  
Like the p75NTR receptor, Toll-1 activates NF-κB signaling downstream: a potent 
neuronal pro-survival factor, with evolutionarily conserved functions also in structural and 
synaptic plasticity (Gutierrez and Davies, 2011; Hoffmann and Reichhart, 2002; Mattson and 
Meffert, 2006). Toll-1 signaling involves the downstream adaptor MyD88, which forms a 
complex with Tube and Pelle (Gay and Gangloff, 2007; Horng and Medzhitov, 2001; 
Tauszig-Delamasure et al., 2002). Activation of Toll-1 triggers the degradation of the NF-κB 
inhibitor Cactus, enabling the nuclear translocation of the NF-κB homologues Dorsal and 
Dorsal-related Immunity Factor (Dif), which function as transcription factors. Other Tolls 
have also been suggested to activate NF-κB (McIlroy et al., 2013; Meyer et al., 2014). 
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However, only Toll-1 has been shown to bind MyD88 (Tauszig-Delamasure et al., 2002), 
raising the question of how the other Tolls signal in flies.  
Whether Tolls regulate cell death is also obscure. Toll-1 activates JNK causing 
apoptosis, but its expression can also be activated by JNK to induce non-apoptotic cell death 
(Liu et al., 2015; Wu et al., 2015a; Wu et al., 2015b). Toll-2,-3,-8 and -9 can induce apoptosis 
via NF-κB and dSarm independently of MyD88 and JNK (Meyer et al., 2014). However, in 
the CNS dSarm induces axonal degeneration, but there is no evidence that it can promote 
apoptosis in flies (Osterloh et al., 2012). In other animals, Sarm orthologues are inhibitors of 
Toll signaling and MyD88 (Carty et al., 2006; Yuan et al., 2010), but there is no evidence that 
dSarm is an inhibitor of MyD88 in Drosophila. Thus, whether or how Tolls may regulate 
apoptosis in flies is unclear. 
In the mammalian brain, Toll-Like-Receptors (TLRs) are expressed in neurons where 
they regulate neurogenesis and apoptosis, neurite growth and collapse - in the absence of any 
insult (Okun et al., 2011). However, their neuronal functions have been little explored, and 
their endogenous ligands in neurons remain unknown. 
Since Toll-1 and p75NTR share common downstream signaling pathways, and p75NTR 
can activate NF-κB to promote cell survival and JNK to promote cell death, here we asked 
whether the DNTs and their Toll receptors could have dual roles controlling cell survival and 
death in the Drosophila CNS.  
 
RESULTS  
Different processing for each DNT ligand 
Using 3D structural modeling based on the crystal structure of Spz (Lewis et al., 2013), we 
compared the mature cystine-knot (CK) domains of DNTs with those of mammalian NTs. 
They all share the structurally conserved CK unique to the NT family, distinct from those of 
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other growth factors, with the characteristic arrangement of anti-parallel β-sheets and 
disulfide bridges (Fig. 1A-D). The overhanging wings are out of phase by 90° in the 
Drosophila versus mammalian ligands, possibly reflecting interactions with different receptor 
types (Fig. B-D). The receptor-binding interface of Spz is not evolutionarily conserved in 
DNT1 or 2, suggesting distinct receptor affinities (Fig. 1E). Thus, Spz, DNT1, DNT2 are NT 
ligands with distinctive features.  
The pro-domains have distinctive features too. The pro-domains of Spz and DNT2 are 
disordered coils, whereas that of DNT1 has helices suggesting a globular structure (Fig. 2A 
and Fig. S1). The DNT1 pro-domain is also twice as long as that of DNT2. The pro-domain 
of Spz has an α-helix just upstream of the Easter cleavage site, which undergoes a 
conformational change upon cleavage, essential for the activation of Toll (Arnot et al., 2010). 
This sequence is not conserved in the pro-domains of the mammalian NTs, nor DNT1 and 2 
(Fig. 2A). This suggests that the activation mechanism of Toll by Spz is unique, and distinct 
from those of Toll-6 and -7 by DNT2 and -1, respectively.  
Mammalian pro-NTs are cleaved intracellularly by furin proteases, or extracellularly 
by Serine-proteases (e.g. BDNF, Fig. 2B). Spz is only secreted full-length, and cleaved 
extracellularly by the Serine-proteases Easter or SPE (Hoffmann and Reichhart, 2002). Furin 
sites were absent from the Spz pro-domain, but several highly conserved sites were found in 
DNT1 and 2 (Fig. 2B). In vivo over-expression of mature Spz-CK, DNT1-CK and DNT2-CK 
is functional and rescues the respective mutant phenotypes (Hu et al., 2004; Ligoxygakis et 
al., 2002; Sutcliffe et al., 2013; Zhu et al., 2008). However, S2 cells transfected with DNT1-
cystine-knot-C-Terminal-Domain tagged with 3xHA (DNT1-CK-CTD-HA) and DNT2-CK-
HA, did not secrete mature DNTs to S2 cell medium (Fig. 2D lane 3 and lane 8). This either 
suggests that the pro-domain is required for trafficking in S2 cells, or that S2 cells do not 
behave like neurons do in vivo. S2 cells transfected with wild-type full-length DNT1-FL-HA 
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did not secrete DNT1-FL either, but instead secreted a product truncated at the R283 site (Fig. 
2D lane 2), suggesting that cleavage occurs naturally at this site. By contrast, S2 cells 
expressing DNT2-FL-HA invariably secreted the mature CK form of 15KDa (Fig. 2D lane 7). 
To test if the conserved furin sites were responsible for these cleavage profiles, we carried out 
site directed mutagenesis of the furin sequences in HA tagged DNT1 and 2 (Fig.2C). DNT1 
lacking the furin site at R499 still secreted a product cleaved at R283, but no secreted protein 
was detected when both R499 and R283 were mutagenized (Fig. 2D, lanes 4 and 5). Thus, 
DNT1 furin site at R283, which is the most conserved, is functional. Mutagenesis of the 
DNT2 furin site R284 resulted in the secretion of two products of 30kDa and 18kDa (Fig. 2D 
lane 10). The 30kDa product corresponds to cleavage at site R214 or R221, implying that 
cleavage at these sites is unlikely to occur naturally or that cleavage at R284 predominates. 
The 18kDa product was not detectable in the media expressing wild-type DNT2, suggesting it 
does not occur naturally and is the result of non-furin cleavage. Mutagenising R214, R221 
and R284 sites resulted in the secretion of DNT2-FL-HA from S2 cells, showing that DNT2 
can be secreted full-length (Fig. 2D lane 11). These findings showed that the DNT2 furin 
cleavage site at R284 is functional and it is the predominant cleavage site.  
To test whether similar DNT processing occurs in vivo, we over-expressed in the 
retina (with GMRGAL4) full length forms tagged at the C-termini with GFP, and visualized 
the resulting products with anti-GFP in western blots. DNT1was predominantly found in full-
length form, and also cleaved at furin sites at 98 (less abundant), 283 (pro-DNT1) and 499 
(DNT1-CK-CTD, Fig.2E). DNT2 was found full-length, but predominantly in mature form 
(DNT2-CK, Fig.2E). These data show that in vivo, DNTs are cleaved by furins, and can be 
found in both pro- and mature forms. 
To conclude, each DNT has unique features. DNT1 is more likely found in pro-form 
than DNT2, and DNT2 is more likely found in mature form. Ultimately, the forms secreted in 
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vivo will depend on the expression profile of proteases, and will be context dependent. The 
distinct processing mechanisms of Spz, DNT1 and DNT2 suggest functional differences. 
 
Pro-DNT1 activates pro-apoptotic and mature DNTs pro-survival pathways 
To ask whether different DNT forms could have distinct functions, we tested whether they 
could activate pro-apoptotic or pro-survival signaling pathways.  
Over-expression of mature DNT1 and -2 promotes cell survival in embryos (Zhu et 
al., 2008). In mammals, apoptosis is activated by pro-NTs binding p75NTR and activating JNK 
(Roux and Barker, 2002). Thus, we asked whether the different DNT forms activate JNK 
signaling, visualised using anti-phospho-JNK antibodies. Over-expression of DNT1-CKCTD, 
DNT2-CK or DNT2-FL in the retina reduced the number of pJNK+ cells compared to 
controls, whereas over-expression of DNT1-FL increased pJNK+ cell number (Fig. 3A). Most 
likely (see Fig.2D,E), DNT2-FL was cleaved intracellularly and secreted as mature CK 
instead. Thus, pro-DNT1 can activate the JNK pro-apoptotic signaling pathway. 
We next tested whether DNTs can activate the pro-survival pathways NF-B and 
ERK. Stimulating S2 cells with purified mature DNT2-CK induced the phosphorylation of 
Dorsal (i.e. activation, Fig. 3B). We also transfected S2 cells with Toll-6 or -7, stimulated 
them with purified mature DNT2-CK, and tested whether it triggered the nuclear translocation 
of Dorsal or Dif, thus activating NF-B signaling. Subcellular fractionation revealed that 
DNT2 induced the degradation of the NF-B inhibitor Cactus in the cytoplasm, and the 
nuclear translocation of both Dorsal and Dif (Fig. 3C and Fig.S2A). These data demonstrate 
that mature DNT2-CK activates NF-B signaling. Stimulation with DNT2-CK also activated 
signaling in non-transfected control cells (Fig. 3C). Since S2 cells express multiple Tolls but 
not Toll-6 (Fig. S2B), this means that DNT2 can also bind other Toll-family receptors. In fact, 
DNT1 binds Toll-7 and DNT2 binds Toll-6 (McIlroy et al., 2013), but DNT1 could also bind 
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Toll-6 and DNT2 could also bind Toll-7 (Fig. S3). Thus, binding of DNT1 and 2 to Toll-6 
and -7 is promiscuous. Importantly, both Cactus degradation and nuclear translocation of 
Dorsal and Dif induced by DNT2, were more pronounced in transfected cells than in mock 
controls (Fig. 3C). This shows that Toll-6 and -7 activate NF-B signaling downstream of 
DNT2.  
To test whether DNTs, Toll-6 and -7 could activate ERK, we over-expressed them and 
visualized activated anti-phospho-ERK. Over-expression of either DNT1-FL or mature spz-
CK in neurons of the larval brain optic lobe (with RGGAL4) did not activate ERK signaling 
(Fig. 3D). By contrast, over-expression of DNT1-CKCTD and DNT2-CK did (Fig. 3D). 
DNT2-FL also activated ERK, but as shown above, DNT2 is readily cleaved prior to 
secretion. Thus, mature DNT1 and -2 (but not Spz) can activate ERK. Furthermore, over-
expression of activated forms of Toll-6CY and Toll-7CY (McIlroy et al., 2013), in retinae, 
significantly increased pERK levels (Fig. 3E). Thus, Toll-6 and -7 activate ERK. Together, 
these data show that DNT1 and 2 can activate the pro-survival signaling pathways NF-B and 
ERK via Toll-6 and -7, and pro-DNT1 can activate the pro-apoptotic JNK pathway.  
 To test whether distinct Toll receptors might differentially regulate neuronal number, 
we asked whether Eve+ neurons were affected by loss or gain of function for Tolls in third 
instar larvae ventral nerve cords (VNCs). Toll-7P8/ Toll-7P114; Toll-626/Toll-631 double mutant 
larvae had slightly fewer Eve+ neurons than wild-type, but Toll-1r3/Toll-1r444 mutants had 
more (Fig.3F). Conversely, over-expression of constitutively active Toll-6CY and Toll-7CY in 
neurons (with ElavGAL4) increased Eve+ neuron number (Fig.3F), whereas constitutively 
active Toll-110b decreased it (Fig.3F). Thus, Toll-6 and -7 promote cell survival, as previously 
reported (McIlroy et al., 2013), but Toll-1 can be pro-apoptotic. Distinct Toll receptors, and 
the potential formation of hetero-dimers between different Toll receptors, might switch the 
response to DNTs from cell survival to cell death (Fig. 3G).  
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Toll-6 activates pro-survival signaling in the CNS via MyD88 
The finding that Toll-6 and -7 could initiate signaling suggested the involvement of the 
MyD88 adaptor. However, no interactions between Tolls, other than Toll-1, and MyD88 had 
been previously detected (Tauszig-Delamasure et al., 2002). To test whether Toll-6 or -7 and 
MyD88 could form a signaling complex, S2 cells were co-transfected with native Toll-6 or -7, 
or activated Toll-6CY or -7CY tagged with Flag, and MyD88 tagged with V5. In co-
immunoprecipitations, MyD88 co-purified with Toll-6 and -7, and Toll-6CY and Toll-7CY 
(Fig. 4A). Thus, both Toll-6 and -7 can bind MyD88. This physical interaction could occur in 
vivo as, like Toll-6 and -7 (McIlroy et al., 2013), MyD88 protein was found throughout the 
embryonic CNS neuropile, and its endogenously tagged downstream targets Dorsal-GFP and 
Dif-GFP were too (Fig. 4B).  
We next asked whether MyD88 is required for the CNS functions of Toll-6 and -7, by 
testing the effect of mutants on Eve, a reporter for Toll-6 neurons.  All Eve+ neurons - except 
pCC and RP2 - express Toll-6 (McIlroy et al., 2013). MyD88kra56 is a hypomorphic allele 
(Charatsi et al., 2003), ideal to test for phenotypic enhancement or suppression in genetic 
interactions. MyD88kra56 mutants had a virtually normal embryonic CNS, but MyD88kra56 Toll-
626 double mutants and MyD88kra56 Toll-7P8 Toll-626 triple mutants had fewer Eve+ neurons 
(Fig. 4C and Fig. S4). This is consistent with MyD88 functioning downstream of Toll-6 and -
7 in the CNS to maintain neuronal survival. In fact, over-expression of MyD88 in all neurons 
(with elavGAL4) increased Eve+ neurons both in third instar larvae and pupae (Fig. 4D). 
Conversely, over-expression of cactus decreased Eve+ neuron number in larvae (Fig.4D), and 
loss of MyD88 function also decreased Eve+ number in pupae (Fig.4D). Together, these data 
show that MyD88 is required for and can promote neuronal survival.  
 11
To verify this, we quantified the effects of altering MyD88 function in apoptosis. 
MyD88kra56 homozygotes are semi-lethal, with a lethality phase at pupariation, indicating this 
is a critical time for MyD88 function. Using anti-Death Caspase 1 (Dcp1), we counted all 
dying cells throughout the VNC of white pupae using adapted DeadEasy Caspase software 
(Forero et al., 2009). In MyD88kra56 homozygotes apoptosis levels did not differ from controls, 
but they increased in MyD88kra56 /DfBSC279 trans-heterozygotes (Fig. 4E). We generated a 
MyD88 null allele using CRISPR/Cas9, MyD88cr2.8. Trans-heterozygous 
MyD88cr2.8/Df(2R)BSC279 pupae also had increased apoptosis (Fig. 4E). Thus, MyD88 is 
required for neuronal survival. Together, these data showed that Toll-6 and -7 signal via the 
canonical MyD88 pathway to promote neuronal survival in the CNS.  
However, over-expression of MyD88 in all neurons also increased apoptosis in pupa 
(Fig. 4E). This could occur downstream of Tolls, as over-expression of activated Toll-6CY or 
Toll-110b also increased apoptosis in pupae (Fig. 4E). Remarkably, the pro-apoptotic effect of 
Toll-6 was enhanced when over-expressed in a MyD88kra56 mutant background (Fig. 4E), 
suggesting that Toll-6 might induce apoptosis in pupae independently of MyD88.  
These data raised two questions: how does MyD88 induce apoptosis? And how can 
Toll-6 induce apoptosis independently of MyD88?  
 
Toll-6 can induce apoptosis via the MyD88 inhibitor dSarm 
In mammals, Sarm1 inhibits MyD88, and can induce neuronal apoptosis (Carlsson et al., 
2016; O'Neill and Bowie, 2007). Thus we wondered whether Drosophila dsarm might be 
involved in pro-apoptotic signaling by Toll-6. We over-expressed dsarm in all neurons using 
EP3610 flies, which drive expression of multiple Ect4 isoforms (Ect4 is a synonym of 
dsarm). Elav>EP3610 increased apoptosis in pupal VNCs (Fig. 5A). Remarkably, over-
expression of dsarm in a MyD88kra56 mutant background increased apoptosis further (Fig. 
 12
5A). This showed that dSarm promotes apoptosis, and antagonises MyD88 function. 
Apoptosis led to neuronal loss, as over-expression of dsarm in normal or MyD88 mutant 
pupae, decreased Eve+ neuron number (Fig. 5B). Since sarm mutants are embryonic lethal, to 
further verify this we looked at the embryonic CNS. dsarm is expressed throughout the 
embryonic CNS, as visualised with a dsarmMIMIC-GFP reporter (Fig.5C). Over-expressing 
dsarm, using either EP3610 or a single dsarm isoform (Osterloh et al., 2012), in all 
embryonic CNS neurons caused Eve+ neuron loss (Fig. 5D, Fig. S4). Conversely, 
dsarm4705/dsarm4621 mutant embryos had more Eve+ neurons (Fig. 5D and Fig. S4). Together, 
these data showed that dSarm induces apoptosis and neuronal loss.   
 JNK is a common pro-apoptotic effector, activated by p75NTR and Sarm1 in mammals, 
and Tolls in flies (Kim et al., 2007; Roux and Barker, 2002; Wu et al., 2015a). Thus to ask 
whether dSarm induces apoptosis by activating JNK, we tested whether JNK knock-down 
could rescue apoptosis caused by dsarm over-expression. Indeed, over-expressing dsarm in 
all neurons together with JNK-RNAi decreased apoptosis compared to Elav>EP3610 (Fig. 
5A). Thus, dSarm activates apoptosis via JNK. To further verify this, we asked whether 
MyD88 and dSarm affected activated pJNK+ cells in larval retinae. MyD88kra56 
/Df(2R)BSC279 mutants had normal pJNK+ cell number, but over-expressing dsarm 
increased pJNK+ cell number (Fig. 5E), and this increased further in a MyD88kra56 mutant 
background (Fig. 5E). This showed that dSarm activates apoptosis via JNK, and antagonises 
MyD88 function.  
 To test whether dSarm could inhibit MyD88 through direct physical interaction, we  
carried out co-immunoprecipitations. S2 cells were co-transfected with MyD88 tagged with 
V5 and dsarm tagged with HA. Precipitating MyD88 co-purified dSarm, showing that dSarm 
and MyD88 interact physically (Fig. 5F). Altogether, data showed that Sarm is an inhibitor of 
MyD88, and it induces apoptosis by antagonising MyD88 and by activating JNK signaling. 
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 But if neuronal apoptosis depends on dSarm, why did MyD88 induce apoptosis in 
pupa? We had shown that over-expression of MyD88 increased neuron number, over-
expression of cactus decreased Eve+ neuron number, and MyD88 loss of function did not 
affect pJNK cell number, implying that NF-κΒ does not directly promote apoptosis. 
Importantly, apoptosis caused by MyD88 over-expression in neurons was rescued by JNK-
RNAi knock-down (Fig.5A), meaning that apoptosis downstream of MyD88 requires JNK. 
This suggests that MyD88 might induce apoptosis by up-regulating the expression of JNK, 
wek or dsarm. 
 Our data had shown that Toll-6 can induce apoptosis, that it functions upstream of 
MyD88 to maintain neuronal survival, but MyD88 is inhibited by Sarm, which also induces 
apoptosis via JNK. So we asked whether Toll-6 and -7 could activate apoptosis by directly 
interacting with dSarm, using co-immunoprecipitations. We co-transfected S2 cells with Toll-
6-Flag or -7-Flag and dsarm-HA, and found that precipitating Toll-6 or-7 did not co-
precipitate dSarm (Fig. 5F). Thus, dSarm does not bind Toll-6 or -7, meaning that dSarm does 
not directly mediate the pro-apoptotic function of Toll-6. 
 Thus, data showed that Toll-6 functions upstream of dSarm and MyD88, to regulate 
neuronal death and survival, respectively (Fig. 5G). But they raised further questions: how 
can Toll-6 induce apoptosis if it does not bind dSarm? And why does Toll-6 promote cell 
survival in embryos and apoptosis in pupae? 
 
Pro-apoptotic Toll-6 signaling requires Wek  
Our data suggested there might be another adaptor linking Toll-6 to dSarm to enable pro-
apoptotic signaling. Weckle (Wek) is an adaptor downstream of Toll-1 that recruits MyD88 to 
form a signaling complex during embryonic development, but not in innate immunity (Chen 
et al., 2006). To test whether pro-apoptotic Toll-6 signaling required Wek, we measured 
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apoptosis in the pupal VNC with anti-Dcp1 in loss and gain of function genotypes. Apoptosis 
levels decreased in wekEX14/Df(2L)BSC690 mutants compared to controls (Fig. 6A). 
Conversely, over-expression of wek in neurons increased apoptosis (Fig. 6A). These 
phenotypes were rescued by the over-expression of wek in neurons in a wek mutant 
background (Fig. 6A). Thus, Wek can promote apoptosis in the CNS.  
To test the relationship of Wek with Toll-6 and dSarm, we carried out epistasis 
analyses. Loss of wek function rescued the increased apoptosis caused by the over-expression 
of Toll6CY (Fig. 6A), showing that Toll-6 requires Wek to induce apoptosis. Loss of wek 
function did not rescue the apoptosis caused by the over-expression of dsarm, meaning that 
dSarm functions downstream of Wek (Fig. 6A). Furthermore, dsarm knock-down rescued the 
apoptosis caused by the over-expression of wek, showing that Wek induces apoptosis 
upstream of dsarm (Fig. 6A). In embryos, over-expression of wek caused Eve+ neuron loss 
(Fig. 6B and Fig. S4). In pupae, the number of Eve+ neurons did not change in 
wekEX14/Df(2L)BSC690 mutants, but decreased upon wek over-expression (Fig. 6C). Together, 
these data showed that Wek can promote apoptosis and neuronal loss downstream of Toll-6 
and upstream of dSarm.  
To test whether Wek could bind Toll-6 and dSarm, we carried out co-
immunoprecipitations. We co-transfected S2 cells with wek-HA and Toll-6-Flag or dSarm-
Flag, and found that precipitating Toll-6 or dSarm also brought down Wek (Fig.6D). Thus, 
Wek can bind both Toll-6 and dSarm.  
 To conclude, Wek is required downstream of Toll-6 to induce neuronal apoptosis via 
dSarm (Fig.6E). But a question still remained: why could Toll-6 promote cell survival in 
embryos, and cell death in pupae? 
 
Adaptor profiles change in space and time 
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Our data suggested that the relative levels of MyD88, dSarm and Wek could determine 
neuronal life or death. Thus we used MyD88GAL4 to ask how increasing the levels of Wek 
and Sarm relative to normal MyD88 levels would affect neurons. Over-expression of wek in 
MyD88+ cells decreased Eve+ neuron number in pupae compared to controls, and over-
expression of sarm (EP3610) decreased Eve+ neurons further (Fig. 7A). Using the nuclear 
reporter Histone-YFP, over-expression of wek reduced cell number in pupae, and over-
expression of dsarm reduced cell number even further (Fig. 7B). Remarkably, concomitant 
neuronal over-expression of wek with MyD88 knock-down resulted in the most severe cell 
loss in pupal VNCs (Fig.7B). Since over-expression of wek alone had only a mild effect, this 
reveals that normally Wek is in a tug of war between dSarm and MyD88 signalling, that 
MyD88 and dSarm have antagonistic functions regulating cell number, and that Wek can 
engage both pathways downstream of Toll-6. Thus, relative levels of Wek, Sarm and MyD88 
determine cell survival or death downstream of Tolls.  
 Toll-6 maintains neuronal survival in embryos and can promote both neuronal survival 
or death in pupae, suggesting that its signaling adaptors change over time. To test this, we 
used quantitative real time reverse-transcription PCR (qRT-PCR) and measured MyD88, 
dsarm and wek transcript levels in whole stage 17 embryos and in the dissected CNS of 
second and third instar larvae (L2, L3) and 1 day-old pupae. MyD88 mRNA levels were high 
in embryos, decreased in L2 CNS, increasing again between L3 and white pupae (Fig.7C). 
Relative to MyD88 transcripts, dsarm mRNA levels were high in embryos, decreasing 
thereafter (Fig. 7C) and wek mRNA levels were virtually absent in embryos, and increased 
from L2 on (Fig. 7C). wek expression was consistently lower than that of dsarm and equal to 
MyD88 from L2 onwards (Fig. 7C). The low levels of Wek in embryos suggest that in the 
embryonic CNS, Toll-6 can bind MyD88 to activate cell survival, but since there is no Wek, it 
cannot activate the dSarm pro-apoptotic pathway. In the pupa, in the presence of Wek, Toll-6 
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can activate either cell survival via MyD88 or cell death via dSarm. Thus, the temporal 
regulation of wek expression explains the different outcomes of Toll-6 function over time. 
To visualise whether the spatial distribution of MyD88 and dSarm may also change, 
we used a dsarmMIMIC-GFP insertion, and MyD88GAL4NP6394 to drive the expression of 
membrane tethered 10xUAS-myr-td-Tomato and anti-DsRed antibodies. Both were widely 
expressed throughout the embryonic CNS neuropile (Fig.4, Fig.5), widespread in larvae 
(Fig.7D), and more restricted in pupae (Fig.7E). In pupae, MyD88>myr-td-Tomato was 
distributed throughout the VNC, but prominently in thoracic interneurons, potentially linked 
to the motor circuitry (Fig. 7E). dsarmMIMIC-GFP was distributed throughout the VNC, but  
prominently in ventral projections, apparently sensory circuits (Fig. 7E). These distinct 
patterns suggest that following cell number regulation, neural circuits acquire a characteristic 
composition of Toll-signalling adaptors. 
 
Mammalian NTs can induce signaling from mammalian TLRs  
To test whether the link between neurotrophins and Toll receptors might also occur in 
mammals, we carried out signaling assays with TLR2 an TLR4, which are cell membrane 
receptors present in the mammalian brain, and TLR5, an intracellular receptor(Gay et al., 
2014). HEK293T cells were transfected with TLR2, 4 and 5, and a NF-κB luciferase reporter, 
and signaling was measured following stimulation with increasing concentrations of mature 
BDNF or NGF (Fig. S5). Whereas there was no effect upon stimulation of TLR2 or TLR5 
with either NGF or BDNF, both ligands induced signaling in cells transfected with TLR4 
(Fig. S5). Furthermore, treatment with NGF or BDNF altered the response of TLR2, -4, -5 to 
stimulation with their canonical innate immunity ligands (Fig.S5). This means that 





DNTs and Tolls regulate cell number plasticity by promoting both cell survival and death in 
the Drosophila CNS, through a three-tier mechanism.  
 In the first tier, each DNT has unique features, conducive to distinctive functions (Fig. 
8A). Spz, DNT1 and DNT2 share with the mammalian NTs the unequivocal structure of the 
CK domain unique to this protein family. However, DNT1, -2 and Spz have distinct pro-
domain features and are processed differently, leading to distinct cellular outcomes (Fig. 8B). 
Spz is only secreted full-length, and cleaved by Serine proteases (Hoffmann and Reichhart, 
2002). DNT1 and -2 are cleaved intracellularly by conserved furins. In cell culture, DNT1 
was predominantly secreted with a truncated pro-domain (pro-DNT1), whereas DNT2 was 
secreted mature. In vivo, both pro- and mature DNTs were produced from neurons. 
Interestingly, DNT1 also has an isoform lacking the CK domain (Zhu et al., 2008) and Spz 
has multiple isoforms with truncated pro-domains (DeLotto et al., 2001). Thus, in vivo, 
whether DNT1 and 2 are secreted full-length or cleaved, and whether Spz is activated, will 
depend on the proteases that each cell type may express. Pro-DNT1 activates apoptotic JNK 
signaling, whereas mature DNT1 and 2 activate the pro-survival NF-κB (Dorsal and Dif) and 
ERK signaling pathways. Mature Spz does not activate ERK. This first tier is evolutionarily 
conserved, as mammalian pro-NTs can promote cell death whereas furin-cleaved mature NTs 
promote cell survival (Lu et al., 2005). NF-B, JNK and ERK are downstream targets shared 
with the mammalian NTs, downstream of p75NTR (NF-B, JNK) and Trks (ERK), to regulate 
neuronal survival and death (Lu et al., 2005; Minichiello, 2009; Roux and Barker, 2002). 
Thus, whether a cell lives or dies will depend on the available proteases, which ligand type, 
and ligand-cleavage product it receives (Fig. 8A). 
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In a second tier, we showed that the specific Toll-family receptor activated by a DNT 
matters (Fig. 8B). Toll-6 and -7 could maintain neuronal survival, whereas Toll-1 had a 
predominant pro-apoptotic effect. Since there are nine Tolls in Drosophila, some Tolls could 
have pro-survival, whereas others pro-apoptotic, functions. Different Tolls also lead to 
different cellular outcomes in immunity and development (McIlroy et al., 2013; Meyer et al., 
2014; Pare et al., 2014; Tauszig et al., 2000; Yagi et al., 2010). Thus, the life or death of a 
neuron will depend on the Toll or combination of Tolls it expresses (Fig. 8B). We also 
showed that binding of Spz to Toll-1 is most likely unique, but DNT1 and 2 bind Toll-6 and -
7 promiscuously, and DNT1 and 2 with Toll-6 and -7 activate NF-B and ERK, whereas pro-
DNT1 activates JNK. This suggests that ligand pro-domains might alter the affinity for Toll 
receptors, and/or facilitate the formation of hetero-dimers between different Tolls, and/or with 
other co-receptors, to induce cell death. A ‘DNT-Toll code’ may regulate neuronal number.  
In a third tier, available downstream adaptors determine the outcome between cell 
survival and death (Fig. 8C). Toll-6 and -7 activate cell survival by binding MyD88 and 
activating NF-B and ERK (whether ERK activation depends on MyD88 is not known), and 
Toll-6 can activate cell death via Wek, dSarm and JNK signaling. We have shown that Toll-6 
binds MyD88 and Wek, which binds dSarm; that dSarm binds MyD88, and promotes 
apoptosis by inhibiting MyD88 and activating JNK. Wek also binds MyD88 and Toll-1 (Chen 
et al., 2006). So, evidence suggests that Wek recruits MyD88 and dSarm downstream of Tolls 
(Fig. 8C). Since Toll-6 binds both MyD88 and Wek, and Wek binds both MyD88 and dSarm, 
Wek functions like a hinge downstream of Toll-6 to facilitate signaling via MyD88 or dSarm, 
resulting in alternative outcomes. Remarkably, adaptor expression profiles change over time, 
switching the response to Toll-6 from cell survival to cell death. In the embryo, when both 
MyD88 and dSarm are abundant, there is virtually no Wek, and Toll-6 can only bind MyD88 
to promote cell survival (Fig.8C). As Wek levels rise, Toll-6 signaling can also induce cell 
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death. If the Wek-Sarm-JNK route prevails, Toll-6 induces apoptosis; if the Wek-MyD88-NF-
κB route prevails, Toll-6 signaling induces cell survival (Fig.8C).  
Thus, the cellular outcome downstream of DNTs and Tolls is context and time 
dependent. Whether a cell survives or dies downstream of DNTs and Tolls will depend on 
which proteases are expressed nearby, which ligand it receives and in which form, which Toll 
or combination of Tolls it expresses, and which adaptors are available for signaling (Fig. 8).  
How adaptor profiles come about or change is not understood. A neuronal type may 
be born with a specific adaptor gene expression profile, or Toll-receptor activation may 
influence their expression. In fact, MyD88 reinforces its own signaling pathway, as Toll-6 
and -7 up-regulate Dorsal, Dif and Cactus protein levels (McIlroy et al., 2013), and TLR 
activation increases Sarm levels (O'Neill and Bowie, 2007). We showed that apoptosis caused 
by MyD88 excess depends on JNK signaling. Since JNK functions downstream of Wek and 
dSarm, this suggests that MyD88 – presumably via NF-κB – can activate the expression of 
JNK, wek or dsarm. By positively regulating wek expression, MyD88 and dSarm could 
establish positive-feedback loops reinforcing their alternative pathways (Fig.8C, bottom). 
Since dSarm inhibits MyD88, mutual regulation between them could drive negative feedback. 
Positive and negative feedback loops underlie pattern formation and structural homeostasis, 
and could regulate neuronal number in the CNS too. Whether cell autonomous or non-
autonomous mechanisms result in the diversification of adaptor profiles, either in time or cell 
type, remains to be investigated. 
Either way, over time the Toll adaptors segregate to distinct neural circuits where they 
exert further functions in the CNS (Fig.8C). Toll-1, -6 and -8 regulate synaptogenesis and 
structural synaptic plasticity (Ballard et al., 2014; Halfon et al., 1995; McLaughlin et al., 
2016). Sarm regulates neurite degeneration, and in the worm, it functions at the synapse to 
determine neuronal identity (Chuang and Bargmann, 2005; Osterloh et al., 2012). The 
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reporters we used revealed a potential segregation of MyD88 to the motor circuit, and dSarm 
to the sensory circuit, but this is unlikely to reflect the endogenous complexity of Toll-
signalling circuitry, as dsarmMIMIC-has a GFP insertion into one of eight potential isoforms 
and dsarm also functions in the motor system (McLaughlin et al., 2016). Importantly, cell 
death in the normal CNS occurs mostly in late embryogenesis and in pupa, coinciding with 
neural circuit formation and remodeling, when neuronal number is actively regulated. Thus, 
the link by DNTs and Tolls from cell number to circuitry offers a complex matrix of possible 
ways to regulate structural plasticity in the CNS.  
We have uncovered remarkable similarities between Drosophila Toll-6 and 
mammalian TLR signalling involving MyD88 and Sarm. All TLRs except TLR3 signal via 
MyD88 and activate NF-κB (Gay and Gangloff, 2007; Gay et al., 2014). Neuronal apoptosis 
downstream of TLRs is independent of NF-κB, and instead depends on TRIF and Sarm1 
(Kaiser and Offermann, 2005; Kim et al., 2007; Ma et al., 2006; Mukherjee et al., 2013). 
Sarm1 is a negative regulator of TLR signaling, an inhibitor of MyD88 and TRIF (Carty et 
al., 2006). sarm1 is expressed in neurons, where it activates JNK and promotes apoptosis 
(Kim et al., 2007; Mukherjee et al., 2013; Osterloh et al., 2012).  However, the endogenous 
ligands for TLRs in the normal, undamaged brain, are not known. Our preliminary analysis 
has revealed the intriguing possibility that NTs either can bind TLRs, or induce interactions 
between Trks, p75NTR and TLRs. It is compelling to find out whether TLRs regulate structural 
plasticity in the mammalian brain in concert with NTs.  
 To conclude, DNTs with Tolls constitute a novel molecular system for structural 
plasticity in the Drosophila CNS. This could be a general mechanism, to be found also in the 
mammalian brain, and in other contexts too, such as epithaelial cell competition and 




MATERIALS AND METHODS   
 
Genetics 
Mutant and reporter stocks 
Control stocks were yw and/or outcrosses of yw, as most transgenic flies were all in a w- 
background. MyD88kra56 is an EMS induced hypomorphic allele(Charatsi et al., 2003) (gift of 
B. Moussian, Tübingen, Germany), wekEX14 is an excision loss of function allele(Chen et al., 
2006) (gift of J.L. Imler, CNRS, Strasbourg). dsarm4705 and dsarm4621 are loss of function 
alleles of dsarm (gift of Marc Freeman, University of Massachusetts) Deficiencies 
Df(2R)BSC279 lacks the MyD88 locus and Df(2L)BSC690 the wek locus, respectively. 
Dorsal-GFP (w1118;PBac{dl-GFP.FLAG}VK00033/TM3, Sb1) and Dif-GFP (w1118;Pbac{Dif-
GFP.FPTB}VK00033), are both GFP exon-trap lines. Ect4MI00854 and sarm are synonyms for 
the same gene, and Ect4MIMICGFP (yw;MiMicECT4[MI08854]) is a MIMIC insertion bearing 
GFP into the Ect4 locus. Stocks were balanced using CyOlacZ and TM6BlacZ to identify 
mutant embryos, or SM6aTM6B balancers carrying Tb- to identify mutant larvae and pupae. 
Double and triple mutants and other stocks were generated by conventional genetics. 
Over-expression in vivo 
GAL4 drivers: (1) w;; elavGAL4 for all neurons; (2) w; GMRGAL4 for the retina (gift of 
Matthew Freeman, University of Oxford);  (3) w; RG-GAL4 drives expression in the ring-
gland and in a single neuron in the optic lobes (our unpublished data); (4) w;MyD88GAL4: 
yw;P{GawB}MyD88NP6394/Cyo, P{UAS-lacZ.UW14}UW14 (Bloomington Stock Centre). 
These were crossed to: (1) the membrane tethered reporter w;; 10xUAS-myr-td-Tomato (gift 
of B. Pfeiffer);  (2) Activated forms of Tolls: w;;UASToll-6CY and w;;UASToll-7CY(McIlroy et 
al., 2013) and UASToll-110b (gift of J.M.Reichhart). (3) w; UAS-MyD88-full-length (gift of J. 
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Kagan);  (4) w; UAS-dsarm (gift of Marc Freeman) drives expression of the dsarm 
cDNA(Osterloh et al., 2012) and w1118;P{EP}EP3610/TM6B,Tb1 drives expression of all Ect4 
(dsarm) isoforms (Bloomington) (Ect4 and sarm are synonyms for the same gene); (5) UAS-
wek-HA; UAScactus-HA (FlyORF). (6) w[11]; UAS JNK RNAi [P(GD10555) (VDRC34138, 
Vienna Drosophila Research Centre); UAS-dsarmRNAi; UAS-MyD88RNAi (VDRC32396). 
 
Structural modeling of DNTs and comparison to mammalian NTs 
DNT1 and DNT2 were modelled on their closest structural homolog Spz using Modeller 
software (Webb and Sali, 2014), which builds ab initio the loops that were not observed 
crystallographically in Spz. The same method was used to complete the 3d model of Spz. The 
structure of the BDNF protomer is known in the context of heterodimerization with either 
NT3 (Robinson et al., 1995) or NT4 (Robinson et al., 1999). We generated a 3d model of the 
BDNF homodimer based on these heterodimers by substituting the neurotrophin with BDNF 
and performing energy minimization in Modeller (Webb and Sali, 2014). Protein sequences 
were analysed by Clustal Omega (Sievers et al., 2011) and Tcoffee (Notredame et al., 2000). 
Figures were generated in PyMol (DeLano Scientific, San Carlos, CA) using the lowest 
energy models with least clashes and best geometry according to Verify3D (Bowie et al., 
1991) and MolProbity (Chen et al., 2010), respectively.  
 
Bioinformatics and sequence analysis 
Analysis of pro-domain: was carried out using PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/), 
a secondary structure prediction programme. 
 
Identification of conserved furin sites  
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Potential furin-cleavage sites in DNT1 and DNT2 were identified by PiTou prediction tool 
(Tian et al., 2012). To test the predicted cleavage sites mutant DNT1 and DNT2 constructs 
were generated by site-directed mutagenesis (see details below). S2 cells were transfected 
with full-length, truncated or mutant forms of DNT1 or DNT2 cloned into pAct5c-3xHA 
expression vector (see details below). After transfection, cells were separated from culture 
media and lysed in NP-40 buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% Igepal CA-
630). HA-tagged proteins in cell lysates and culture media were detected by anti-HA antibody 
using standard Western blots. 
 
Primer design 
Primers were designed using the public resource Primer3Plus 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi). For site-directed 
mutagenesis primers were designed using QuickChange Primer Design on-line tool 
(http://www.genomics.agilent.com/primerDesignProgram.jsp). For qRT-PCR to detect which 




Generation of fusion constructs 
Full-length or truncated cDNAs of DNT1 and DNT2 were cloned into an expression vector 
using a standard Gateway procedure, inserting them first into pDONR and subsequently into 
pAct5c-3xHA to generate the following constructs: pAct5c-DNT1-FL-3xHA; pAct5c-DNT1 
(Sp+CK+CTD)-3xHA; pAct5c-DNT2-FL-3xHA; pAct5c-DNT2 (Sp+CK)-3xHA. Cloning to 
generate HA-tagged dsarm was also carried out using the Gateway system. dsarm cDNA was 
amplified from a  pUAST-dSarm plasmid (gift from Marc Freeman) then subcloned  first into 
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pDONR and subsequently into the destination vector resulting in pAct5c-dsarm-3xHA. UAS 
DNT1-FL-GFP and UAS-DNT2-FL-GFP were tagged at the C-terminus with GFP by cloning: 
DNT1-FL-GFP was cloned into pUASt using conventional ligation and transgenesis; DNT2-
FL-GFP was cloned by Gateway cloning into pUAS-GW-GFP, followed by conventional 
transgenesis, using white as the selection marker. For all primers, see list in Table S2. 
 
Generation of MyD88cr2.8 mutant allele by CRISPR/Cas9 
A MyD88 CRISPR mutant allele was created by designing a guide RNA targeting exon 1 of 
MyD88, using http://crispr.mit.edu/, with primers: MyD88BbSI sense 
gtcgCCGAGGGAGTTATGGACTCC and MyD88 BbSI anti-sense 
aaacGGAGTCCATAACTCCCTCGG, cloned in to the BbsI site of the pCFD3 U6.3 vector 
and verified by sequencing. Transgenic flies bearing U6.3 MyD88 gRNA were generated by 
φC31 transgenesis (injections by BestGene Inc).  Flies bearing the guide RNA (yscv;;U6.3MyD88gRNA attp2/TM3(sb)) were crossed to flies carrying Cas9 driven by the nanos promoter (ym{nosCas9}ZH2A). Independent balanced stocks were stablished from F1 males (w;MyD88CRISPR/CYO), and sequenced. MyD88cr2.8 bears a 7bp deletion that causes a frameshift at amino acid 64, and a premature stop codon at amino acid 94. This corresponds to the start of the Death Domain (DD, amino acids 90-172). This allele lacks the DD and TIR domains and is therefore a null allele. The sequence of the lesion is given below, the guideRNA sequence is given in bold: 
MyD88WT         GTCAGTTATCGGCGTTATCGCACCGCTGGCATGGTGGTGGCCGAGGGAGTTATGGACTCC 
MyD88CR2.8      GTCAGTTATCGGCGTTATCGCACCGCTGGCATGGTGGTGGCCGAGGGAGTTATG------ 
                ******************************************************       
 
MyD88WT         GGGTCGGGATCGGGCACGGGAACGGGCTTGGGGCACTTCAACGAGACCCCATTATCCGCA 
MyD88CR2.8      -GGTCGGGATCGGGCACGGGAACGGGCTTGGGGCACTTCAACGAGACCCCATTATCCGCA 
                 *********************************************************** and the aminoacid sequence: 
MyD88WT         MRPRFVCHQQHSVAHSHYQPHSHFHHHTHRHPNPPHHHHIYGATDVSYRRYRTAGMVVAE 
MyD88CR2.8      MRPRFVCHQQHSVAHSHYQPHSHFHHHTHRHPNPPHHHHIYGATDVSYRRYRTAGMVVAE 
                ************************************************************ 
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MyD88WT         GVMDSGSGSGTGTGL------GHFNETPLSALGIETRTQLSRMLNRKKVLRSEEGYQRDW 
MyD88CR2.8      GVMGRDRARERAWGTSTRPHYPHWASRPAPSCPACSTOP  
 
Reverse transcription-PCR  
RT-PCR was performed to see which Toll receptors are expressed in S2 cells. Total RNA was 
isolated from S2 cells by Trizol (Ambion) reagent following a standard protocol. Reverse 
transcription was carried out by using GoScript system (Promega). Standard PCR reaction 
was performed to amplify Toll receptor cDNA fragments using Taq DNA polymerase 
(Invitrogen). For list of primers see Supplemental Table S2. 
 
Site directed mutagenesis   
One or more point mutations were generated in pAct5c-DNT1-FL-3xHA and pAct5c-DNT2-
FL-3xHA fusion constructs by site-directed mutagenesis according to (Wang and Malcolm, 
1999)). The following mutant expression clones were used for S2 cell transfection: pAct5c-
DNT1-FL-R499G-3xHA; pAct5c-DNT1-FL-R283/499G-3xHA; pAct5c-DNT2-FL-R284G; 
pAct5c-DNT2-FL-R214/221/284G-3xHA. For primers, see Table S2. 
 
Quantitative Real Time PCR (Q-RT-PCR) 
From 2 hour staged egg collections at 25°C, whole dechorionated embryos were harvested 20 
hours after egg laying (AEL), and the CNS was dissected from L2 larvae at 48 hours AEL, L3 
at 96 h AEL, and pupa 0-12 hours after puparium formation (APF), samples were placed 
immediately into TRI reagent (Ambion #AM9738) and frozen at -80°C. Total RNA was 
extracted from 20 embryos or 20 dissected larval or pupal CNS, using TRl and following 
manufactures instructions.  cDNA was synthesized from 200ng of total RNA using the 
GOScript reverse transcription system (Promega #A5001) using random primers, diluted 
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three-fold for qPCR reactions and 2µl used per reaction. ‘No-reverse-transcription’ controls 
were run alongside cDNA reactions. Transcript levels were determined in triplicate for each 
sample using SensiFAST Hi-ROX SYBR GREEN (bioline #BIO-92020) run on an ABI 
Prism 7000 sequence detection system. The reference gene was RpL32, as it remained 
constant over the course of development. Primers used are given in Supplemental Table S1. 
 To obtain fold change values using the 2-∆∆Ct method (Livak and Schmittgen, 2001) 
for the developmental profiles of MyD88, dsarm and wek, the Ct value of Rpl32 was 
subtracted from the Ct value of each gene and developmental time point to obtain ∆Ct. All 
values were then normalized to the calibrator, which for this set of experiments was MyD88 
mRNA at embryo (∆∆Ct). Three independent biological replicates were carried out per 
experiment, and the mean ± standard deviation is provided in Fig. 5b.   
  
Cell culture 
Cell culture, transfection, stimulation and subcellular fractionation 
S2 cells were maintained at 27 °C in InsectXpress medium (Lonza) supplemented with 10% 
heat-inactivated fetal bovine serum and 1% penicillin-streptomycin-glutamine (Gibco). 
TransIT2020 (Mirus) transfection reagent was used to express target proteins in S2 cells. 
To stimulate S2 cells with mature DNT2-CK, S2 cells were transfected with pAct5c-Toll-6-
3xHA or pAct5c-Toll-7-3xHA and were grown over-night in a 6-well plate (2 x 106 cells/well) 
Cells were serum starved for at least 6 hours and then were treated with purified  DNT2-CK 
(50 nM)  for 5-60 minutes.  
To separate nuclear and cytoplasmic fractions, cells were pelleted and washed in ice-
cold PBS at 500g for 5 min at 4°C. The cells were lysed in ice-cold harvest buffer (10 mM 
HEPES pH 7.9, 50 mM NaCl, 0.5 M Sucrose, 0.1 mM EDTA, 0.5% TritonX-100, 1 mM DTT 
supplemented with a protease inhibitor cocktail (Thermo) and 5 mM NaF and 2 mM Na3VO4) 
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for 5 min on ice. Lysate was spun at 800g for 10 min at 4 °C. Supernatant was treated as 
cytoplasmic/membrane and pellet was treated as nuclear fraction. Cytoplasmic/membrane 
fraction was transferred in an empty tube and subsequently purified by centrifugation at 
14.000g for 10 min at 4°C. Nuclei pellet was re-suspended in buffer A (10 mM HEPES pH 
7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT supplemented with protease 
inhibitor cocktail and 5 mM NaF and 2 mM Na3VO4) and spun at 800g for 10 min at 4 °C. 
Supernatant was discarded and the pellet was re-suspended in buffer C (10 mM HEPES pH 
7.9, 500 mM NaCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.1% NP-40, 1mM DTT supplemented 
with a protease inhibitor cocktail and 5 mM NaF and 2 mM Na3VO4) and incubated on ice for 
30 min. Nuclear fraction was purified by centrifugation at 14.000 g for 10 min at 4 °C. 
To analyse total cell lysate S2 cells were pelleted and washed in ice-cold PBS then 
lysed in RIPA buffer (10 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% TritonX-
100, 0.1% SDS, 0.1% Na-deoxycholate supplemented with a protease inhibitor cocktail and 5 
mM NaF and 2 mM Na3VO4). Total cell lysate or subcellular fractions were analysed by 
SDS-PAGE followed by Western blot using standard procedures.  
 
Co-Immunoprecipitations from co-transfected S2 cells  
Co-immunoprecipitations from S2 cells were carried out as previously(McIlroy et al., 2013). 
S2 cells were transfected with the following combinations of plasmids: (1) pAct5c-Toll-6-
3xHA and pAct5c- Pro-TEV6HisV5-DNT1-CK-CTD; pAct5c-Toll-7-3xHA and pAct5c-Pro-
TEV6HisV5-DNT2-CK; (2) pAct5c-MyD88-V5 and pAct5c-Toll-6-3xFLAG or pAct5c-Toll-
6CY-3xFLAG or pAct5c-Toll-7-3xFLAG or pAct5c-Toll-7CY-3xFLAG; (3) pAct5c- dsarm-3xHA 
and pAct5c-MyD88-V5; pAct5c- dsarm-3xHA and pAct5c-Toll-6CY-3xFLAG or pAct5c-Toll-
7CY-3xFLAG; ; (4) pAct5c-Wek-3xHA and pAct5c-Toll6CY-3xFLAG or pAct5c-dsarm-
3xFLAG. pAct5c-MyD88-V5 plasmid was a gift of S. Wasserman; .pAct5c-Wek-3xHA was a 
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gift from J.L.Imler. Cells were collected 48h after transfection and lysed in NP-40 buffer or in 
FLAG affinity chromatography (FAC) buffer (50 mM HEPES pH:7.5, 80 mM KCl, 5 mM 
MgCl2, 2 mM EGTA, 0.2% TritonX-100) supplemented with protease inhibitor cocktail. 
Immunoprecipitations from lysates were carried out using mouse anti-V5 antibody in 
combination with protein-A/G magnetic beads (Thermo) or anti-FLAG antibody-conjugated 
agarose or magnetic beads (Sigma).  Proteins were analysed by SDS-PAGE and western 
blotting, as described below. 
 
Luciferase Reporter Assay in mammalian cells 
HEK293 cells were seeded at 1 x 105cells/well in a 96-well plate 36 h prior to transfection 
with jetPEI (Polyplus). NF-κB-dependent gene expression was determined using a luciferase 
reporter construct concomitantly with indicated TLR vectors. The Renilla luciferase-
thymidine kinase encoding plasmid (pRL-TK) was used to normalize for transfection 
efficiency, and pcDNA3.1 empty vector was used to maintain constant DNA.  Cells were 
stimulated in a dose-dependent manner using neurotrophic agents: hNGF-β (H9666, Sigma), 
hBDNF (R&D Systems) or mNGF-7S (N0513, Sigma). Transfected cells were lysed using 
Passive lysis buffer (Promega) and assayed for luciferase and Renilla activity using luciferase 
assay reagent (Promega). Luminescence readings were corrected for Renilla activity and 
expressed as fold increase over unstimulated control values. Data is presented as mean +/- 
SEM of one of three independent experiments. Statistical analysis was performed using Two-
Way ANOVA where we compared TLR signaling upon stimulation with varying 





In vivo immunostainings in larval and pupal CNS 
Dissections, fixations and immunostainings were carried out following standard procedures, 
except that for stainings to detect apoptosis in the pupal CNS only pupae within the first 10 
minutes of puparium formation were used, to minimize biological variability in apoptosis 
levels over time. Primary antibodies used were:  rabbit anti-GFP (1:500 in larvae and pupae, 
1:1000 in embryos, Invitrogen #A11122), rabbit anti-DsRed (1:100, Clontech #632496), 
rabbit anti-βgal (1:5000, Cappel), mouse anti-Eve (1:5-1:10, DSHB 2B8), Mouse anti-Eve 
(1:20, DSHB 3C10), mouse anti-pERK (1:500 in retina and 1:100 in optic lobe, Cell 
Signaling #9106); mouse anti-Repo (1:250, DSHB 8D12); rabbit anti-pJNK (1:200, Promega 
V7931); rabbit anti-Myd88 (1:250)(gift of Steve Wasserman); rabbit anti-Dcp1 (cleaved 
Drosophila Dcp-1 (Asp216), 1:500 Cell Signaling 9578S). Secondary antibodies were 
directly conjugated Alexa488, 546 and 647 (1:250, Molecular Probes) or biotinylated mouse 
or rabbit (1:300) followed by avidin amplification using the Vectastain ABC Elite kit (Vector 
Labs) or the Tyramide Signal Amplification kit (Life Technologies T20922), using 
manufacturers instructions. For sample sizes see Supplemental Table S2.  
 
Western blots  
Western blotting was carried out following standard procedures. Primary antibodies used 
were: mouse anti-V5 (1:5000, Invitrogen, #R960-25), rabbit anti-FLAG (1:2000, Sigma, 
#F7425); mouse anti-Histone-H1 (1:10000,Upstate, #05-629); mouse anti-Tubulin (1:10000, 
Sigma, #T9026); chicken anti-HA (1:2000 and 1:5000, Aves, #ET-HA100), mouse anti-HA 
(12CA5)(1:2000, Roche, #11 583 816 001); mouse anti-Dorsal (7A4) (1:500, Hybridoma 
Bank), mouse anti-Cactus (3H12) (1:500, Hybridoma Bank), rabbit anti-Dif (1:500)(gift from 
D. Ferrandon). Secondary antibodies used were: anti-mouse HRP (1:5000, Vector Labs, #PI-
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2000), anti-rabbit HRP (1:5000, Vector Labs, #PI-1000), anti-chicken HRP (1:10000, Jackson 
ImmunoResearch, #703-035-155).  
 
Microscopy and imaging 
Imaging 
For microscopy, samples were mounted either in 70% Glycerol 30% PBTriton (larval and 
pupal fluorescent CNS, and non-fluorescent embryos) or in Vectashield (H-1000, Vector 
Labs; fluorescent embryonic CNS), Wide-field microscopy was carried out in a Zeiss 
Axioplan 2 microscope and 63x objective; images were taken under Nomarski optics with an 
AxioCam colour camera, and Zen Zeiss software. Fluorescent microscopy was carried out 
using secondary antibodies directly conjugated to Alexa 488, Alexa 546 and Alexa 647 
(Molecular Probes). Laser-scanning confocal microscopy was carried out at room temperature 
using a Leica SP2-AOBS and a 40x or 63x lens at 512x512 or 1024x1024 pixels resolution, 
with 0.5 or 1 µm steps, and a Zeiss LSM 710 with 25x (oil) lens at 512x512 pixels resolution, 
with 1µm steps. Confocal image acquisition was carried out with Leica or Zeiss software, as 
per system. Each confocal stack comprised 100-300 images, which were processed as 
follows: (1) for image data, using Image J, to view the entire stacks of images, carry out 
horizontal and transverse projections, and rotate images; occasionally, a median or ‘dust & 
scratches’ filter was applied to a projection image, over the whole image. Adobe Photoshop 
was used to adjust levels, rotate and crop image and adjust image size to 300d.p.i. Adobe 
Illustrator was used to compile figure plates. (2) For quantitative data (e.g. number of Dcp1+ 
or Eve+ or YFP+ cells), we used the image-J plugins DeadEasy Larval Glia (which counts 
nuclear stains) and DeadEasy Caspase for Larvae (for apoptotic cells), as previously 
described and validated (Forero et al., 2012; Forero et al., 2009; Kato et al., 2011). DeadEeasy 
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analyses the entire stacks of images in 3D and identifies cells based on pixel intensity and 3D 
volume, and counts cells automatically in an entire CNS in 3D in less then a minute. 
 
Quantitative data analysis 
Penetrance is the frequency with which a phenotype is manifested within a population; 
expressivity the severity of the phenotype. Eve+ cells in embryos analysed under wide-field 
Nomarski optics were counted manually under an Axioplan 2 microscope and a 63x objective. 
Fluorescent pJNK+ cells in the retina were counted manually within the stacks of confocal 
sections, using ImageJ and the Cell Counter macro. 
Dcp1+ apoptotic apoptotic cells from the entire VNC of the CNS were counted 
automatically using DeadEasy Caspase for Larvae (see above)(Forero et al., 2009), specific 
for apoptotic cells and optimized for the larval/pupal CNS (Kato et al., 2011). The entire 
VNC was counted, using the edges of the optic lobes as anterior boundaries. Eve+ in the 
larval CNS were counted automatically with DeadEasy Larval Glia software, which counts 
nuclear stains (see above)(Forero et al., 2012). For Eve+ cell counting, the thoracic (T1-T3) 
and posterior tip cells were excluded as cells there are too packed together, and only the cells 
from abdominal segments A1-A6 were counted. 
Quantification of pixel intensity was carried out with ImageJ, setting a fixed Regions 
of Interest over the area posterior to the morphogenetic furrow or over the morphogenetic 
furrow, and the mean intensity in this area was normalized over the mean intensity of a fixed 
region of interest over the eye disc, anterior to the morphogenetic furrow. 
 
Statistical analysis 
Statistical analyses were carried out using SPSS and GraphPad Prism. Continuous data – e.g. 
number of Dcp1+, pJNK+ and Eve+ cells – were analysed first for normality, using curve 
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shape or kurtosis and skewness, and testing the homogeneity of variance with a Levene’s test. 
If the Levene’s test was not significant, One Way ANOVA was used, and Welch ANOVA if 
samples did not pass the Levene’s test. Multiple genotypes were compared to a single control 
with post-hoc Dunnett, or compared to each other using Bonferroni, multiple comparison 
corrections tests. For TLR signaling, data were analysed using Two-Way ANOVA, and 
Dunnett post-hoc tests for multiple comparisons to NT=0 controls. For genetic experiments, 
reproducibility was confirmed by the overall large population sizes and consistent results in 
multiple repetitions of the experiments; for cell culture data, Q-RT-PCR and co-
immunoprecipitations, the experiments were carried out at least three times. All p values, tests 
and sample sizes are provided in figure legends and further details in Supplemental Table S1.  
 
Supplemental Material includes: five figures (Supplemental Fig.S1-S5), Table S1 with all 
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FIGURE LEGENDS 
Fig. 1 Structural models of DNTs compared to Spz and mammalian NTs. (A-D) Crystal 
structures and homology models of mammalian NTs and DNTs compared in the same 
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orientation relative to the CK. Representations in: (A,B,D) cartoon; (B’, D’) molecular 
surface color-coded by protomer; (B’’, D’’) surface charge distribution with a gradient from 
red to white to blue, corresponding to electronegative to neutral to positively charged 
molecular surfaces. Mammalian NTs (A, B: BDNF, D: NGF) and DNTs (B, D) have 
conserved CK but deviating beta-hairpin wings. Compare Spz and NGF (A, D), and DNT2 
(green and grey) with BDNF (magenta and grey) in ribbon representation (C). (E) Spz 
residues mediating Toll-1 binding are not conserved among DNTs. Clustal annotation is * for 
identity, : for increased similarity).  In Red: Spz residues from the proximal Spz chain 
interfacing with Toll-1; in yellow: from the distal Spz chain; blue triangles: conserved areas. 
Of 33 Toll-contact residues in Spz, only 11 are conserved in DNT1 and 2, with a single 
identical residue Tyr64 in Spz.  
 
Fig. 2 DNT1 and -2 are cleaved by conserved furin proteases. (A) The pro-domain 
α−helix of Spz (box) required to activate Toll-1 is not conserved in DNT1 and 2, yellow 
highlight: corresponding sequences are not conserved. (B) The pro-domains of DNT1 and 2 
but not Spz have conserved furin sites. (C) Site directed mutagenesis of furin sequences. (D) 
Mutant DNT1-FL-HA and DNT2-FL-HA forms, expressed in S2 cells and visualized in 
western blot with anti-HA from lysate and secreted medium. FL: full length; CK: cystine-
knot; CTD: C-terminal domain; black arrowheads: normal forms; red arrows, mutant 
products. (E) Anti-GFP western blot upon over-expression of C-terminus-tagged DNTs in the 
retina with GMRGAL4 shows that furin cleavage occurs in vivo. 
 
Fig. 3 DNTs and Tolls activate pro-apoptotic and pro-survival pathways.  (A) Over-
expression of DNTs in larval retina with GMRGAL4 altered pJNK activation. Box-plot graph: 
One-Way Anova p<0.001, *Dunnett post-hoc. (B) Stimulation of S2 cells with purified 
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DNT2-CK induced Dorsal phosphorylation. (C) Stimulation of S2 cells with DNT2-CK 
provoked the degradation of the cytoplasmic inhibitor Cactus, and the nuclear translocation of 
Dif and Dorsal, particularly in Toll-6 or -7 transfected cells. (D) Over-expression of DNT1-
CK-CTD and DNT2-CK, but not DNT1-FL or spz-CK, activated ERK in RGGAL4 neurons of 
the larval optic lobe, n=5-11. (E) Over-expression of activated Toll-6CY and -7CY in the retina 
increased pERK, GMRGAL4>TORDER  is a positive control. Bar chart, error bars: standard 
devisation (s.d.), One-Way ANOVA p<0.0001, *Dunnett post-hoc, n=8-13. (F) Distinct effect 
of loss and gain of function for Tolls in Eve+ neuron number in larvae. Box-plots: Left: One 
Way Anova p<0.0001, *post-hoc Dunnett; Right: One Way ANOVA p<0.0001, *post-hoc 
Dunnett, n=5-22. (G) Different ligand forms and Toll receptors can induce either cell survival 
or death. For genotypes, statistical details and sample sizes, see Table S1. **p<0.01, 
***p<0.001. .> means GAL4/UAS. Scale bar: 50µm. 
 
Fig. 4  Toll-6 promotes cell survival via MyD88. (A) Co-immunoprecipitations showing 
that MyD88-V5 binds Toll-6Flag and Toll-7Flag, and activated Toll-6CYFlag and Toll-
7CYFlag. IB: immuno-blot; IP: immuno-precipitation. (B) Anti-MyD88, and exon trap 
reporters Dorsal-GFP and Dif-GFP visualized with anti-GFP, are distributed throughout the 
embryonic CNS neuropile. Left: Horizontal views; right: transverse sections. (C) Loss of 
Eve+ neurons (arrows) in the CNS in MyD88kra56Toll7P8Toll-626 triple mutant embryos. For 
quantification see Fig.S4. (D) Altering MyD88 signalling affects Eve+ neuron number.  Box-
plots: Larvae: One Way ANOVA p<0.001; *post-hoc Dunnett; Pupae: Welch ANOVA 
p<0.01, *post-hoc Dunnett, n=8-12. (E) Apoptotic cells visualized with anti-Dcp1 in white-
pupal VNCs and counted automatically with DeadEasy software. Box-plot: Welch ANOVA 
p<0.001, *Dunnett post-hoc. *p<0.05, **p<0.01, ***p<0.001, n=5-16. For statistical details, 
see Table S1. > means GAL4/UAS. Scale bar: (B,C) 100µm; (D,E) 50µm. 
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Fig. 5 dSarm antagonizes MyD88 and promotes apoptosis downstream of Toll-6. (A) 
Apoptotic cells visualized with anti-Dcp1 in pupal VNCs, and quantified with DeadEasy. 
Box-plots: Left: Welch ANOVA p<0.0001; *Bonferroni post-hoc. Right: One Way ANOVA 
p<0.0001, *post-hoc Tukey, n=9-16 (B) Eve+ neuron number in the abdominal VNC of L3 
larvae is regulated by dSarm. Box-plot: One Way ANOVA p<0.0001, *post-hoc Dunnett, 
n=9-12. (C) Anti-GFP in dsarmMI08854GFP is distributed throughout the embryonic CNS 
neuropile. (D) Loss and gain of dsarm function affects Eve+ neuron number in embryos. For 
quantification see Fig.S4. (E) dSarm can activate JNK signaling, seen with anti-pJNK, in the 
larval retina. Box-plot: One-Way ANOVA p<0.001, *Dunnett post-hoc, n=4-18.  (F) Co-
immunoprecipitation from S2 cells showing that dSarm binds MyD88, but does not bind Toll-
6 or -7. IB: immuno-blot; IP: immuno-precipitation. (G) dSarm inhibits MyD88 and activates 
JNK, promoting apoptosis. **p<0.01, ***p<0.001 See Table S1. >: GAL4/UAS. Scale bar: 
(A, C,E) 50µm; (B) 100µm. 
 
Fig. 6 Wek mediates the pro-apototic function of Toll-6 upstream of dSarm. (A) 
Apoptotic cells in the white-pupal VNC visualized with anti-Dcp1 and quantified with 
DeadEasy. Box-plot: Welch ANOVA p<0.001, *Bonferroni post-hoc, n=8-16. (B) Over-
expression of wek in all neurons with elavGAL4 caused loss of Eve+ neurons in embryos 
(quantification in Fig. S4), and (C) in pupae. Box-plot: One Way ANOVA p<0.001, *post-
hoc Dunnett, n=5-13. (D) Co-immunoprecipitation from S2 cells showing that Wek binds 
Toll-6 and dSarm. IB: immuno-blot; IP: immuno-precipitation. (E) Wek recruits dSarm and 




Fig. 7 Adaptors matter and change in space and time. (A) Over-expression of wek or 
dsarm (EP3610) with MyD88GAL4 decreased Eve+ neuron number in pupal VNCs. Box-
plot: One Way ANOVA p<0.001, *post-hoc Dunnett, n=6-9. (B) MyD88-expressing cells 
visualized with MyD88GAL4NP6394 and nuclear Histone-YFP are lost in pupae by altering 
levels of adaptors. Box-plot: Welch ANOVA p<0.001, *Bonferroni post-hoc, n=5-9. (C) 
qRT-PCR showing temporal profile of mRNA levels for MyD88, dsarm and wek, from whole 
embryos, L2 and L3 larval CNS and pupal CNS, normalized to MyD88 mRNA in embryos 
(three biological replicates, mean ± standard deviation). (D,E) Expression of MyD88 
visualized with MyD88NP6394GAL4>20xUASmyr-td-tomato and anti-DsRed, and of dsarm 
visualized with Ect4MI08854GFP and anti-GFP, in the VNC of L3 larvae and pupae. Horizontal 
views, transverse views on the right for each. **p<0.01, ***p<0.001. See Table S1. >: 
GAL4/UAS. Scale bar: 50µm. 
 
Fig. 8 Three-tier regulation of cell number plasticity by DNTs and Tolls. (A) Tier 1: 
Different ligand forms result from cleavage by furin proteases, and isoforms, and can lead to 
different cellular outcomes. Pro: pro-domain; CK: Cystine-knot domain; CTD: C-terminal 
domain. (B) Tier 2: Different Tolls can lead to different outcomes. (C) Tier 3: different 
adaptors downstream of Tolls drive alternative cellular outcomes. Adaptor expression 
changes in time and space. In embryos, Wek levels are low, and dSarm and MyD88 have 
independent functions. As Wek levels rise, it recruits dSarm and MyD88, and dSarm inhibits 
MyD88. Toll-6 promotes cell survival via MyD88 in the embryonic CNS, and with Wek it 
can also induce apoptosis in pupa. Surviving cells segregate into potentially overlapping but 
distinct neural circuits. 
 
Fig. S1 Structural analysis of the pro-domains of Spz, DNT1 and DNT2 reveals 
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unique features in each ligand. Pink barrels indicate α-helices, orange arrows β-strands, 
lines coils, and yellow sequence highlight indicate the putative sequence that might 
correspond to the Spz α-helix in yellow involved in the activation of Toll-1. This helix is 
absent in DNT1 and -2 suggesting that their mechanism for receptor activation differs from 
that of Spz and Toll-1. 
 
Fig. S2 S2 cells express Toll-1, -2, -5, -7 and -8. (A) Western blot showing the purity 
of subcellular fractionation samples for Fig.3C: anti-tubulin is restricted to the 
cytoplamisc/membrane (C/M) fraction, and anti-Histone-1 is enriched in the nuclear fraction 
(N). (B) Reverse transcription Ploymerase Chain Reaction (RT-PCR) from S2 cells, using 
primers to each of the Tolls, showing the presence of bands corresponding to expected 
product sizes, which are indicated on the left. The experiment was repeated in two 
consecutive passages of S2 cells, shown here as top and bottom gels. GAPDH was used as a 
house keeping control. Negative control reactions were performed in the absence of reverse 
transcriptase. S2 cells express Toll-1, Toll-2, Toll-5, Toll-7 and Toll-8, but not Toll-6. 
 
Fig. S3 DNT1 and 2 bind Toll-6 and -7 promiscuously. Co-immunoprecipitations 
from S2 cells co-transfected with Toll-6HA or Toll-7HA, and DNT1-CK-CTD-V5 or DNT2-
CK-V5, respectively. First three panels are controls. On the right: precipitating the ligands 
with anti-V5 brings down the receptors detected in western blot with anti-HA. Mock: no 
stransfection; CK: cystine-knot; CTD: caroxy-terminal domain; IP: immunoprecipitation; 
WB: western blot. 
 
Fig. S4 Penetrance of Eve+ neuron number phenotypes in the embryonic CNS. 
(A-E) Percentage bar charts showing phenotypic penetrance of decrease in Eve+ neuron 
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number. (A) Dorsal aCC, pCC, RP2 Eve+ neurons are lost most prominently in MyD88 Toll-7 
Toll-6 triple mutants. Chi Square p<0.0001, Bonferroni multiple comparisons correction 
***p<0.001, n=52-170. (B) Loss of dorsal aCC, pCC, RP2 Eve+ neurons in dsarm mutants. 
Chi Square p=0.0002, Bonferroni multiple comparisons correction ***p<0.001, n=41-170. 
(C) Loss of EL+U/CQ Eve+ neurons in MyD88, Toll-7 and Toll-7 loss of function mutants, 
double and triple mutants. Chi square all together p=0.0002, Bonferroni multiple comparisons 
correction ***p<0.001, n=28-119. (D) Eve+ ELs and U/CQs are lost in embryos over-
expressing sarm in all neurons, and in dsarmc705/dsarm4621 mutants. Chi square all together: 
p<0.0001; post-hoc Fisher’s Exact test and Bonferroni correction: **p<0.001; ***p<0.001, 
n=33-106. (E) ELs and U/CQs are lost in embryos over-expressing wek in all neurons. 
Fisher’s Exact test ***p<0.001, n=106, 269. (F-G) Phenotypic penetrance of increase in the 
number of Eve+ neurons. (F) The number of dorsal Eve+ neurons aCC, pCC and RP2 
increases in dsarm mutant embryos. Chi square *p<0.05, n=41, 170. (G) The number of 
EL+U/CQ Eve+ neurons increases in dsarm mutant embryos. Fisher’s Exact test **p<0.01, 
n=16, 91. For statistical details, p values and sample sizes, see Table S1. 
 
Fig. S5 Mammalian NTs elicit signaling from TLR4 and alter the response of 
several TLRs to their canonical immunity ligands. HEK293T cells transfected with TLR2, 
4 and 5, stimulated with varying concentrations of purified NGF and BDNF cysknot dimmers, 
and their canonical ligands, activated or modulated a luciferase reporter NF-B signaling 
readout. NGF and BDNF induced signaling from TLR4 but not TLR2 or 5. Two-Way 
ANOVA: for TLR4 BDNF: p<0.0001; for TLR4 NGF: p<0.0001. Dunnett post-hoc multiple 
comparison corrections to NT=0 controls, three repeats per experiment. NGF and BDNF 
altered the response of TLR4, TLR2 and 5 to their canonical ligands involved in innate 
immunity. This suggests either that BDNF and NGF compete with the canonical ligands to 
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activate TLRs, or they bind other receptors that then modify signaling by TLRs. Two-Way 
ANOVA p<0.0001. Dunnett post-hoc multiple comparison corrections to NT=0 controls, 
three repeats per experiment. *p<0.05; **p<0.01; ***p<0.001. All data are from three 
replicates. For statistical details and sample sizes, see Table S1. 
 








